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I 
RESUM 
TITOL:  
 
Estudi estructura-funció sobre la monoubicuitinació de Rpn10. 
 
 
RESUM: 
 
L’homeòstasi cel·lular depèn, en part, de la proteòlisi regulada pel sistema 
Ubicuitina-Proteasoma (UPS). Aquesta proteòlisi inclou la degradació de les 
proteïnes defectuoses o innecessàries per la cèl·lula i consta de dues etapes. En 
un primer pas, molècules d’ubicuitina s’uneixen covalentment a un grup amino (ε-
NH2) d’alguna lisina del substrat diana. 
 Aquest procés depèn de l’activitat enzimàtica de tres enzims, E1, E2 i E3. 
Tot seguit, el proteasoma s’encarrega de la seva degradació. El proteasoma és un 
complex multiproteic en forma de túnel de 2,5 MDa present en el nucli i el 
citoplasma de totes les cèl·lules eucariotes i Archaebacteria.  
La senyal típica de degradació és una cadena d’ubicuitines que es forma a través 
d’enllaços isopeptídics entre la glicina G76 a la part C-terminal de la molècula i la 
lisina K48 de la següent ubicuitina.  
 
Avui dia, s’han descrit tres receptors proteasomals de substrats poliubicuitinats, 
Rpn10, Rpn13 i Rpn15. La subunitat Rpn10 (Rpn10 en llevat de gemmació i S5a 
en humans), que també es troba en fraccions citosòliques, s’uneix a les cadenes 
de poliubicuitina mitjançant el domini UIM (Ubiquitin-interacting motif). Aquest 
domini és essencial per l’ubicuitinació del propi receptor. Els enzims involucrats en 
tal modificació són Uba1 (E1), Ubc4 (E2) i Rsp5 (E3). La poliubicuitinació de 
Rpn10 depèn de la participació d’una quarta ubicuitina lligasa, Hul5, i comporta la 
seva degradació proteasomal. Alhora, s’ha vist que una fracció de Rpn10 està 
conjugada a una sola molècula d’ubicuitina. Aquest tipus de modificació post-
traduccional s’anomena monoubicuitinació. Quan Rpn10 està monoubicuitinat, 
deixa d’interaccionar amb substrats poliubicuitinats, afectant l’activitat proteolítica 
del proteasoma.  
Resum 
II 
Desxifrar els mecanismes pels quals Rpn10 es monoubicuitina ha estat l’objectiu 
d’aquesta tesi. La hipòtesi inicial és que la proteïna monoubicuitinada pateix un 
plegament provocat per l’interacció entre l’ubicuitina unida a Rpn10 i l’UIM. Aquest 
plegament bloquejaria l’UIM i no permetria l’addició de noves ubicuitines per part 
de la lligasa Rsp5. Per intentar validar la hipòtesi, hem començat optimitzant la 
reacció de monoubicuitinació de Rpn10 in vitro i hem trobat la seqüència mínima 
indispensable per obtenir tal monoubicuitinació. Hem observat que la meitat N-
terminal de Rsp5, és dispensable per l’ubicuitinació de Rpn10 i hem vist que 
l’augment de la monoubicuitinació de Rpn10 causa un defecte en el creixement de 
les cèl·lules. Finalment, hem aconseguit poliubicuitinar Rpn10 in vitro, sense la 
participació de Hul5, mitjançant una mutació en bloc de la seqüència precedent 
l’UIM. Hem vist que aquesta seqüència està intrínsecament desestructurada i que 
la seva flexibilitat podria ser la raó per la qual l’UIM quedés inaccessible quan 
Rpn10 està monoubicuitinat. 
 
Un coneixement en profunditat del sistema ubicuitina-proteasoma és fonamental 
per trobar la cura de les patologies humanes derivades de seu mal funcionament. 
La feina que fem al nostre laboratori és la base per a que en un futur malalties que 
semblen estar relacionades amb l’UPS -malalties autoinmunes, neurològiques, 
càncer, cardiopaties...- tinguin un millor tractament. 
 
 
PARAULES CLAU: 
 
Monoubicuitinació, Rpn10, proteasoma, Rsp5, ubicuitina, proteïna 
desordenada.  
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RESUMEN 
 
TÍTULO:  
 
Estudio estructura-función sobre la monoubicuitinación de Rpn10. 
 
RESUMEN: 
 
La homeostasis celular depende, en parte, de la proteólisis regulada por el 
sistema Ubicuitina-Proteasoma (UPS). Esta proteólisis incluye la degradación de 
las proteínas defectuosas o innecesarias para la célula y consta de dos etapas. En 
un primer paso, moléculas de ubicuitina se unen covalentemente al grupo amino 
(ε-NH2) de alguna lisina del sustrato diana. Este proceso depende de la actividad 
enzimática de tres enzimas, E1, E2 y E3. Acto seguido, el proteasoma se encarga 
de su degradación. El proteasoma es un complejo multiproteico en forma de túnel 
de 2,5 MDa presente en el núcleo y el citoplasma de todas las células eucariotas y 
Archaebacteria.  
La señal típica de degradación es una cadena de ubicuitinas que se forma a través 
de enlaces isopeptídicos entre la glicina G76 en la parte C-terminal de la molécula 
y la lisina K48 de la siguiente ubicuitina.  
 
Hoy día, se han descrito tres receptores proteasomales de sustratos 
poliubicuitinados, Rpn10, Rpn13 y Rpn15. La subunidad Rpn10 (Rpn10 en 
levadura de gemación y S5a en humanos), que también se encuentra en las 
fracciones citosólicas, se une a las cadenas de poliubicuitina mediante el dominio 
UIM (Ubiquitin-interacting motif). Este dominio es esencial para la ubicuitinación del 
propio receptor. Las enzimas involucradas en tal modificación son Uba1 (E1), Ubc4 
(E2) y Rsp5 (E3). La poliubicuitinación de Rpn10 depende de la participación de 
una cuarta ubicuitina ligasa, Hul5, y conlleva su degradación proteasomal. 
Asimismo, se ha visto que una fracción de Rpn10 está conjugada a una única 
molécula de ubicuitina. Este tipo de modificación post-traduccional se llama 
monoubicuitinación. Cuando Rpn10 está monoubicuitinada, deja de interaccionar 
con sustratos poliubicuitinados, afectando la actividad proteolítica del proteasoma.  
Resumen 
IV 
Descifrar los mecanismos por los cuales Rpn10 se monoubicuitina ha sido el 
objetivo de esta tesis. La hipótesis inicial es que la proteína monoubicuitinada sufre 
un plegamiento provocado por la interacción entre la ubicuitina unida a Rpn10 y el 
UIM. Este plegamiento bloquearía el UIM y no permitiría la adición de nuevas 
ubicuitinas por parte de la ligasa Rsp5. Para intentar validar la hipótesis, hemos 
empezado optimizando la reacción de monoubicuitinación de Rpn10 in vitro y 
hemos encontrado la secuencia mínima indispensable para obtener tal 
monoubicuitinación. Hemos observado que la mitad N-terminal de Rsp5 es 
dispensable para la ubicuitinación de Rpn10 y hemos visto que el aumento de la 
monoubicuitinación de Rpn10 causa un defecto en el crecimiento de las células. 
Finalmente, hemos conseguido poliubicuitinar Rpn10 in vitro, sin la participación de 
Hul5, mediante una mutación en bloc de la secuencia que precede al UIM. Hemos 
visto que esta secuencia está intrínsecamente desestructurada y que su flexibilidad 
podría ser la razón por la que el UIM quedaría inaccesible cuando Rpn10 está 
monoubicuitinada. 
 
Un conocimiento en profundidad del sistema ubicuitina-proteasoma es fundamental 
para encontrar la cura de las patologías humanas derivadas de su mal 
funcionamiento. El trabajo que hacemos en nuestro laboratorio es la base para que 
en un futuro enfermedades que parecen estar relacionadas con el UPS -
enfermedades autoinmunes, neurológicas, cáncer, cardiopatías...- tengan un mejor 
tratamiento. 
 
 
PALABRAS CLAVE: 
 
Monoubicuitinación, Rpn10, proteasoma, Rsp5, ubicuitina, proteína desordena 
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SUMMARY 
 
 
 
TITLE:  
 
Structure-function study on Rpn10 monoubiquitination. 
 
 
SUMMARY: 
 
Cellular homeostasis depends, partially, on the proteolysis regulated by the 
Ubiquitin-Proteasome System (UPS). This proteolysis includes the degradation of 
misfolded, damaged or unnecessary proteins for the cell and comprises two 
phases. In the first stage, molecules of Ubiquitin are attached covalently to a target 
substrate at the amide group (ε-NH2) of some lysine residues. This process 
depends on the enzymatic activity of three enzymes, E1, E2 and E3. Afterwards, 
the proteasome takes care of the degradation of the substrate. The proteasome is 
a barrel-shaped multiprotein complex of 2,5 MDa present in the nucleus and 
cytosol of eukaryotic and Archaebacteria cells. The canonical degradation signal is 
a chain of ubiquitins, which is built via isopeptide bonds between the glycine G76 at 
the C-terminus of the molecule and lysine K48 of the next Ubiquitin.  
 
So far, three Ubiquitin proteasomal receptors, Rpn10, Rpn13 and Rpn15, have 
been described. The Rpn10 subunit that can also be found in an extraproteasomal 
pool, binds Ubiquitin chains by means of the Ubiquitin-binding motif (UIM). This 
domain is also essential for the ubiquitination of Rpn10 itself. The enzymes 
involved in this modification are Uba1 (E1), Ubc4 (E2) and Rsp5 (E3). Rpn10 
polyubiquitination requires an additional Ubiquitin ligase, Hul5, and promotes 
Rpn10 degradation. However, a fraction of Rpn10 has been shown to be 
conjugated to only one Ubiquitin molecule, a type of post-translational modification 
that is called monoubiquitination. When Rpn10 is monoubiquitinated, its capacity to 
bind polyubiquitinated substrates is impaired, affecting the catalytic activity of the 
proteasome.  
The goal of this thesis is to decipher the mechanisms by which Rpn10 is 
monoubiquitinated. The initial hypothesis was that the monoubiquitinated protein 
Summary 
VI 
undergoes a change in its conformation caused by the interaction between the 
Ubiquitin bound to Rpn10 and the UIM. This change would block the UIM and 
would not allow the conjugation of new ubiquitins by the ligase Rsp5. To validate 
the hypothesis, we started by optimizing the reaction of monoubiquitination of 
Rpn10 in vitro and we have determined the minimal sequence of Rpn10 required 
for this ubiquitination. We have shown that the N-terminus of Rsp5 is not essential 
for Rpn10 ubiquitination and observed that an increase in the levels of 
monoubiquitinated Rpn10 causes a slow-growth defect. Finally, we have been able 
to polyubiquitinate Rpn10 in vitro, independently of Hul5, via a mutation en bloc of 
the sequence that precedes the UIM. We have seen that this sequence is 
intrinsically unstructured and that its flexibility could be the reason why the UIM 
could be blocked when Rpn10 is monoubiquitinated. 
 
A detailed knowledge of the Ubiquitin-Proteasome System is essential to find the 
cure for the pathologies that derive from its malfunction. The work we do in our lab 
is the base for that, in a future, diseases that seem to be related to the UPS -
autoimmune, heart or neurological diseases, cancer,…- have a better treatment. 
 
 
KEYWORDS: 
 
Monoubiquitination, Rpn10, proteasome, Rsp5, Ubiquitin, disordered protein 
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 1 
Ubiquitin: the kiss of death tags for destruction 
Post-translational modifications are regulatory processes altering the 
composition of a protein, usually through the covalent addition of a small molecule 
to one of the amino acid residues. Phosphorylation, methylation, acetylation, 
glycosylation, lipidation, ubiquitination, SUMOylation and proteolysis are some of 
the modifications that proteins undergo (Hochstrasser, 2000; Pickart, 2001).  
Ciechanover was the first to describe a post-translational modification finding that a 
small molecule, Ubiquitin (termed APF-1 initially), formed covalent conjugates with 
endogenous reticulocyte proteins (Ciechanover et al, 1980). Since then, the 
Ubiquitin (Ub) field seems to be ever expanding. Ub is an essential protein of 76 
amino acids (∼8KDa) that participates in complex and diverse regulatory roles and 
its involvement in multiple processes makes it one of the most versatile signaling 
molecules in the cell.  
Ubiquitination consists of a multi-enzymatic cascade that covalently links Ub 
to a wide pool of proteins by means of the activity of three enzymes, the Ubiquitin-
activating enzyme (E1), the Ubiquitin-conjugating enzyme (E2), and the Ubiquitin 
ligase enzyme (E3). This enzimatic system is involved in the regulation of multiple 
and diverse cellular processes, such as proteasomal-dependent protein 
degradation, antigen processing, apoptosis, biogenesis of organelles, cell cycle and 
division, DNA transcription and repair, differentiation and development, neural and 
muscular degeneration, morphogenesis of neural networks, modulation of cell 
surface receptors, the secretory pathway, response to stress and extracellular 
modulators, ribosome biogenesis or viral infection (Deshaies & Joazeiro, 2009; 
Raiborg & Stenmark, 2009; Ulrich & Walden, 2010; Zinngrebe et al, 2013). 
Ubiquitin belongs to the Ubiquitin-like proteins (UBLs) family, which are 
proteins modifiers of around 8 to 20 KDa that are related in sequence to Ub, 
structurally resemble it and are also covalently linked to other proteins to regulate 
their functions in eukaryotes via an enzymatic cascade that resembles 
ubiquitination (Schwartz & Hochstrasser, 2003; Pickart & Eddins, 2004). Some of 
them are Sumo, Nedd8, ISG15 and Fat10 (van der Veen & Ploegh, 2012). 
Proteolytic elimination is one of the most common fates of ubiquitinated 
proteins, making Ub an ideal regulator. Ubiquitin can modify the localization, 
stability and properties of its target protein. A proteomics approach to identify 
Introduction 
 2 
Ubiquitin conjugates from Saccharomyces cerevisiae lysate showed that Ub 
modifies around a thousand different proteins (Peng et al, 2003). There is an 
extensive ubiquitination machinery in human cells with more than four to five 
thousand proteins that can be modified by Ub suggesting that the complexity of 
protein regulation by ubiquitination could be comparable to that of phosphorylation 
(Kim et al, 2011b; Wagner et al, 2011). 
The secondary structure of Ub consists of a fold dominated by a β-sheet with five 
anti-parallel β-strands and one α-helix segment. This fold was termed the Β –grasp 
(β-GF), because the β –sheet appears to grasp the α-helix region (Overington, 
1992). The first and last strands are adjacent and parallel to each other; the two 
strands flanking the former ones are in an anti-parallel position. There is an 
additional strand that packs against the conserved third strand at the margin of the 
core β-sheet and the α-helix is packed against one face of the sheet (Burroughs et 
al, 2007). 
The characteristic topological feature of Ubiquitin is stabilized by 
hydrophobic interactions conferring a strong stability and resistance to temperature, 
pH changes and proteolysis (Ibarra-Molero et al. 1999; Lenkinski et al. 1977; 
Schlesinger et al. 1975). 
 
Ubiquitin is one of the most conserved polypeptides in eukaryotes: only four 
of its amino acids differ among yeast, plants and animals, which shows that during 
evolution, Ub has been extremely refractory to amino acid changes (Glickman & 
Ciechanover, 2002; Catic & Ploegh, 2005; Zuin et al, 2014). Strinkingly, only 
sixteen of the 63 surface residues of Ub are essential for vegetative growth in 
yeast. These essential amino acids are found in two distinct functional patches near 
Ile44 and Phe4 of the Ubiquitin globular domain and in the C-terminus (Sloper-Mould 
et al, 2001). The mutation of the rest of non-essential positions, even though not 
deeply characterized, are likely to cause a reduced phenotypical fitness. 
Three of the essential residues, Leu8, Ile44 and Val70, are known as the 
hydrophobic patch and are required for proteasomal binding and degradation and 
endocytosis (Shih et al, 2000; Sloper-Mould et al, 2001). Mutation of pairs of Leu8, 
Ile44 and Val70 inhibits degradation of the polyubiquitinated substrates by blocking 
the binding of Ub chains to ubiquitin receptors in the proteasome.  
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A second surface region consisting of residues Gln2, Phe4, and Thr12 is 
required for endocytosis. The mutation of Ile44 and Phe4 may prevent the interaction 
with different endocytic proteins (Sloper-Mould et al, 2001). 
 
Figure 1. Ubiquitin residues essential for life and internalization. 
3D strucuture of Ubiquitin. Left, essential amino acids are highlighted in blue. Right, 
key residues that promote endocytosis are highlighted in magenta. In pink, residues 
that play a minor role in internalization. 
 
 
Ubiquitin can be conjugated to substrate proteins or to itself by means of a 
covalent isopeptide bond between the C-terminal glycine 76 of Ubiquitin and the 
amino group of a lysine residue of the protein substrate, a process known as 
ubiquitination. Additionally, Ubiquitin can bind to specific surfaces, such as 
Ubiquitin-binding domains, and can also form non-covalent interactions either with 
Ubiquitin moieties or with Ubiquitin chains (Dikic et al, 2009).  
 
Protein conjugation by Ubiquitin-like proteins is not exclusive of eukaryotes: 
Ubiquitin-systems play also an important regulatory role in prokaryotes and 
Archaea. The existence of prokaryotic sulphur-carrier proteins involved in 
molybdenum cofactor (MoaD) and thiamin (ThiS) biosynthesis structurally related to 
Ubiquitin, sharing a conserved carboxy-terminal Gly-Gly motif, suggest a common 
origin (Lake et al, 2001; Burroughs et al, 2009). Regarding the thiamine synthesis, 
ThiF, a homolog of the E1 enzyme that activates Ubiquitin, adenylates the C-
terminus of ThiS. Similarly, MoeB activates the C-terminus of MoaD to form an 
acyl-adenylate. 
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A homologous conjugation system has recently been reported in Bacteria. TtuB, a 
bacterial Ubiquitin-like protein found in Thermus thermophilus that functions as a 
sulfur carrier in tRNA thiouridine synthesis, was found to be covalently attached to 
target proteins by means of its glycine at the C-terminus (Shigi, 2012).  
Regarding archaea, SAMPs (small archaeal modifier proteins) are Ubiquitin-like 
protein modifiers, in the archaea Haloferax volcanii, that just require an E1 Ubiquitin 
activating enzyme competent for sampylation (Humbard et al, 2010). However, 
SAMPs show very low sequence identity (9%) with eukaryotic Ubiquitin 
(Bienkowska et al., 2003; Darwin, 2009). Interestingly, mutants showing decreased 
proteasome activity in Haloferax volcanii accumulate SAMP conjugates, indicating 
that SAMPs may play a role in proteasome-dependent degradation.  
The genome of Caldiarchaeum subterraneum has been sequenced showing 
that this archaea species harbors an Ubiquitin-like protein modifier system 
consisting of one single-copy Ubiquitin gene, one Ubiquitin activating enzyme, one 
Ubiquitin conjugating enzyme, one RING-type Ubiquitin-protein ligase and one 
deubiquitinating enzyme (DUB) with structural motifs specific to eukaryotic protein 
system, a system clearly distinct from the prokaryote-type system previously 
described in Haloferax (Nunoura et al, 2011). These five genes in C. subterraneum 
are organized in an operon-like cluster, representing the most simplified genetic 
arrangement encoding an eukaryote-like Ubiquitin signaling system (Nunoura et al, 
2011). However, in eukaryotes, the organization of the Ubiquitin-system is 
substantially different: Ubiquitin is encoded by a multigene family containing three 
primary members: head-to-tail repeats encoding a polyubiquitin precursor protein 
(approximately from 4 to 15 Ubiquitin molecules) and two fusions with L40 and S27 
ribosomal proteins (Sharp & Li, 1987; Finley et al, 1989; Catic & Ploegh, 2005; 
Ozkaynak et al, 1984). Eukaryotic genomes are also provided with a full set of 
Ubiquitin signaling factors, E1, E2 and E3 enzymes that define a consistent 
hierarchical structure. 
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Distinct ubiquitination products generate diversity in 
Ubiquitin signaling ubiquitination 
 
Ubiquitin contains 7 lysines (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, and 
Lys63) that can all be linked to the C-terminus of another Ub or to the N-terminal 
methionine, resulting in the formation of polymers (Figure 2). When the length of 
the chain is large enough, containing at least four ubiquitins, the substrate is 
polyubiquitinated. When there is a single Ubiquitin molecule attached to the protein, 
the substrate is monoubiquitinated. When the protein is conjugated to one single 
Ub molecule at more than one lysine, the protein is multi-monoubiquitinated. Both 
in yeast and in mammalian cells, Ubiquitin linkage types are equally represented 
(Peng et al, 2003; Xu et al, 2009; Ziv et al, 2011). Depending on the length and 
type of linkage, the targeted substrate will have one fate or another (Husnjak & 
Dikic, 2012).  
Monoubiquitination (and multi-monoubiquitination) plays a role in the regulation of 
endocytosis, lysosomal targeting, meiosis and chromatin remodeling while 
polyubiquitination plays a role in targeting substrates to the proteasome, immune 
signaling and DNA repair. 
Ubiquitin chains can contain one or more than one type of linkage. The first case 
refers to homotypic chains in which just one lysine participates in the conjugation of 
Ubiquitin. The second situation refers to the use of distinct lysine residues to 
connect Ubiquitin moieties- Lys 6/11, Lys 27/29, Lys 29/48 or Lys 29/33 (Kim et al, 
2007). There is another scenario in which Ubiquitin is connected to other Ubiquitin-
like modifiers such as Sumo-2 and Sumo-3 giving rise to heterologous Ub chains 
(Tatham et al, 2001). Finally, Ub-Ub linkages can also be formed on Met1 
producing linear chains. In these chains, the C-terminal Gly of Ubiquitin is linked to 
the Met1 of the next Ubiquitin (Kirisako et al, 2006). 
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Figure 2. Different Ubiquitin linkages. 
Ubiquitin can form eight different homotypic chains. a, b and c show diubiquitins 
adopting a compact conformation. d and e show diubiquitins in an extended 
conformation. Linkages are shown inside squares and a rectangle at the right. Adapted 
from (Husnjak & Dikic, 2012). 
 
 
 
Ubiquitin moieties interact at different levels with adjacent ubiquitins. When the only 
interaction takes place in the linkage site, the Ub chain adopts an “open 
conformation”. That is the case for linear and K63 chains (Komander et al, 2009b; 
Tenno et al, 2004). In contrast, adjacent ubiquitins in K6, K11 and K48 chains 
interact with each other and adopt a “compact conformation” (Bremm et al, 2010; 
Tenno et al, 2004; Varadan et al, 2002).  
However, the conformation of these chains is dynamic. Indeed, when the chains 
are in complex with Ubiquitin-binding domains their conformations change, 
alternating between open and closed states (Dikic et al, 2009).  
The conformational properties adopted by the different linkages allow the 
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substrates to be recognized by downstream receptor proteins making the linkages 
determine the fate of the ubiquitinated substrates. Ubiquitination becomes then a 
source of signals that has power over the function of a myriad of proteins.  
In yeast, Ubiquitin linkages are represented as follows: K6, 10.9%; K11, 28%; K27, 
9%; K29, 3.2%; K33, 3.5%; K48, 29% and K63, 16% (Xu et al, 2009). In 
mammalian cells, linear, K6, K27, and K33 linkages represent not more than 0.5%; 
K11, 2%; K29, 8%; K63, 38% and K48, 52% (Dammer et al, 2011).  
The Ubiquitinome pattern is not static. For instance, K11 chains are important in 
both degradative and nonproteolytic pathways. Depending on the stage of the cell 
cycle, the nature of the linkages can change. During mitosis, K11 chains promote 
proteasomal degradation. At that moment of the cell-cycle, the E3 ligase 
Anaphase-Promoting Complex (APC/C) assembles K11-linked chains in substrates 
such as Securin and Cyclin B1 before degradation (Jin et al, 2008). In contrast, 
other studies associate K11 chains to substrate endocytosis (Boname et al, 2010).  
Bedford and collaborators found that linkages K6, K11, K29 and K48 contribute to 
proteasomal degradation in mammalian neurons (Bedford et al, 2011). K63 chains 
act in a range of processes including endosomal trafficking to the lysosome, 
intracellular signaling, and DNA repair (Ikeda & Dikic, 2008). However, K63 chains-
linked substrates cannot be degraded by the proteasomes because soluble factors 
bind these chains and prevent their association with the proteasome (Nathan et al, 
2013). In yeast, proteasomal degradation is mediated by K6, K11, K27, K29, K33 
and K48 linkages, the latter being described as the principal signal for targeting 
substrates to the proteasome (Xu et al, 2009).  
The RBR Ubiquitin ligase Parkin builds atypical K27 chains on the mitochondrial 
protein Miro1 that may have a role in mitophagy (removing of damaged 
mitochondria) (Birsa et al, 2014). Yuan et al, showed that K33 polyubiquitinated 
Coronin 7, a protein involved in the protein export from the Golgi, regulates protein 
trafficking (Yuan et al, 2014). K29 chains have been found in substrates targeted 
for lysosomal degradation (Chastagner et al, 2006). 
When the linkage does not involve any lysine, the chain formed is called linear. In 
this type of chain, the N-terminal methionine of an Ubiquitin molecule is linked to 
the C-terminal glycine of the next Ubiquitin. Linear chains are involved in the 
development of the immune system and the prevention of chronic inflammation 
(reviewed in Walczak et al, 2012). 
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Enzymatic cascade 
Eukaryotes possess a distinctive enzymatic apparatus for Ub-modification, 
comprised of E1, E2 and E3 enzymes, in which the E1 produces E2 thioesterified 
with Ubiquitin (E2-Ub) and the E3 binds both to E2-Ub and to the substrate (Dye 
and Schulman, 2007; Scheffner et al. 1995). The polyubiquitinated substrates will 
be (often) subsequently targeted to, recognized and degraded by the Ubiquitin-
Proteasome System (UPS) (Figure 3).  
 
 
 
Figure 3. Schematic of the Ubiquitin-Proteasome System and fate of 
ubiquitinated substrates.  
After Ub is activated and transferred from the E1 to an E2, it is attached to an E3 that 
finally will bind it to a substrate. The linkage topology between ubiquitins determines 
the fate of the protein. One of the different fates that a polyubiquitinated protein can 
follow is proteasomal degradation. Several subunits of the proteasome and other 
factors are involved in this multi-step process. DUBs are deubiquitylases responsible 
for the recycling of Ubiquitin and chain editing.  
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These enzymes first catalyze the formation of an isopeptide bond between the C-
terminus of Ubiquitin and the amino group of a lysine residue of the protein 
substrate, leading to monoubiquitination. Multiple lysine residues can be modified 
with one Ubiquitin leading to multi-monoubiquitination. When the process is 
repeated several times, elongation occurs, adding Ubiquitin molecules to each 
other in a growing chain.  
The first step is ATP-dependent and is carried out by an Ubiquitin-activating 
enzyme, E1: a high-energy thioester linkage between Ub and the E1 is generated. 
Next, the transfer of Ub from the E1 to the active-site cysteine of an Ubiquitin-
conjugating enzyme, E2 is catalyzed. Finally, the last step is executed by a 
member of the Ubiquitin-protein ligase family, E3, resulting in the formation of an 
isopeptide bond between the C-terminal glycine of Ubiquitin and free lysines either 
in the target or in the preceding Ubiquitin in the chain (Ciechanover et al, 1982; 
Hershko et al, 1983; Glickman & Ciechanover, 2002). In most cases, Ub is 
conjugated to the epsilon-amino group of a lysine (Glickman and Ciechanover, 
2002). In some cases, however, Ubiquitin is conjugated to the NH2-terminal group 
of the substrate (Ciechanover and Ben-Saadon, 2004), as well as to Cys, Ser, and 
Thr residues of target proteins (Cadwell and Coscoy, 2005; Ravid and 
Hochstrasser, 2007).  
In yeast, an Ubiquitin chain elongation factor, E4, binds to the Ub moieties of 
preformed short conjugates and catalyzes Ub chain elongation. Substrates with 
polyubiquitin chains of more than four Ubiquitins are ready for proteasomal 
degradation (Crosas et al, 2006; Koegl et al, 1999).  
 
The structure of the UPS is hierarchical. There is a very reduced number (or, 
generally, one single representative in unicellular organisms) of Ubiquitin-activating 
enzymes (E1) that activate Ub and transfer it to a higher number of E2s (Hershko 
and Ciechanover, 1998; Pickart, 2001). Each of these E2 interacts with several E3s 
and a much larger number of E3s recognize a set of substrates via their recognition 
motifs. 
This hierarchy is not simply based on a pyramidal structure: there is a whole 
network of interactions that involves multiple components and raises the complexity 
of the mechanism to unpredicted levels. A single E3 can interact with two or more 
distinct E2s, can have several recognition sites targeting different substrates and 
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the same domain can interact with many substrates. At the same time, different 
E3s can target one same substrate by recognizing different motifs. 
 
 
Ubiquitin‐activating enzymes, E1 
At the start of each ubiquitination cascade is an Ubiquitin-activating enzyme, 
which activates Ub by binding ATP-Mg2+ and Ub. This E1 catalyzes an acyl-
adenylation at the C-terminus of Ubiquitin (occupied by a totally conserved Glycine 
in eukaryotes) (Haas & Rose, 1982). Next, the E1 attacks the adenylated form of 
Ub by means of its catalytic cysteine creating a complex between the E1 and Ub 
(Ciechanover et al, 1981). At this stage, there is a thioester bond formed between 
the enzyme and Ubiquitin. Addionally, there is a second Ub bound to the E1 that is 
adenylated. Finally, the E1 transfers the C-terminus of the activated Ub to a 
catalytic Cys of an E2 conjugating enzyme catalyzing a thioester bond (Haas et al, 
1982; Pickart & Rose, 1985). 
 
Ubiquitin activation and conjugation cycle. 
The steps involved in Ub activation and conjugation are represented in the 
following scheme (Figure 4): 
 
Figure 4. Ub conjugation machinery. 
In (1), Ub(A) represents Ubiquitin that is adenylated and forms an Ubiquitin-AMP 
adduct bound to the enzyme. In (2), the catalytic Cys of E1 forms a thioester 
linkage with Ubiquitin, Ub(T). In (3), a second Ub is adenylated, being E1 loaded 
with two ubiquitins. In (4), E1 interacts with an E2 enzyme and Ub is transferred to 
the E2. The E1-Ub(A)-adenylate complex follows step (2). Adapted from (Dye & 
Schulman, 2007). 
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In humans, there are eight E1s that are known to activate UBLs. When the 
molecule to be activated is Ubiquitin, there are just two E1s or Ubiquitin-activating 
enzymes: UBE1 (UBA1 in yeast) and UBA6, which are ~40% identical (Pelzer et al, 
2007; Jin et al, 2007). In fact, for many years, Uba1 was thought to be the only 
Ubiquitin-activating enzyme charging E2s with Ubiquitin. In yeast, only a single E1 
has been described to activate Ubiquitin, UBA1. 
The origins of E1s start with prokaryotes. The eukaryotic Ubiquitin and the 
prokaryotic ThiS/MoaD proteins contain the same β-grasp fold. The two latter are 
UBL sulfur-carrier proteins that carry sulphur for incorporation into molybdopterin 
and thiazole, respectively. In parallel, MoeB and ThiF share sequence homology 
with the domain of eukaryotic E1s. MoeB catalyzes the adenylation of the C-
terminus of MoaD and ThiF adenylates the C-terminus of ThiS (Taylor et al, 1998; 
Burroughs et al, 2009). 
 
 
Ubiquitin‐conjugating enzymes, E2 
The family of Ubiquitin-conjugating enzymes (E2)  is present in all 
eukaryotes. At least 38 active E2 genes have been identified in humans and 13 
genes in Saccharomyces cerevisiae (van Wijk & Timmers, 2010; Ye & Rape, 
2009). 
E2s contain sites through which they interact with E1 and with E3 enzymes. They 
accept the activated Ub from an E1 and are responsible for Ubiquitin-ligase (E3) 
selection and substrate modification. E2s can dictate the final product to be mono 
or polyubiquitinated and the lysine to be modified in the substrate, influencing the 
fate of the substrate (Ye and Rape, 2009). Active E2s contain a highly conserved 
Ubiquitin-conjugating (UBC) domain that accommodate the Ub protein through a 
thioester bond onto its active-site (Burroughs et al, 2008; Schulman & Harper, 
2009). Unlike E1s, no enzymes containing a UBC domain have been identified in 
bacteria (Iyer et al, 2008). 
UBC domains are highly conserved and adopt similar structures. They bear an also 
highly-conserved cysteine in their active site that binds an Ubiquitin/Ubl protein that 
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has been previously transferred from the E1. After this step, E2s engage E3s to 
catalyze substrate ubiquitination. 
Not every E2 is active. For instance, UEV proteins are E2 enzymes that, although 
they contain a UBC domain, lack the active-site Cys residue and cannot bind 
Ubiquitin (VanDemark et al, 2001). However, they regulate active E2s activity and 
linkage specificity. 
 
 
Ubiquitin‐l igases enzymes, E3  
Ubiquitin-ligase enzymes (E3) promote the ubiquitination of either the N-
terminus or internal lysine residues of targeted substrates. There are two major 
types of E3s in eukaryotes: the HECT type and the RING type. 
HECT (Homologous to E6AP C-Terminus) enzymes contain a Cys residue that is 
loaded with an activated Ubiquitin molecule forming an intermediate thioester. Next, 
Ubiquitin is ligated to the substrate, catalyzing substrate ubiquitination (Figure 5a) 
(Rotin & Kumar, 2009). 
The RING (Really Interesting New Gene) ligase family binds simultaneously the 
E2-Ubiquitin intermediate and the targeted protein promoting ubiquitination (Figure 
5b). RINGs seem to lack a catalytic site. 
 
 
Figure 5. Transfer of Ub by the HECT and RING Ubiquitin ligases. 
In a, the E2 binds the HECT domain. Next, Ub is transferred from the E2 to the HECT 
to be finally transferred to the substrate that is interacting with the HECT ligase. In b, 
the E2 interacts with the RING domain and Ub is transferred to the substrate, which 
binds directly or indirectly, through an adaptor, to the RING ligase. RING E3s are 
characterized by a Cys-X2-Cys-X(9-39)-Cys-X(1-3)-His-X(2-3)-Cys-X2-Cys-X(4-48)-
Cys-X2-Cys sequence. Adapted from Rotin & Kumar, 2009. 
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The human genome is estimated to encode for over 600 E3s, 300 of which belong 
to the RING family and 28 to the HECT family. In yeast, around 80 genes were 
found to encode E3s, 47 of which encode RING ligases and 5 that encode HECT 
ligases (Li et al, 2008). HECT-type E3s contain a HECT domain of ~350 amino 
acids found at the C-terminus of the protein. The domain can be divided into two 
parts separated by a flexible linker, the N lobe and the C lobe. The N-terminus 
contains protein-protein or protein-lipid interaction domains, and this is where the 
E2 and the E3 interact. Depending on the nature of this N-terminus, HECTs are 
divided into 3 groups: the Nedd4 family, the HERC family and other HECTs 
(TRIP12, HUWE1 and UBE3B) (Rotin & Kumar, 2009; Park et al, 2009). The C lobe 
represents one-third of the domain and contains a conserved Cys residue to which 
the activated Ubiquitin is transferred from the E2 (Scheffner et al, 1995). 
The structures of the Nedd4 HECT domain and of that domain interacting with Ub 
suggested a model for the transfer of ubiquitins from the HECT to the substrate, in 
which a Ub molecule is added from the catalytic Cys of the HECT to a lysine of the 
substrate. The Ub molecule is then kept close to the catalytic cysteine to promote 
addition of more ubiquitins (Maspero et al, 2011).  
Nedd4 family members are characterized by containing two additional domains: C2 
domain and WW domains. The C2 domain is a ~120 amino acids calcium-binding 
domain that binds to phospholipids and mediates intracellular targeting to the 
plasma membrane, endosomes and multivesicular bodies (MVBs) (Dunn et al, 
2004). This domain also binds other proteins such as annexin (Plant et al, 2000) or 
the growth factor receptor-bound Grb (Morrione et al, 1999). It is also possible that 
a C2 domain binds the HECT domain of the Nedd4 family, generating inter- and 
intramolecular interactions (Wiesner et al, 2007). 
By contrast, the WW domains are ~37 amino acids long protein interaction domains 
that contain two conserved tryptophan residues, 20-22 amino acids apart. Nedd4 
family members can contain between two to four WW domains. WW domains bind 
to PY (PPXY/PPLP) motifs or phospho-serine/threonine residues in substrate 
proteins (Dupré et al, 2004; Lu et al, 1999; Staub et al, 1996). WW domains can 
also bind the HECT domain of the same protein (Gallagher et al, 2006). The 
binding of the HECT either by the C2 domain or the WW domains inhibits its activity 
and prevents the auto-ubiquitination of these enzymes (Bruce et al, 2008). 
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Misregulation of HECTs-mediated ubiquitination is associated with cancers, 
neurological disorders, autoimmunity and hypertension (Bernassola et al, 2008; 
Rotin & Kumar, 2009; Metzger et al, 2012; Scheffner & Kumar, 2014). 
The RING type E3s transfer Ubiquitin to both heterologous substrates and to the 
RING proteins themselves. The RING domain comprises eight potential metal 
ligands and binds two atoms of zinc. It is defined by a series of specifically spaced 
conserved cysteine and histidine residues: Cys-X2-Cys-X(9-39)-Cys-X(1-3)-His-
X(2-3)-Cys-X2-Cys-X(4-48)-Cys-X2-Cys, where X is any amino acid. Cys and His 
residues are buried within the core of the domain, where they help to maintain the 
overall structure by binding the two atoms of zinc (Borden & Freemont, 1996). 
RING fingers serve as a scaffold that brings E2 and substrate together. The RING 
ligase promotes the transfer of a Ubiquitin molecule from the catalytic cysteine of 
an E2 to a substrate (Deshaies & Joazeiro, 2009). They can be found as 
monomers, dimers and multisubunit complexes. The dimerization takes place at the 
RING finger domain and it can be either homo- or heterogeneous. Some 
heterodimers contain one RING domain that lack catalytic activity.  
Activity of RING enzymes can be controlled by covalent modifications 
(phosphorylation or ubiquitination), by noncovalent binding of proteins, or by 
competition among substrates. 
Deregulation of RING Ubiquitin ligases is often involved in human diseases. 
Mutations in the E3s, BRCA1 and BRCA2 (breast cancer 1 and 2, respectively) are 
found in breast and ovarian cancer (Welcsh & King, 2001). The Mdm2 Ubiquitin 
ligase regulates the tumor suppressor p53. An increased activity of Mdm2 is 
associated with human cancers (Lipkowitz & Weissman, 2013). 
 
 
Rsp5 HECT ligase  
Rsp5 is the only NEDD4 E3 ligase family member in Saccharomyces 
cerevisiae and is the single E3 encoded by an essential gene (Huibregtse et al, 
1995). Rsp5 preferentially synthetizes K63 chains in vitro and in vivo (Kee et al, 
2005, 2006; Lin et al, 2008). However, in the absence of K63, Rsp5 is also able to 
synthetize shorter K11, K33 and K48 chains (Kim & Huibregtse, 2009). Additionally, 
Rsp5 has been reported to become auto-ubiquitinated through an intramolecular 
transfer of Ubiquitin (Lee et al, 2009; Huibregtse et al, 1995). 
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Originally, Rsp5 was associated with providing cells with unsaturated fatty acids. 
Rsp5 was found to polyubiquitinate two transcription factors, Spt23 and Mga2, 
which activate transcription of Ole1 (Hoppe et al, 2000). Ole1 encodes an ER-
bound enzyme required for the synthesis of monounsaturated fatty acids, 
palmitooleic and oleic acids. Later, Rsp5 was found to be involved in several 
processes such as intracellular trafficking, including endocytosis of plasma 
membrane proteins and sorting at the multivesicular body (Horák, 2003; Morvan & 
Froissard, 2004), chromatin remodeling, mitochondrial inheritance (Fisk & Yaffe, 
1999) and mediating Golgi to ER trafficking (Jarmoszewicz et al, 2012). All this 
suggests that Rsp5 probably has a multitude of diverse membrane-bound as well 
as nuclear substrates. 
The endosomal sorting complex for transport (ESCRT) consists of four protein 
complexes (ESCRT-0, -I, -II and –III) that captures ubiquitinated cargoes in the 
endosome membrane and sorts them to the internal vesicles of multivesicular 
bodies (MVB) (Katzmann et al, 2002). The ubiquitination of these cargoes is 
generated by specific E3 Ubiquitin ligases (d’Azzo et al, 2005). If ubiquitination is 
inhibited, MVB sorting is abolished resulting in the recovery of cargoes at the 
vacuolar membrane rather than in the vacuolar lumen. 
Ubiquitination and endocytosis of plasma membrane proteins mediated by Rsp5 
was first studied through the amino acid permeases, Gap1 and Fur4 (Springael & 
André, 1998; Galan et al, 1996). Lack of ubiquitination of both transporters was 
observed when reduced levels of Rsp5 were expressed. In some cases, such as 
for Gap1, evidence exists that indicates that the signal for vacuolar degradation can 
be polyubiquitination. Rsp5-dependent ubiquitination is also required for the sorting 
of membrane proteins originating from the Golgi apparatus or the plasma 
membrane to the MVBs (Katzmann et al., 2002). 
Rsp5 is the yeast homolog of the mammalian E3 ligase Nedd4. Like other 
members of the Nedd4 family, Rsp5 contains an amino-terminal C2 domain, three 
WW domains and a HECT domain at the C-terminus (Figure 6). The C2 domain 
was found to be important for subcellular localization to endosomal membranes 
(Dunn & Hicke, 2001). However, the C2 domain of Rsp5 is not required for the vital 
function of this enzyme (Wang et al, 1999). The WW domains are required for 
recognition of phosphorylated substrates that undergo endocytosis. Receptor 
ubiquitination and internalization is impaired when conserved residues in any of the 
three WW domains are mutated, but cell viability is not affected (Dunn & Hicke, 
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2001). The third WW domain together with the HECT domain is sufficient to provide 
its essential function under normal growth conditions (Hoppe et al, 2000; 
Kamadurai et al, 2013).  
When the N lobe of the HECT domain binds the charged E2-Ub, Ubiquitin is 
transferred to the catalytic cysteine of the C lobe forming a thioester bond. The C 
lobe rotates 130 degrees in a way that Ubi can be newly transferred to a substrate 
lysine (Kamadurai et al, 2013; Huibregtse et al, 1995). 
 
 
Figure 6. Schematic representation of Rsp5 highlighting its domains. 
Rsp5 contains a C2 module, three WW domains and the HECT domain. 
 
 
Rsp5 interacts with and affects the regulation of numerous substrates in different 
ways. Here we detail some of these interactions: 
• Rsp5 binds and polyubiquitinates the largest subunit of RNA polymerase II, 
Rpb1, and targets it for degradation (Huibregtse et al, 1997). 
• Vps9, a protein involved in the yeast endocytic pathway, is 
monoubiquitinated in vivo by Rsp5. Vps9 contains a CUE domain that is 
required for its monoubiquitination (Shih et al, 2003). 
• A proteomic in vitro ubiquitination screen using a protein microarray platform 
was developed by Gupta and colleagues to discover substrates of E3 
ligases (Gupta et al, 2007). They estimated that ~4% of proteins in yeast 
contain one or more PPXY motifs and ~7% contains LPXY motifs. 72% of 
the high-­‐confidence Rsp5 substrates was found to bear at least one PY 
motif, the preferred one being PPXY (the most common residues at the third 
position, X, were Pro, Ala and Ser).  
Arrestin-related trafficking adaptors (ART) are a family of proteins that target 
plasma membrane proteins to the endocytic system. Each ART protein 
contains several PY motif that are used to recruit Rsp5, which ubiquitinates 
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both the adaptor and the substrate (Lin et al, 2008). Bul1 and Bul2 are two 
arrestin-like proteins that regulate the endocytosis of a subset of plasma 
membrane proteins. The regulation of these substrates is made after an 
interaction between Rsp5 and Bul1 or Bul2 that promotes their ubiquitination 
(Helliwell et al, 2001). Gap1, Fur4, Rfa1, Zrt1 and Tat2 are some of these 
substrates that both do not contain PY motifs and do not bind Rsp5, but that 
interact with Bul1 and Bul2 (Nikko & Pelham, 2009; Hein et al, 1995; Galan 
et al, 1996). 
• Smf1 is a manganese transporter that is ubiquitinated by Rsp5. In order that 
the ubiquitination is achieved, the arrestin-like proteins Ecm21 or Csr2 first 
need to interact with Rsp5 (Nikko et al, 2008). 
• Cps1 is a MVB cargo that is ubiquitinated by Rsp5 (Katzmann et al, 2004). 
Although Cps1 does not contain any PY motif, it contains a short sequence 
(PVEKAPR) that interacts with the C-lobe of the HECT domain of Rsp5. 
Additionally, residues within the N-lobe contribute to Cps1 recognition and 
subsequent ubiquitination (Lee et al, 2009). 
• Cue1 is a substrate of Rsp5 that does not contain any PY motif and does 
not need any adaptor to be ubiquitinated. However, Cue1 has an Ubiquitin-
binding domain (CUE domain) whose interaction with Ub could enable its 
monoubiquitination (Kang et al, 2003). 
• The proteasomal subunit Rpn10 is monoubiquitinated by Rsp5 in vitro and 
in vivo. Rpn10 contains an Ubiquitin binding domain, (Ubiquitin-interacting 
motif or UIM), indispensable for Rpn10 ubiquitination (Isasa et al, 2010). 
 
 
Deubiquitination, a key regulatory reaction in Ubiquitin 
signaling  
Ubiquitination is a process reversed through the action of a large family of 
deubiquitylases (DUBs), which remove Ubiquitin moieties from polypeptides and 
polyubiquitin chains. In humans, there are almost 100 different DUBs expressed, 
11 of which are not catalytically active (Nijman et al, 2005). In Saccharomyces 
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cerevisiae, 24 deubiquitination enzymes are expressed (Reyes-Turcu & Wilkinson, 
2009). 
DUBs can be divided into five families: Ubiquitin-specific proteases (USP), Ubiquitin 
C-terminal hydrolases (UCHs), ovarian tumor proteases (OTUs), Josephines and 
the JAB1/MPN/MOV34 family (JAMMs). In humans, there are ∼55 USPs, 4 UCHs, 
14 OTUs, 4 Josephines DUBs and 10 JAMM family DUBs (Komander et al, 2009a). 
The first four families contain a cysteine active site. The base of their activity relies 
on three different amino acids. An aspartic acid polarizes a histidine that will 
deprotonate the catalytic cysteine that will perform a nucleophilic attack between 
the carbonyl group of the C-terminus of Ub and the amino group of the substrate 
lysine. 
In contrast, the JAMM/MPN+ family members are zinc metalloproteases. A zinc 
atom is stabilized by an aspartate and two histidine residues. Zn2+ is then bound to 
a polarized molecule of water that coordinates the fourth link to the metallic atom, 
facilitating reactivity (Ambroggio et al, 2004). 
DUBs have both endo- and exo-activity. When they cleave Ub moieties or chains 
from within an Ub chain, this is called endo-activity. When they hydrolyze the 
Ubiquitin from the end of a chain, this is exo-activity. The hydrolysis takes place 
between a lysine of an Ub moiety and the C-terminus of the next Ub. 
There are many other ways to hydrolase Ub. For instance, DUBs can recognize 
polyubiquitinated substrates and take off the entire chain at once through the 
cleavage of the isopeptide bond linking the polyubiquitin chain to the substrate. 
DUBs can also identify monoubiquitinated substrates and remove a single Ub. 
Other DUBs remove all the Ub moieties except the one that is bound to the 
substrate, leading to a monoubiquitinated substrate.  
Deubiquitinating enzymes have to deal with chains of distinct linkage. The type of 
chain can dictate the activity of the DUB. For instance, JAMMs have an exclusive 
preference for K63-linked chains (Komander et al, 2009b). A deubiquitinase 
enzyme of the OTUs family, Cezanne, shows a K11-linked chains preference, while 
OTUB1 is K48-linkage-specific and does not hydrolyze linear or K63-linked chains 
(Bremm et al, 2010; Wang et al, 2009). In contrast, the USP family hydrolyses all 
type of linkages and show little specificity for chain types (Faesen et al, 2011). 
Despite this fact, the USP14 hydrolase has a preference for K48-linked, K63-linked 
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and linear chains, and CYLD for K63-linked and linear chains (Komander et al, 
2008; Hu et al, 2005). 
Ubp2 belongs to the USP family and is important for normal trafficking of Rsp5 
membrane protein substrates, such as Fur4, to the MVB (Lam et al, 2009). This Ub 
protease interacts with Rsp5 and modulates the auto-ubiquitination status of Rsp5 
in vitro and in vivo (Lam & Emili, 2013; Huibregtse et al, 1995; Lee et al, 2009) as 
well as Rsp5-catalyzed substrate ubiquitination (Kee et al, 2005). The interaction 
between Ubp2 and Rsp5 is stabilized by the co-factor Rup1 (an Ubiquitin-
associated (UBA) domain-containing protein that binds Ubiquitin chains). Rsp5 
preferentially assembles K63-linked chains, while Ubp2 preferentially disassembles 
K63 chains, promoting monoubiquitination. Both activities act, for instance, on Spt3, 
which is monoubiquitinated in an Rsp5-dependent way in vivo (Rape et al, 2001).  
Rpb1, a RNA polymerase II subunit is a substrate of Rsp5 that is poly- and 
monoubiquitinated in vivo. Rsp5 binds the C-terminus of Rpb1 and promotes K63 
Ubiquitin chain elongation. Nonetheless, the activity of Ubp2 modifies the substrate 
resulting in a monoubiquitinated form (Harreman et al, 2009). Ubp2 can also 
efficiently hydrolyze the Ubiquitin-substrate link. This is also the case for another 
RNAPII-targeting Ubiquitin protease, Ubp3 (Kvint et al, 2008). 
  
The Rsp5-Ubp2 association has also been shown to control the levels of 
monoubiquitination of the proteasome subunit Rpn10 in vivo (Isasa et al, 2010). 
 
 
Proteasome 26S 
In the 1970s, an intracellular protein degradation pathway in eukaryotes was 
discovered: the Ubiquitin-Proteasome System (Hershko et al, 1983; Varshavsky, 
1997). This system includes a large multimeric enzyme that degrades ubiquitinated 
proteins, the proteasome. The 26S proteasome is a multisubunit protease (2,5 
MDa) highly conserved in evolution composed of a barrel-shaped 20S core particle 
(CP) capped at either end by one or two 19S regulatory particles (RP) (Finley, 
2009). The proteasome degrades Ubiquitin–protein conjugates into small peptides 
in an ATP-dependent manner. For that, the proteasome needs to first recognize the 
substrates to be degraded, a function held by the subunits in the RP. Next, other 
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subunits in the RP deubiquitinate, unfold and translocate the substrate into the 
proteolytic core particle (Tanaka, 2009). Once in the CP channel, the proteolytic 
active sites degrade the protein (Figure 7). 
The general structure of the Saccharomyces cerevisiae 26S proteasome has been 
resolved by Cryo-electron microscopy (Beck et al, 2012; Sakata et al, 2012; Lander 
et al, 2012; Förster et al, 2010). 
 
Figure 7 Schematic representation of the 26S proteasome 
The subunits of the lid and the base of the RP are shown. 
 
The core particle 
 
The core particle is a complex composed of 28 subunits organized in four 
stacked rings of subunits (Figure 7 and 8). Each ring contains 7 distinct subunits 
that are all arranged in a hollow (Groll et al, 1997). The two outer rings are known 
as α-rings, the two inner rings as β-rings, forming a structure α1-7-β1-7-β1-7-α1-7. 3 out 
of 7 subunits forming the β rings are responsible for the proteolytic activity. Each of 
these subunits has its unique proteolytic activity: β1 has caspase-like activity and 
cleaves peptide bonds after acidic amino acids, β2 has trypsin-like activity and 
cleaves after basic residues and β5 is chymotrypsin-like in cleaving after 
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hydrophobic residues. The two β-rings together create the chamber where the 
substrates are degraded to become oligopeptides of 3 to 15 amino acids (Tanaka, 
2009). 
In mammals, there are 4 additional β subunits: β1i, β2i, β5i and β5t (i stands for 
immuno and t for thymo). These subunits are overexpressed in some tissues of the 
immune system and they substitute the canonical β subunits, affecting the 
proteolytic specificity. Proteasomes containing β1i, β2i and β5i subunits are termed 
immunoproteasomes; proteasomes containing β1i, β2i and β5t are called 
thymoproteasomes (Tomko & Hochstrasser, 2013). 
 
 
Figure 8. Molecular strucutures of the bovine 20S proteasome. 
A) Side view of the 20S proteasome. It consists of two outer rings, the α-rings, and two 
inner rings, the β-rings. B) Top views of the α-ring (closed) and the β-ring (open). 
Adapted from Murata et al, 2009.  
 
The access of substrates into the inner chamber is regulated by the α-ring. The 
position of the 7 subunits forming the α-ring blocks or allows the entrance of the 
substrate. This gate exists in a continual alternation between open and closed 
states (Osmulski et al, 2009). When the N-termini of the 7 subunits faces the 
interior of the ring, the chamber remains closed (Groll et al, 2000). To open the 
gate, additional factors, such as subunits of the RP, need to bind the outer ring of 
the CP, which allows a shift of the N-termini α subunits (Stadtmueller & Hill, 2011). 
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The regulatory particle 
 
The 20S proteasomes exhibit a very low proteolytic activity; they need to 
bind to regulatory particles to be really efficient. The RP is anchored to the α rings 
at either of the CP ends. Most of the 20S proteasomes in S. cerevisiae are capped 
at either end by the RP. The RP is a 900 KDa complex composed of 19 subunits 
divided into two subassemblies: 10 subunits form the base, and 9 subunits the lid 
(Pickart & Cohen, 2004).  
 
 
The base 
The base includes six ATPases from the AAA family, also known as 
Regulatory Particle Triple A proteins or Rpt1–6, and four non-ATPase subunits, 
Rpn1, Rpn2, Rpn10 and Rpn13 (regulatory particle non-ATPase). The electron 
microscopy structure of the proteasome holoenzyme and the lid subcomplex 
revealed the spatial rearrangement of the diverse subunits (Figure 9 and 10) 
(Lander et al, 2012). The 6 ATPases form an heterohexameric ring organized as 
follows Rpt1-Rpt2-Rpt6-Rpt3-Rpt4-Rpt5 (Tomko et al, 2010). The ATPase ring and 
the 7 α subunits of the CP form a complex when they contact each other. The 
ATPases unfold the substrate in an ATP-dependent step and the substrate is then 
translocated into the proteolytic chamber (Aubin-Tam et al, 2011). The C-terminal 
residues of the ATPases are critical for gate opening and stability of 26S 
proteasomes (Smith et al, 2007). 
The 26S proteasome structure from S. cerevisiae showed that the ATP ring 
undergoes conformational changes which could enable the entrance of the 
substrate through the central pore and its processing. A coordinated ATP-
hydrolysis would promote the rotation of the ATPase subunits and give the energy 
to exert a pulling force to unfold and translocate the substrate partially. The 
repetition of this cycle would allow the entire translocation into the peptidases 
(Matyskiela et al, 2013). 
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Figure 9. Three-dimensional electron microscopy reconstruction of the 
regulatory particle. 
A negative-stain reconstruction of the isolated lid subcomplex (top) and a 
reconstruction of the proteasome (bottom). The lid is coloured and the CP is in grey. 
Adapted from Lander et al, 2012. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Model for the recognition, deubiquitination and engagement of a 
polyubiquitinated substrate by the proteasome. 
A tetraubiquitinated substrate (red) binds to the Ubiquitin receptor Rpn13 (orange) via 
the attached ubiquitins (magenta). Rpn11 (green) deubiquitinates the substrate and 
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Rpt1-Rpt6 subunits translocate it into the core particle. Adapted from Lander et al, 
2012. 
 
 
 
Regarding the Rpn subunits of the base, Rpn1 and Rpn2 are the largest 
subunits in the proteasome (110 and 104 KDa, respectively). They are composed 
of 11 α-helical proteasome/cyclosome repeats that are responsible for the 
interaction between the proteasome and Ubiquitin binding proteins, such as Rpn13 
and Rad23 (Elsasser et al, 2002; Schreiner et al, 2008). Indeed, the repeats in 
Rpn2 allow the interaction with Rpn13 (He et al., 2012). Rpn1 contacts the outside 
face of the ATPase ring (subunit α4) which could help to control substrate docking 
(Lander et al, 2012). 
Rpn10 and Rpn13 are both Ubiquitin receptors that bind Ub chains through their 
UIM and PRU domains, respectively (Verma et al, 2004; Mayor et al, 2007; 
Elsasser et al, 2004; Husnjak et al, 2008).  
The UIM of Rpn10 bridges Rpn11 and the lid subunit Rpn9 and also contacts the 
coiled coil formed by Rpt4 and Rpt5 (Lander et al, 2012; Sakata et al, 2012). 
Polyubiquitinated substrates can also bind to extrinsic Ub receptors such as Rad23, 
Dsk2, and Ddi1, which are Ubiquitin-associated (UBA) and Ubiquitin-like (UBL) 
domain-containing proteins (Bertolaet et al, 2001; Funakoshi et al, 2002). These 
proteins have the dual property of binding polyubiquitin, through the UBA domain 
and of interacting with the proteasome, through the UBL motif (Elsasser et al, 2002; 
Finley, 2009). For instance, Ddi1, Rad23 and Dsk2 interact with Rpn1 through their 
UBL domain and the leucine-rich-repeat-like (LRR-like) domain in Rpn1  and 
Rad23 can also bind the proteasome via the UIM of Rpn10/S5a (Elsasser et al, 
2002; Hiyama et al, 1999). 
 
 
The lid 
 
The lid interacts with both the base and the CP. It is composed of 9 non-
ATPase subunits: Rpn3, 5, 6, 7, 9, 11, 12 and 15 (Glickman et al, 1998b). Rpn3, 5, 
6, 7, 9, and 12 contain a PCI domain that allows interaction between subunits. 
Rpn5 and Rpn6 contact with the C-terminus of α1 and α2 subunits, respectively 
and they both touch Rpn13. Rpn7 interacts with Rpt2 and Rpt6 (Lander et al, 
2012). Rpn15 has been recently described as a novel intrinsic Ubiquitin receptor 
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(Paraskevopoulos et al, 2014) that bridges the cleft between Rpn7 and Rpn3 (Bohn 
et al, 2013). Rpn8 and 11 subunits contain an MPN domain that allows interaction 
with PCI subunits Rpn5, 6 and 9 (Tomko & Hochstrasser, 2011; Lander et al, 
2012). Rpn11 is at the entrance of the pore, surrounded by the base subunits 
Rpn10 and Rpn13. Rpn11 is a JAMM DUB family member in charge of 
deubiquitinating proteasome substrates (Verma et al, 2002; Glickman et al, 1998b). 
Its activity depends on the interactions with other lid subunits. When the lid is in an 
isolated form, substrate deubiquitination is avoided, while when the lid is part of the 
holoenzyme, the DUB activity can take place. 
 
The proteasomal degradation process 
First of all, there is an interaction of an ubiquitinated substrate (Ub-S) with a Ub 
binding receptor (Rpn10, Rpn13 or Rpn15) in the proteasome or with a Ub shuttle 
receptor (Rad23, Dsk2 and Ddi1) that is recruited to the base (Lander et al, 2012) 
(Figure 11). None of these Ubiquitin receptors is essential for yeast viability 
(Husnjak et al, 2008) and it is likely that additional receptors will be identified in the 
future. Interestingly, Rpn10 is essential in both mouse (Hamazaki et al, 2007) and 
D. melanogaster (Szlanka, 2003) and Rad23 is essential in mouse (Hamazaki et al, 
2007). 
Next, the Ub-S is deubiquitinated by Rpn11, Ubp6 or Uch37. Rpn11 cleaves 
Ubiquitin chains en bloc by a cleavage at proximal Ub (Verma et al, 2002). Ubp6 is 
a base-associated DUB that cleaves within polyubiquitin chains or trims them from 
their distal end. Ubp6 prevents Rpn11 deubiquitinase activity, which delays 
proteasomal degradation or allows dissociation of the substrate from the 
proteasome (Hanna et al, 2006). Uch37 is a proteasome-associated DUB that 
removes ubiquitins one at a time (Lam et al, 1997). In contrast with these three 
proteases, Hul5, a Ubiquitin ligase associated to the proteasome, promotes chain 
extension on substrates that had been previously ubiquitinated and that are bound 
to the proteasome (Crosas et al, 2006).  
Before the substrate is translocated to the CP, it first needs to be unfolded, which is 
carried out by the Rpt subunits of the base. Having the substrate unfolded, the 
substrate is translocated to the CP where it is finally degraded into short peptides 
Sometimes, the proteases in the CP process the protein into a truncated form, 
creating a new protein that will have different cellular activities. For instance, once 
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the NF-kß precursor p105 is ubiquitinated, the proteasome degrades the C-terminal 
region and transforms it into p50, a stable and active subunit of the NF-kß 
transcription factor (Palombella et al, 1994). 
 
 
 
Figure 11. Steps of proteasomal degradation.  
Binding, unfolding, deubiquitination, translocation and degradation of a polyubi-
quitinated substrate. 
 
The regulation and homeostasis controlled by the proteasome is highly precise. It is 
indispensable that the proteasome degrades solely the proteins that need to be 
degraded and avoids unwanted removal of other proteins. Depending on the 
physiological demands, proteasome levels and proteasome composition vary 
(Lecker et al, 2006; Hanna et al, 2007). Under proteotoxic stress, there is an 
upregulation of all proteasome genes. In S. cerevisiae, the transcription factor Rpn4 
is responsible for the adaptive expression of the subunits of the proteasome 
(Leggett et al, 2002). Under normal conditions, Rpn4 has a very short life of around 
2 minutes and is degraded by the proteasome (Ju & Xie, 2004).  
The activity of the proteasome is also regulated by its own auto-ubiquitination. 
Indeed, some Ubiquitin receptors within the human 26S proteasome have been 
found to be ubiquitinated which impairs the ability of the proteasome to bind, 
deubiquitinate and degrade ubiquitinated substrates (Jacobson et al, 2014). 
Analogously, in yeast, the ubiquitination in the proteasome of the Ubiquitin receptor 
Rpn13 causes a strong decrease in Ub-dependent proteolysis (Besche et al, 2014). 
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Dysfunction of the proteolytic activity of the proteasome is associated with many 
human diseases. Accumulation of toxic aggregated, misfolded proteins leads 
mainly to neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, 
Huntington's disease, amyotrophic lateral sclerosis and spongiform 
encephalopathies). For instance, Tau is a protein that stabilizes microtubules. It has 
been suggested that when Tau aggregates, the proteasomal activity decreases 
resulting in Alzheimer’s disease (Keck et al, 2003). In parallel, Parkinson disease is 
characterized by the formation of Lewy Bodies (LB). α-synuclein is the main 
component of the LB. Depletion of the proteasome subunit Rpt2 results in 
accumulation of α-synuclein and Lewy Body-like inclusions in mice (Bedford et al, 
2008). 
Although in vitro studies showed that tetraubiquitin is the minimum signal for 
efficient proteasomal targeting (Thrower et al, 2000), it has been shown that 
polyubiquitination is not the only signal to get proteasomal degradation. Indeed, 
simpler forms of proteasomes have been identified in Archaea and actinobacteria, 
whilst Ub is just found in eukaryotes suggesting that ancestral proteasomes were 
able to degrade proteins that were not ubiquitinated (Gille et al, 2003; Maupin-
furlow et al, 2000). For example, Ornithine decarboxylase (ODC) is degraded by 
the proteasome without being previously ubiquitinated (Murakami et al, 2000). 
Moreover, mono- or multi-monoubiquitinated substrates can also be degraded by 
the proteasome. For instance, α-globin and ferritin are monoubiquitinated and, 
subsequently degraded (Shaeffer & Kania, 1995; De Domenico et al, 2006). In fact, 
several studies showed that a protein containing more than 20 residues with a Ub 
fused to its C-terminus can be degraded (Verhoef et al, 2009; Shabek et al, 2009). 
Ub would serve as an anchor to the proteasome and the short substrate would be 
translocated into the core particle. Furthermore, a recent study proved that 
monoubiquitinated proteins shorter than 150 residues can be degraded by the 
proteasome whereas longer ones need to be polyubiquitinated to have the same 
fate (Shabek et al, 2012). 
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Monoubiquitination 
Modification of a substrate by a single Ubiquitin moiety is called 
monoubiquitination. Monoubiquitination regulates DNA repair, histone function, 
gene expression, and receptor endocytosis (Hicke, 2001; Di Fiore et al, 2003; 
Hoeller et al, 2006; Bergink & Jentsch, 2009). 
There are various ways tin which monoubiquitination can occur. E2s, E3s, or the 
substrate itself determine whether only one lysine on the substrate is modified 
(monoubiquitination), more than one lysine is modified (multi-monoubiquitination) or 
if a lysine on the substrate is modified with a chain of Ub molecules 
(polyubiquitination). 
Proteins that contain Ubiquitin-binding domains (UBD) are defined as Ub receptors. 
These receptors can be monoubiquitinated following a process known as “coupled 
monoubiquitination” which requires their UBD. Once a UBD protein is 
monoubiquitinated, it can suffer a change in its conformation due to an 
intramolecular binding between the UBD and the Ub molecule attached to it. The 
protein is then intrinsically switched off and is no longer able to bind ubiquitinated 
substrates (Di Fiore et al, 2003; Hoeller et al, 2006; Woelk et al, 2006). 
Eps15 is an endocytic protein that contains two UBDs, specifically two UIMs, and 
undergoes coupled monoubiquitination by means of two different ligases, Nedd4 
and Parkin. When Eps15 is ubiquitinated by a Nedd4, the ligase needs to be first 
modified by ubiquitination and contain a thiolester conjugated Ubiquitin. Next, the 
UIM2 of Eps15 binds the Ubiquitin moiety linked to the Nedd4 ligase and then the 
thiolester-bound Ub is transferred to Eps15 (Woelk et al, 2006). 
When the ligase is Parkin, the UBL domain in Parkin interacts with the UIM of 
Eps15 and then the E2 transfers the Ub to Eps15 resulting in its monoubiquitination 
(Fallon et al, 2006). Once Eps15 is monoubiquitinated, the UIM interacts 
intramolecularly with the attached Ub avoiding both further Ubiquitin chain 
extension in Eps15 and the interaction with ubiquitinated substrates. 
Analogously to Eps15, it has been suggested that the UIM of Rpn10 interacts with 
the ubiquitins linked to the lysines in Rpn10. The intramolecular interaction could 
suppose a mechanism to both regulate the interaction with polyubiquitinated 
substrates and prevent Rpn10 from being polyubiquitinated (Isasa et al, 2010). 
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UBD-containing proteins can also be monoubiquitinated in an E3-independent step. 
The Ubiquitin attached to the active site of an E2 interacts with the UBD and Ub is 
transferred directly to the substrate (Hoeller et al, 2007). 
Additionally, monoubiquitination can be generated by restricting polyubiquitination. 
Rad18 E3 ligase blocks the Ubiquitin-chain synthesis activity of the E2 Rad6, 
promoting monoubiquitination of the proliferating cell nuclear antigen, PCNA 
(Hibbert et al, 2011). 
Moreover, in the process of histone H2A monoubiquitination by the polycomb 
complex Bmi1-RING1, a model was proposed in which the rigidity of the E2-E3 
complex assembled to DNA and nucleosomes promotes K119 specific 
monoubiquitination (Bentley et al, 2011). 
Monoubiquitination is also promoted by the catalytic activity of DUBs that trim 
polyubiquitin chains on substrates leaving just one Ubiquitin molecule (Kee et al., 
2005). 
The process of monoubiquitination can be induced by an external protein cofactor 
that modulates enzyme processivity, such as Vps23. When the arrestin family 
protein Rim8/Art9 is monoubiquitinated by Rsp5, the UBD of Vps23 interacts with 
the Ub linked to Rim8/Art9, which then prevents its further polyubiquitination 
(Herrador et al, 2010). 
A thorough study from our lab on the mechanisms of monoubiquitination has been 
recently accepted (Puig-Sàrries, & Crosas, 2015). 
 
 
Rpn10 
Rpn10, previously known as Mcb1 for Multiubiquitin chain-binding protein, is 
a subunit of the proteasome that can also be found in an extraproteasomal pool 
(van Nocker et al, 1996b). Rpn10 is composed of an N-terminal von Willebrand 
factor A domain (VWA) and a C-terminal Ubiquitin-interacting motif (UIM) that binds 
to Ubiquitin (Figure 12). The VWA domain is a globular domain thought to be 
responsible for the lid-base interaction of the proteasome. When Rpn10 is deleted 
or the VWA domain is mutated, the RP is dissociated into the base and the lid 
(Verma et al, 2004; Glickman et al, 1998a; Fu et al, 1998). However, Lander and 
coworkers observed by electron microscopy that the VWA does not contact the 
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base but bridges Rpn9 and Rpn11 subunits, increasing lid-base affinity (Lander et 
al, 2012). The VWA of S5a, the Rpn10 human orthologue, has been described as a 
receptor for FAT10, an Ubiquitin-like protein that targets substrates for proteasomal 
degradation. The proteolysis of targets linked to FAT10 can be accelerated by the 
UBA-UBL protein, NUBL1 that also binds the VWA. Interestingly, the VWA suffices 
to enable FAT10 degradation while the lack of this globular domain causes 
accumulation of FAT10 (Rani et al, 2012). 
 
 
Figure 12. Three-dimensional representation of Schizosaccharomyces pombe 
Rpn10 based on the VWA crystal structure and the homology-modeled C-
terminus. 
Rpn10 consists of the globular domain, VWA and the UIM domain within an helix. The 
LALAL motif is represented in cyan. Adapted from (Riedinger et al, 2010). 
 
 
In yeast, Rpn10 contains one UIM while human S5a, and Drosophila Psmd4 
orthologues, contain two and three copies, respectively (Young et al, 1998). The 
UIM is a sequence motif of about 20 amino acids that is found in the context of an 
α-helix and contains 5 hydrophobic residues that form an alternating pattern of 
large and small side chains, Leu-Ala-Leu-Ala-Leu in S5a, and this pattern is 
essential for binding Ub chains (Deveraux et al, 1994; Young et al, 1998). In yeast, 
the pattern changes slightly to Leu-Ala-Met-Ala-Leu (LAMAL motif). This motif is 
conserved throughout eukaryotes and it can be found in proteins involved in 
different processes such as endocytosis, protein trafficking, and signal 
transduction. All conserved residues are found exposed on one face (Shekhtman & 
   Introduction 
	  
 31 
Cowburn, 2002), nevertheless, UIMs can be partially or totally masked by the 
folded protein in which they are contained.  
 
Rpn10, together with Rpn13 and Rpn15, functions as the main Ubiquitin 
receptor of the proteasome (Deveraux et al, 1994; Husnjak et al, 2008; Schreiner et 
al, 2008; van Nocker et al, 1996b; Paraskevopoulos et al, 2014). These three 
subunits are not essential for yeast viability, indicating the presence of other 
proteasomal Ubiquitin receptors (van Nocker et al, 1996b; Husnjak et al, 2008; 
Finley, 2009). Cyclin B1, Sic1, Gic2 and Gcn4 are some of the substrates that 
Rpn10 targets to the proteasome (Hanna et al, 2006; Seong et al, 2007; Verma et 
al, 2004). The elimination of a portion of newly synthesized proteins upon oxidative 
and thermal damage also depends on the Rpn10 subunit (Medicherla & Goldberg, 
2008). 
An electron cryomicroscopy study localized Rpn10 and Rpn13 in the apical 
part of the RP (Sakata et al, 2012). The surface of the VWA domain of Rpn10 
interacts with several proteins in the RP: Rpn1, 2, 9 and 12 (Riedinger et al, 2010; 
Xie & Varshavsky, 2000; Takeuchi et al, 1999), while the UIM is close to Rpt4 and 
Rpt5. Rpn13 interacts only with Rpn2 (Sakata et al, 2012). The fact that both Ub 
receptors are found in an apical position and that they are not necessary to 
maintain the structural integrity of the proteasome agrees with the survival of their 
knockouts. In addition to these two receptors, there exist shuttling Ub receptors, 
including Rad23, Dsk2 and Ddi1 that bind the proteasome through their UBL 
domain (Bertolaet et al, 2001; Funakoshi et al, 2002). For instance, Dsk2 binds 
Rpn1, 10 and 13 (Matiuhin et al, 2008, Funakoshi et al. 2002, Husnjak et al. 2008). 
In an extraproteasomal context, Rpn10 was seen to have a biological role in 
restricting the access of Dsk2 to the proteasome by means of an interaction 
between the UIM and the UBL of Dsk2 (Matiuhin et al, 2008).  
Rpn10 has high ability to bind K48 Ubiquitin chains and preferentially binds 
Ub chains rather than monomers (van Nocker et al, 1996a, 1996b; Haracska & 
Udvardy, 1997). Substituting the UIM sequence with five asparagines abolishes 
chain binding, produces a decrease in the proteolytic capacity of the proteasome 
and is lethal in mouse (Fu et al, 1998; Elsasser et al, 2004; Verma et al, 2004; 
Isasa et al, 2010; Hamazaki et al, 2007). 
Quantitative analysis of Ubiquitin conjugates from Saccharomyces cerevisiae 
cultures underscored the importance of Rpn10 on targeting ubiquitinated substrates 
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to the proteasome. Mayor et al. identified around 60 Ubiquitin conjugates that 
accumulated upon proteasome inhibition in a strain lacking Rpn10, 12 of which also 
accumulated in a strain carrying an Rpn10 mutant that lacked the UIM (Mayor et al, 
2007). The substrates that accumulated in rpn10Δ, but not in the strain lacking the 
UIM, probably are dependent upon the VWA domain. This finding agrees with the 
phenotypes observed when expressing both kind of strains, where rpn10Δ strain 
has a more severe growth defect (Fu et al, 1998). 
Recently, it has been shown that in the mammalian brain, Rpn10 proteasome 
association/dissociation is tightly regulated by Id1 protein, having special relevance 
in dendrite development (Puram et al, 2013). Crosas et al. reported that the 
Ubiquitin ligase Hul5 promotes Rpn10 polyubiquitination and subsequent 
degradation by the proteasome (Crosas et al, 2006). Later, a former member of our 
lab observed the monoubiquitination of Rpn10 (mUb-Rpn10) in both proteasomal 
and extraproteasomal pools (Isasa et al, 2010). Isasa et al found that mUb-Rpn10 
levels are regulated by the Ubiquitin ligase Rsp5 and the DUB, Ubp2. On the 
contrary, it has been suggested that S5a is polyubiquitinated by a large variety of 
Ub ligases, and even likely by all E3s (Kim & Goldberg, 2012).  
Rpn10 is mainly ubiquitinated at lysines K84, in the VWA domain, and K268, at the 
C-terminus of the protein, although ubiquitins can also be linked at K77 and K99. 
Importantly, the UIM is indispensable for Rpn10 ubiquitination and mUb-Rpn10 can 
no longer bind polyubiquitinated substrates in vitro, reducing the proteolytic activity 
of the proteasome (Isasa et al, 2010). The inability of mUb-Rpn10 to bind Ub 
chains could be explained by an intramolecular interaction between the linked Ub 
and the UIM leading to a self-inactivated state of the protein. Indeed, a ‘fold-back’ 
model, based on a structural conformational change in the monoubiquitinated 
protein promoted by the interaction between a Ubiquitin-binding domain (UIM, 
CUE…) and Ubiquitin, has been proposed in several works (Polo et al, 2002; 
Hoeller et al, 2006; Shih et al, 2003). Interestingly, a flexible linker region 
connecting the VWA domain and the UIM has been described (Wang et al, 2005; 
Riedinger et al, 2010). However, a correlation between structural properties and 
monoubiquitination of the substrate has never been established.  
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OBJECTIVES 
 
The main objective of this thesis has been to uncover the mechanisms by which 
Rpn10 is monoubiquitinated by Rsp5. This goal has been divided into the following 
points: 
 
1. To optimize the Rpn10 ubiquitination reaction. 
2. To evaluate the effect of an additional Rsp5 interacting motif on Rpn10. 
3. To determine the efficiency of Ubiquitin ligases other than Rsp5 in the 
reaction of Rpn10 ubiquitination. 
4. To assess Ubp2 activity in deubiquitinating Rpn10. 
5. To analyze the effect of Rpn10 monoubiquitination in vivo. 
6. To determine the minimal sequence requirements for Rpn10 ubiquitination. 
7. To reproduce Rpn10 monoubiquitination with its human orthologue S5a, 
using the Rsp5 orthologue, Nedd4. 
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This project started with my master thesis and continued for four years 
more. During this time, different initiatives have been approached to better 
understand the mechanisms underlying Rpn10 ubiquitination. I would like to 
include, as a first chapter, part of the work I did during the master and beginning of 
the thesis. 
 
 
 
Purification of UbRpn10L85 to analyze K84 
ubiquitinated Rpn10 
 
The subunit of the proteasome Rpn10 was found to be ubiquitinated at four 
different lysines (Isasa et al, 2010). Mass spectrometry analyses of in vitro and in 
vivo pools of Rpn10 revealed that Rpn10 is mainly ubiquitinated at lysines 84 and 
268 by Rsp5, lysine 84 being the most abundantly modified residue (Isasa et al, 
2010). It has been suggested that, once Rpn10 is monoubiquitinated, the linked Ub 
interacts with the UIM of Rpn10. To investigate whether this hypothesis was true, 
we decided to analyze Rpn10 monoubiquitination at lysine 84 by X-ray and NMR 
and see if that interaction existed. To be able to do this characterization, we 
needed large amounts of very pure protein. For that reason, we decided to prepare 
a plasmid that would allow us the overexpression and purification of a protein that 
would mimic the ubiquitination of Rpn10 at lysine 84. This protein consisted of a 
chimera that included the entire Ubiquitin sequence (residues 1-76) fused by 
means of a short linker to residues 85-268 of Rpn10 and was N-terminally GST 
tagged. Normally, the C-terminal glycine residue of Ub forms an isopeptide bond 
with the side chain of lysine 84 in Rpn10. The stop codon in Ub was mutated to a 
glycine and the short linker consisted of two other glycines because the result is 
almost isosteric with the side chain of lysine 84 and the isopeptide bond to the C-
terminus of Ubiquitin (Freudenthal et al, 2010). We obtained then, by PCR 
amplification, GST-Ubiquitin-GGG-Rpn1085-268, hereafter, GST-UbRpn10L85.  
GST-UbRpn10L85 was cloned into a pGEX-4-T vector and transformed into E. coli 
strain BL21. We expressed the chimera as a GST fusion protein that we induced 
with IPTG and we purified by GST affinity chromatography. The elutions obtained 
were run in a Coomassie gel and we observed that they contained two bands 
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(Figure 13). The upper band had a mobility close to the one expected for GST-
UbRpn10L85 (54,5KDa), while the lower band appeared to be a contaminant of a 
molecular weight (MW) of around 34 KDa. It is important to note that Rpn10 
properties affect the mobility of the protein when it is run in SDS-PAGE gels, 
resulting in a considerable different estimated molecular mass from the true one. 
For this reason, it was reasonable to observe that the protein ran more slowly than 
expected (60KDa vs. 54,5KDa).  
 
Figure 13. Purification of GST-UbRpn10L85. 
Coomassie staining of SDS-PAGE showing GST-UbRpn10L85 and a contaminant. 
 
 
To analyze the nature of the band with the slower mobility, we did a mass 
spectrometry analysis, which proved the band to be GST-UbRpn10L85. The 
conformation of glycine residues has great freedom so that they can provide 
flexibility for adjacent residues (Yan & Sun Qing, 1997; Serrano et al, 1992) This 
fact led us to hypothesize firstly, that the presence of a contaminant could be due to 
the truncation of the protein between GST-Ub and Rpn10L85 fragment because of 
the flexibility given by the three glycines and, secondly, that this contaminant was 
GST-Ub. In fact, the GST and the Ubiquitin together have a MW of around 34 KDa, 
which was consistent with the molecular weight of the band observed. However, we 
could not observe any additional band that could correspond to Rpn10L85 
fragment. 
 
To verify our hypothesis, we performed a thrombin cleavage in order to remove the 
GST tag. If the hypothesis was true and the contaminant was GST-Ub, the product 
of the thrombin cleavage should include UbRpn10L85, GST and Ubiquitin. The 
observation of a band (although weak) with a MW close to the one that Ub has (8,5 
KDa) made us conclude that the contaminant must have been GST-Ub (Figure 14). 
GST-UbRpn10L85!
contaminant!
Coomassie!
60 
34 
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Two additional bands were observed that we presumably associated with 
UbRpn10L85 (∼ 28, 5 KDa) and GST (26 KDa).  
 
The thrombin cleavage resulted in the removal of GST from both, GST-
UbRpn10L85 and GST-Ub, which explained the stronger band of the GST alone 
with respect to the UbRpn10L85 band. 
 
 
Figure 14. Thrombin cleavage of GST-UbRpn10L85. 
Left panel shows GST-UbRpn10L85 and the contaminant before the thrombin cleavage 
(BTC). Right panel shows the products of the digestion after the thrombin cleavage 
(ATC). 
 
 
For NMR and X-ray methods, the protein to be analyzed needed to be as pure as 
possible. For that, we proceeded to apply a size-exclusion chromatography using a 
Superdex 200 10/300 column (GE Healthcare), a technique that separates proteins 
according to their size. The molecular weight of the contaminant appeared to be 
sufficiently lower than our protein to make separation feasible. We expected that 
the larger molecule, GST-UbRpn10L85, would elute earlier than GST-Ub and, thus, 
that we would obtain two different peaks. However, although observing two peaks, 
a SDS-PAGE gel revealed that the separation was not complete and the 
contaminant was not fully removed from the full-length protein (Figure 15).  
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Figure 15. Size-exclusion chromatograpy of GST-UbRpn10L85 using a Superdex 
200 column. 
Profile of a size-exclusion chromatography. Fractions 15 through 19 (peak 1) and 22, 
23 and 24 (peak 2) were loaded on a Coomassie staining of SDS-PAGE. 
 
 
Next, we concentrated the fractions 15 through 19 that contained mainly the 
protein of interest and we performed an ion-exchange chromatography (monoQ) 
with a salt gradient that gradually elutes the proteins. Indeed, this technique 
separates proteins with different ionic strengths. We analyzed on a Coomassie gel 
the different elutions that we obtained and we observed that the fractions 
containing GST-UbRpn10L85 were not completely pure (Figure 16).  
 
 
2
Peak 2 
Peak 1 
 
contaminant!
Coomassie!
Peak 1! Peak 2!
Fractions! 15 16 17 19 18 22 24 23 
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Figure 16. Ion-exchange chromatography. 
Coomassie staining of SDS-PAGE of the fractions obtained after performing an ion-
exchange chromatography that contained GST-UbRpn10L85. 
 
 
To further purify the protein, we concentrated the elutions that mainly contained 
GST-UbRpn10L85 and we performed a thrombin cleavage. In order to remove the 
GST tag, we bound the elution to new Glutathione Sepharose beads (not shown). 
Next, we injected our sample into a size-exclusion column (Figure 17). Surprisingly, 
the Superdex could not elute Ub and UbRpn10L85 separately while all the GST 
was successfully removed from the fractions. 
 
 
Figure 17. No traces of GST after the size-exclusion chromatography. 
Coomassie staining of SDS-PAGE showing the proteins eluted after using a Superdex 
200. 
 
 
Finally, we concentrated the fractions containing mostly UbRpn10L85 and we 
performed an ion-exchange chromatography (Figure 18) resulting in UbRpn10L85 
95% pure. We observed some minor bands that could derive from a degradation of 
UbRpn10L85.  
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Figure 18. UbRpn10L85 is 95% pure. 
Profile of the ion-exchange chromatography. Arrow points the peak including the 
fractions we ran: fractions 30 through 36. Below, Coomassie staining of SDS-PAGE 
showing the fractions obtained after running the sample through a monoQ column. 
Asterisks show some minor bands. 
 
 
As a summary, after expressing 5 L of culture and finding the right 
conditions to purify UbRpn10L85, we just could purify 172 µg of 95% pure protein, 
which did not seem feasible to obtain large enough amounts for X-ray and NMR.  
 
 
Optimization of the Rpn10 ubiquitination reaction 
 
Rpn10 is ubiquitinated only when a three-step enzymatic cascade catalyzes 
the reaction. The incubation of Rpn10 with recombinant E1 (Uba1), E2 (Ubc4), E3 
(Rsp5) and Ubiquitin results in the mono or multi-monoubiquitination of the 
substrate. Multi-monoubiquitination consists of the linkage of up to four ubiquitins to 
1
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the four ubiquitinable lysines in Rpn10, generating di-, tri- or tetraubiquitinated 
Rpn10 (Isasa et al, 2010). 
To study in more detail the mechanisms by which Rpn10 is ubiquitinated, we 
decided to optimize the in vitro enzymatic reaction of Rpn10 ubiquitination that was 
firstly described by Isasa and collaborators (Isasa et al, 2010). 
Before starting the optimization, the conditions we used to perform 
ubiquitination reaction of Rpn10 were the following: 
Rpn10, Uba1, Ubc4 and Rsp5 were purified in the lab while Ub was 
commercial. We used 50 nM of Rpn10, 285 nM of Uba1, 10.9 µM of Ubc4, 150 nM 
of Rsp5 and 37,5 µM of Ubiquitin. Reactions were carried out in 100 mM Tris‐HCl 
pH 7.4, 200 mM NaCl, 10 mM ATP, 10 mM MgCl2, 1 mM DTT buffer at 30ºC for 3 
hours.  
According to Isasa et al, 100 nM of Uba1 from Enzo Life Sciences were enough to 
carry out the reaction. However, we used to use 285 nM of Uba1 from a purification 
I did during my visit to the University of Wurzburg, Germany at the lab of Dr. 
Schindelin (more information in the section Material and methods; (Lee & 
Schindelin, 2008)). We adjusted that amount in order to reach the same enzyme 
activity that we had when using the commercial Uba1: 285 nM Uba1 corresponded 
to 100 nM Uba1 (Enzo) with respect to the activity of the enzyme.  
We started the optimization of the reaction by first varying the amount of 
ligase needed keeping all other components constant (Figure 19A and B). We 
observed that 50 nM of Rsp5 was the most suitable amount of ligase to produce 
ubiquitinated Rpn10, since there was little increase of modified Rpn10 when using 
higher amounts of Rsp5 (Figure 19A and B). Next, we evaluated the concentration 
of Uba1 needed. During this thesis, two Uba1 enzymes have been used. The first 
one was purified during my visit to Dr. Schindelin’s lab, as mentioned above, and 
was used in Figure 19A, B and C (Purif. 1). Later, we purified Uba1 in our lab. To 
assess its activity, we did a titration in an ubiquitination reaction (Figure 19C, Purif. 
2). Following the same criteria as for Rsp5, we concluded that working with 87 nM 
of Uba1 was enough to achieve an adequate ubiquitination reaction (Figure 19C). 
In a parallel assay, we optimized the amount of Ubc4 required for our reactions. 
The reaction was not more efficient when using more than 5,7 µM of the 
conjugating enzyme (Figure 19D).  
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Figure 19. Optimization of the in vitro reaction of Rpn10 ubiquitination. 
A) and B) Increasing concentrations of Rsp5 were used for Rpn10 ubiquitination 
reactions. C) Rpn10 ubiquitination reactions using different amounts of Uba1 enzyme. 
Purif. 1 refers to the purification during my visit to Schindelin’s lab in Wurzburg. Purif. 2 
refers to the purification done in our lab. D) Different concentrations of Ubc4 were used 
for each reaction. Concentrations of the other enzymes used to perform the reactions 
are included in the panels. Equal amounts of GST-Rpn10 were used for all the 
reactions, that is 50 nM. Reactions were all incubated at 30ºC for 3 hours. 
 
 
As a summary, we include below a table detailing the reagent’s 
concentrations of optimized in vitro ubiquitination reactions. 
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 Interestingly, even under optimal conditions or with an excess of E1, E2 or 
E3, we never obtained Rpn10 polyubiquitinated.  
 
 
Effect of the PPAY motif in Rpn10 ubiquitination 
 
As seen in Figure 19 of the previous chapter, Rsp5 is virtually unable to 
build polyubiquitin chains on Rpn10 (Keren-Kaplan et al, 2011; Isasa et al, 2010) 
(Figure 19). This is striking since the ability of Rsp5 to modify substrates by 
polyubiquitination has been extensively demonstrated (Kim et al, 2009; Saeki et al, 
2009; Kim et al, 2011a; Kee et al, 2005, 2006; Rotin & Kumar, 2009). We were 
interested in understanding the basis and to test the hypothesis that features of the 
substrate, in this case Rpn10, determine the nature of the ubiquitination. First of all, 
we wanted to investigate whether Rsp5 is able to polyubiquitinate Rpn10 at all. For 
this reason, we analyzed Rsp5 activity in our Rpn10 ubiquitination assays by 
evaluating the effect of an additional enzyme interaction motif on Rpn10. To do 
that, we placed a proline-proline-alanine-tyrosine (PPAY) motif at its N-terminus. A 
large group of Rsp5 substrates are PPXY-containing proteins, which bind to the 
WW motifs of Rsp5 and thus promote a productive substrate-enzyme interaction 
that usually yields polyubiquitination (Gupta et al, 2007; Kim et al, 2009; Lu et al, 
2008; Saeki et al, 2009). We performed ubiquitination reactions using wild type 
Rpn10 (Rpn10) and the form carrying a PPAY motif (PPAYRpn10) and we observed 
that, whereas the reaction using Rpn10 produced monoubiquitination at 2 or 3 
positions (see also Isasa et al, 2010), the one using PPAYRpn10 resulted in a strong 
signal of polyubiquitinated forms (Figure 20A). Using different concentrations of 
Rsp5 we observed that this pattern was reproducible at all concentrations used 
(Figure 20B). Thus, by adding the PPAY enzyme-binding motif, the pattern of 
modification of Rpn10 changed substantially, from monoubiquitination to 
polyubiquitination. The specificity of the reaction catalyzed by Rsp5 was also 
assessed by a chain topology analysis. Previous work showed that Rsp5 builds 
K63 Ubiquitin chains on protein substrates (Kee et al, 2005; Kim et al, 2009; Saeki 
et al, 2009). We carried out reactions with Rpn10 and PPAYRpn10 in the presence of 
WT, K63R, K48R, K63-only and K48-only versions of Ubiquitin. We observed that 
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the Ub forms containing lysine 63 (WT, K63-only and K48R ubiquitins) were 
competent in producing polyubiquitination on PPAYRpn10, while K48-only and K63R 
ubiquitins produced short oligoubiquitination or multi-monoubiquitination (Figure 
20C). Therefore, in our assays, Rsp5 exhibited a K63-based Ubiquitin-chain 
synthesis activity, in agreement with the previously characterized topological 
specificity (Kee et al, 2005; Kim et al, 2009; Saeki et al, 2009). We therefore 
conclude that the monoubiquitination of Rpn10 does not result from an impaired 
polyubiquitination activity of Rsp5, but is determined by specific features of Rpn10. 
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Figure 20. Rsp5 polyubiquitinates PPAYRpn10. 
A) Ubiquitination reactions of Rpn10 and PPAYRpn10 analyzed by western blotting using 
Rpn10 antibody. Time points were taken as shown. Long (L) and short (S) exposures 
of the film are shown. B) PPAYRpn10 is polyubiquitinated using different concentrations 
of Rsp5. Ubiquitination reactions of Rpn10 and PPAY Rpn10 using three different 
concentrations of Rsp5 were analyzed by anti-Rpn10 western blotting. C) 
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Ubiquitination reactions of Rpn10 and PPAYRpn10 incubated with WT, K63R, K48R, 
K63-only and K48-only versions of Ubiquitin. 
 
 
 
 The Ubiquitin-interacting motif (UIM) of Rpn10 is an indispensable motif that 
gives Rpn10 the capacity to interact with Ubiquitin conjugates. Moreover, the UIM 
has been described as a requirement for Rpn10 monoubiquitination (Isasa et al, 
2010). For that reason, we wondered whether the UIM motif was still indispensable 
to guarantee the reaction when the PPAY motif was also present. Considering the 
ability of Rsp5 to polyubiquitinate substrates that carry a PPAY motif and lack a 
UIM, it was reasonable to expect a modification in the status of Rpn10 (Figure 21). 
Interestingly, when the UIM was mutated (we introduced a block substitution from 
residues 228 to 232 of the UIM (LAMAL à NNNNN) (Elsasser et al, 2004)), the 
reaction was completely abrogated, for either mutant, Rpn10UIM or PPAYRpn10UIM. 
Thus, the presence of the PPAY motif was not enough to ensure the reaction. This 
result underscores, once more, the key role that the UIM plays in Rpn10 
ubiquitination. 
 
 
Figure 21. The UIM is still required to ubiquitinate PPAYRpn10. 
Ubiquitination reaction of Rpn10, Rpn10UIM, PPAYRpn10 and PPAYRpn10UIM analyzed by 
anti-Rpn10 western blotting. 
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The HECT domain of Rsp5 is sufficient for Rpn10 
monoubiquitination 
 
The polyubiquitination of PPAYRpn10 by Rsp5 most likely resulted from an 
interaction between the Rsp5 WW domain and the PPAY motif. However, it was 
also possible that the N-terminal PPAY motif caused an altered conformation of 
Rpn10, facilitating an aberrant ubiquitination. To approach this point, we analyzed 
ubiquitination of PPAYRpn10 in the presence of an Rsp5 version lacking WW motifs. 
Therefore, we generated a HECT domain construct (Rsp5HECT), encompassing 
residues 420 to 809, which includes the catalytic domain but not the WW motifs 
(Figure 22A). We tested the activity of full-length Rsp5 and Rsp5HECT in reactions 
using Rpn10 and PPAYRpn10 as substrates, and observed that, while full-length 
Rsp5 showed distinct activities towards Rpn10 and PPAYRpn10 (multi-
monoubiquitination and polyubiquitination, respectively), Rsp5HECT exhibited 
monoubiquitination on both these substrates (Figure 22B), suggesting that the N-
terminal PPAY motif on Rpn10 does not cause aberrant ubiquitination. Moreover, 
with these assays we could show that Rsp5HECT was even more efficient in Rpn10 
monoubiquitination than the full-length Rsp5 protein. 
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Figure 22. Rpn10 is monoubiquitinated in vitro by the HECT domain of Rsp5. 
A) Schematical representation of Rsp5 and Rsp5HECT. Rsp5 contains an amino-terminal 
C2 domain, three WW domains and the HECT domain. The catalytic cysteine of the 
HECT is shown (C777). Rsp5HECT encompasses residue positions 420 and 809. B) 
Reactions of ubiquitination of Rpn10 and PPAYRpn10 incubated with Rsp5 full-length or 
Rps5HECT. Long (L) and short (S) exposures of the film are shown. 
 
 
 Of the five HECT Ubiquitin ligases found in yeast, only Rsp5 has been 
proved to be the major E3 that ubiquitinates Rpn10, so far (Isasa et al, 2010). Hul5 
and Ufd4 ligases have been already ruled out (Isasa et al, 2010), while Tom1 and 
Hul4 have never been studied from the point of view of Rpn10 ubiquitination. In 
order to shed light on this subject, we studied the efficiency of these two ligases in 
the ubiquitination of Rpn10. After performing ubiquitination reactions, we observed 
that Rsp5HECT appeared to be much more efficient than the HECT domain of Tom1, 
in the reaction of Rpn10 monoubiquitination. Parallel assays using Rsp5HECT and 
Tom1HECT, showed that, despite the fact that Tom1HECT shows higher catalytic 
activity than Rsp5HECT, assessed by the level of auto-ubiquitination (Figure 23A), 
Rsp5HECT was much more competent in ubiquitinating Rpn10 (Figure 23B and C). 
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Figure 23. Rsp5 is more efficient than another Ubiquitin ligase in ubiquitinating 
Rpn10. 
A) Autoubiquitination reaction of Rps5HECT and Tom1HECT with Ub WT analyzed by 
western blotting using an anti-Ub antibody. B) Rpn10 ubiquitination assays using 
Rsp5HECT or Tom1HECT at different concentrations analyzed by western blotting using an 
Rpn10 antibody. C) 2 µg of purified Rsp5HECT (black arrow) and Tom1HECT were 
resolved by SDS-PAGE and detected using Coomassie blue staining. 
 
 
We also tested the efficiency of the HECT domain of the Ubiquitin ligase Hul4 in 
ubiquitinating Rpn10. Interestingly, Rpn10 was not modified after performing an 
ubiquitination reaction with this ligase at any concentration used (Figure 24A). To 
know whether this result was due to a lack of specificity or a lack of activity of 
Hul4HECT, we assessed the levels of auto-ubiquitination of the ligase. We observed 
that Hul4HECT was not auto-ubiquitinated and therefore not active, which would 
explain the absence of reaction in Rpn10 (Figure 24B). 
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Figure 24. Hul4HECT is not catalytically active.  
A) Rpn10 ubiquitination reactions with Rsp5HECT or Hul4HECT at different 
concentrations. B) Autoubiquitination assay of Rps5HECT and Hul4HECT with Ub WT. 
 
 
From these assays we could conclude that Rsp5HECT, although inactive in the 
polyubiquitination of Rpn10, is the most efficient HECT ligase in S. cerevisiae in 
ubiquitinating Rpn10, although an active Hul4HECT should be tested before being 
able to confirm this. Moreover, from the results obtained in Figure 22, we can say 
that Rsp5HECT showed a stronger activity towards Rpn10 ubiquitination than Rsp5 
full-length. 
 
 
Ubp2 rescues monoubiquitination in PPAYRpn10 
ubiquitination reactions 
  
Ubp2 is a deubiquitinating enzyme that exhibits antagonistic activity with 
respect to Rsp5 and that exists in a complex with Rsp5 (Kee et al., 2005). The 
hydrolysis takes place between a lysine of an Ubiquitin moiety and the C-terminus 
of the next Ubiquitin. When the DUB removes all the Ub moieties except the one 
that is bound to the substrate, the result is a monoubiquitinated substrate. 
Harreman et al, observed that polyubiquitinated RNAPII was efficiently hydrolyzed 
by Ubp2, generating monoubiquitinated RNAPII (Harreman et al, 2009). It was 
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previously shown in our lab that the levels of mUb-Rpn10 are regulated by Ubp2 
(Isasa et al, 2010; Kee et al, 2005). Therefore, we next wanted to evaluate whether 
the polyubiquitination chains formed in PPAYRpn10 could be counteracted by Ubp2 
activity and consequently, monoubiquitinated Rpn10 could be generated. For that, 
we did an ubiquitination reaction of both, Rpn10 and PPAYRpn10. We incubated the 
product of these reactions with different amounts of Ubp2 and for different times 
(Figure 25A and B). Although the ubiquitination reaction of PPAYRpn10 was not very 
efficient, Ubp2 was competent in partially hydrolyzing the Ubiquitin chains. Indeed, 
after 120 minutes of incubation with Ubp2, most of Rpn10 and PPAYRpn10 were 
mono or diubiquitinated.  
  To further evaluate the complex formed by Rsp5 and Ubp2, we did an 
ubiquitination reaction in the presence of Ubp2. We wondered how the reaction 
would be influenced by the presence of the hydrolase. We observed that Ubp2 was 
extremely efficient in deubiquitinating Rpn10 considering that no modified state of 
Rpn10 was visible at all (Figure 25B). Indeed, with only 10 nM Ubp2, whereas 50 
nM Rsp5 was present, monoubiquitination of Rpn10 was not observed. In contrast, 
in a 3 hours’ reaction, where Ubp2 is not present, at least mono- and 
diubiquitination of Rpn10 can be observed (Figure 25A and B, lane 2). 
 On the other hand, a longer incubation and a higher amount of Ubp2 were 
needed to obtain the same result when studying the effect of the deubiquitinase on 
PPAYRpn10 (Figure 25B, lower panel). The higher affinity between Rsp5 and the 
PPAY motif and the subsequent polyubiquitination of the substrate could explain 
this result. Interestingly, only 10 nM Ubp2 after a 2 hours’ incubation were needed 
to rescue PPAYRpn10 mono- and diubiquitination.  
 Finally, the same experiment was repeated using Rsp5HECT instead of Rsp5 
full-length in the presence of Ubp2. Under these conditions, it seemed that Ubp2 
was not able to catalyze complete Rpn10 deubiquitination and monoubiquitinated 
proteins remained. This is consistent with a stronger capacity of Rsp5HECT to 
ubiquitinate Rpn10 compared to Rsp5 full-length. 
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Figure 25. Ubp2 deubiquitinates PPAYRpn10. 
A) Ubiquitination reaction of Rpn10 and PPAYRpn10 (lanes time 0) followed by a time-
course deubiquitination reaction with Ubp2. B) Time-course ubiquitination reaction of 
Rpn10 and PPAYRpn10 in the presence of Ubp2 and 50 nM Rsp5. The 3 hours’ 
reactions (upper and lower panels) show an ubiquitination reaction of these substrates 
without Ubp2 to facilitate comparisons. C) Time-course ubiquitination reaction of Rpn10 
and PPAYRpn10 in the presence of Ubp2 and 50 nM Rsp5HECT. The first four lanes 
(upper and lower panels) show an ubiquitination reaction of these substrates without 
Ubp2 to facilitate comparisons. Asterisks in Figure 25B and C show a protein present in 
the Ubp2 purification that crossreacts with the anti-Rpn10 antibody. 
 
 
 We conclude from these experiments that the balance of the activity of these 
two counteracting proteins, Rsp5 and Ubp2, is important for the final outcome of 
ubiquitination of Rpn10.  
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Slow growth defect caused by increased levels of 
monoubiquitinated Rpn10 
 
 The high level of Rpn10 monoubiquitination by Rsp5HECT (Figures 22B and 
23B) could be used as a valuable tool for the physiological analysis of Rpn10 
monoubiquitination in vivo. In a previous study, it was shown that mUb-Rpn10 is 
inactive as a polyubiquitin receptor, causing a decrease in proteasome activity, thus 
constituting a direct mechanism of polyubiquitin receptor regulation (Isasa et al, 
2010). Moreover, the levels of Rpn10 monoubiquitination are tightly controlled in 
vivo, and high levels of Rpn10-Ubiquitin (Rpn10 including C- terminally fused 
Ubiquitin) cause growth deficiency in yeast (Isasa et al, 2010). Our finding here that 
the HECT domain of Rsp5 alone is sufficient for monoubiquitination of Rpn10 gave 
us the opportunity to functionally analyze the impact of Rsp5-dependent Rpn10 
monoubiquitination without affecting the regulation of numerous PPXY-dependent 
protein substrates in vivo (Gupta et al, 2007; Lin et al, 2008; Lu et al, 2008; 
Belgareh-Touzé et al, 2008; Nikko & Pelham, 2009). Therefore, we placed 
Rsp5HECT under the control of the GAL4 promoter and tested the capacity of 
galactose-induced Rsp5HECT to produce monoubiquitinated Rpn10 in a wild-type 
strain in Saccharomyces cerevisiae. With this approach, we observed that Rpn10 
monoubiquitination was efficiently induced during several hours of galactose-
induced Rsp5HECT expression (Figure 26A).  
In order to show more directly that the band with a slower mobility was 
monoubiquitinated Rpn10, we next tested the effect of increased expression of 
Rsp5HECT and the catalytically inactive mutant Rsp5HECT C777A on Rpn10 and 
Rpn10K84,268R, a mutant involving the two lysine residues mainly targeted for 
ubiquitination. As expected, when Rsp5HECT was induced in the presence of 
Rpn10K84,268R monoubiquitination was totally impaired (Figure 26B, lane 8). 
Interestingly, the induction of Rsp5HECT C777A in the presence of Rpn10 resulted in a 
slight band, revealing the activity of endogenous Rsp5. 
With the same purpose to verify the nature of the band above the 
unmodified Rpn10, we performed an immunoprecipitation. After the induction of 
Rsp5HECT in a rpn10Δ strain carrying Rpn10 and Rpn10K84,268R, we 
immunoprecipitated Rpn10 in order to detect the modified Rpn10 using anti-
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Ubiquitin. Unfortunately, we had problems due to a strong cross-reactivity with 
Rpn10, which made the approach inconclusive. 
Finally, we analyzed the susceptibility of this band to deubiquitination 
(Figure 26C). As we observed previously (Figure 25; Isasa et al, 2010), Ubp2 
deubiquitinates Rpn10. If the band with the slower mobility was mUb-Rpn10, Ubp2 
should be able do deubiquitinate it. For this, a whole cell extract obtained after 
inducing the HECT domain of Rsp5 was incubated in the presence of recombinant 
Ubp2. We observed that in the control in absence of additional Ubp2, the band with 
slower mobility decreased with time while the Rpn10 band remained constant 
(Figure 26C, left lanes). In the presence of recombinant Ubp2, the disappearance 
of the band was notably accelerated. We reason that the presence of endogenous 
Ubp2 and other DUBs in the whole cell extract may be responsible for the 
processing of monoubiquitinated Rpn10 in the control, and that the addition of 
recombinant Ubp2 results in the increase of the hydrolysis of monoubiquitinated 
Rpn10 in the extract. Therefore, we conclude that the band above unmodified 
Rpn10 is monoubiquitinated Rpn10. 
Next, we analyzed the effect of Rpn10 monoubiquitination on the steady 
state levels of polyubiquitinated protein in the cell. It was previously shown in our 
lab that monoubiquitination of Rpn10 exhibits low affinity to polyubiquitinated 
substrates in vitro and that this results in a decrease in the proteolytic activity of the 
proteasome (Isasa et al, 2010). Therefore, we expected to see a rich proportion of 
polyubiquitinated substrates after inducing Rsp5HECT in a strain that carried Rpn10. 
To analyze the accumulation of polyubiquitinated conjugates, we used the whole 
cell extracts that we obtained after expressing Rpn10 or Rpn10K84,268R and inducing 
Rsp5HECT and Rsp5HECT C777A (Figure 26B and D). Interestingly, a strong 
accumulation of polyubiquitin signal was observable after induction (4 hours) of 
Rsp5HECT in cells expressing wild-type Rpn10 (Figure 26D). This observation 
suggests that a sudden increase of Rpn10 monoubiquitination correlates with 
accumulation of polyubiquitinated conjugates, which would imply the incapacity of 
Rpn10 to bind polyubiquitinated substrates and, therefore, a decrease in 
proteasome activity. 
 We next tested the effect of increased Rpn10 monoubiquitination on yeast 
growth. We expressed Rpn10 and Rpn10K84,268R in a rpn10Δ strain that carried 
HARsp5HECT or HARsp5HECT C777A galactose-inducible plasmids. Cultures were grown 
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in glucose and galactose for 4 hours and later prepared for a spot assay. Plates 
with glucose or galactose were grown at room temperature. The induction of Rpn10 
monoubiquitination by over-expressing Rsp5HECT resulted in a severe slow-growth 
phenotype (Figure 26B, lane 7 and E). Notably, both Rpn10 monoubiquitination and 
the deleterious phenotype were completely dependent on Rsp5HECT activity, since 
the catalytically inactive mutant Rsp5HECT C777A did not show the effect (Figure 26D, 
lane 10; and 2E). Moreover, a partial rescue of the slow growth phenotype was 
observed when Rpn10K84,268R was expressed and Rsp5HECT induced (Figure 26E), 
indicating the high functional impact of Rsp5-induced Rpn10 monoubiquitination on 
yeast growth. 
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Figure 26. Slow growth phenotype caused by Rpn10 monoubiquitination in vivo. 
A) Wild-type strain (FY56) carrying a HARsp5HECT galactose-inducible plasmid was 
grown in galactose or glucose media for the indicated hours. Upper panel shows the 
induction levels analyzed by western blotting using an anti-HA antibody. Endogenous 
Rpn10 was analyzed by Rpn10 western blotting, shown in the lower panel. B) rpn10Δ 
strain (S72) carrying plasmids Rpn10, Rpn10K84,268R, from its own promoter, or the 
empty plasmid and either the HARsp5HECT or HARsp5HECT C777A galactose-inducible 
plasmids were grown in glucose and galactose media for 4 hours. Rpn10 was analyzed 
by Rpn10 western blotting, shown in the upper panel. The lower panel shows the 
induction levels of Rsp5 proteins analyzed by western blotting using an anti-HA 
antibody. C) The whole cell extract used in panel C carrying plasmids Rpn10 and 
HARsp5HECT was incubated with and without recombinant Ubp2. Reactions were 
analyzed by Rpn10 western blotting and with anti-pgk1 antibody as a loading control. 
D) Accumulation of polyubiquitin signal is shown for the whole cell extracts used in 
panel B carrying plasmids Rpn10 and Rpn10K84,268R, and HARsp5HECT or HARsp5HECT 
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C777A. Polyubiquitinated conjugates were analyzed by Ubiquitin western blotting. Blots 
were also developed with an anti-pgk1 antibody as a loading control. E) The same 
cultures shown in panel B carrying Rpn10 and Rpn10K84,268R and HARsp5HECT or 
HARsp5HECT C777A were diluted to an OD600 = 0.04, spotted in 5-fold serial dilutions and 
grown at room temperature (22ºC), as shown. 
 
 
 
 In order to evaluate the effect of the overexpression of two other HECT 
containing proteins on Rpn10 ubiquitination in vivo, we cloned Tom1HECT and 
Hul4HECT in galactose-inducible plasmids. We transformed each plasmid carrying 
Rsp5HECT, Tom1HECT and Hul4HECT in a WT strain. Unfortunately, after 4 hours 
growing the cultures in galactose, no induction was detected by western blot either 
for Tom1HECT or for Hul4HECT. The experiment was repeated several times with no 
success. Thus, we cannot draw conclusions regarding the specificity of Rsp5 for 
Rpn10 ubiquitination in vivo. 
 
 
Induction of Rsp5HECT in other yeast strains 
 
Since Upb2 antagonizes Rsp5 activity, we hypothesized that the absence of 
Ubp2 might result in a stronger Rpn10 ubiquitination and therefore a stronger 
growth defect phenotype. To test this hypothesis, we overexpressed the HECT of 
Rsp5 under control of a galactose-inducible promoter in a wild-type strain and in an 
ubp2Δ strain. We observed that the levels of mUb-Rpn10 were the same in both 
strains and that both depended on Rsp5 induction (Figure 26A and 27A). In order 
to make clearer the modification of Rpn10, we repeated the induction reaching the 
same result (Figure 27B), suggesting that other DUBs may be controlling Rpn10 
ubiquitination levels.  
Additionally, we tested the effect of Rsp5 induction at 35ºC in a double mutant 
strain with a thermosensitive mutation for Rsp5 and ubp2Δ (rsp5–1 ubp2Δ). The 
rsp5–1 mutant results in a single mutation change in the HECT domain, which 
makes the protein deficient in the formation of Ubiquitin-thioester intermediates at 
35ºC (Wang et al., 1999). The premise was again that overexpression of Rsp5 
would cause an increase in mUb-Rpn10 levels in rsp5–1 ubp2Δ strain, only 
dependent on the induced Rsp5HECT. As previously seen, only when Rsp5 was 
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induced, the monoubiquitination of Rpn10 was detected, although the intensity of 
the band was very similar for both the wild-type and the double mutant strain 
(Figure 27C). We did not expect these results considering that Isasa et al observed 
that levels of mUb-Rpn10 were strongly increased in the absence of Ubp2 (Isasa et 
al, 2010). 
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Figure 27. Rpn10 is monoubiquitinated in ubp2Δ and rsp5-1 ubp2Δ strains. 
A) and B) Wild-type strain (FY56) and ubp2Δ carrying a HARsp5HECT galactose-
inducible plasmid were grown in galactose or glucose media for the indicated hours. 
Upper panels show the induction levels analyzed by western blotting using an anti-HA 
antibody. Endogenous Rpn10 was analyzed by Rpn10 western blotting, shown in the 
lower panels. C) Time-course induction of HARsp5HECT in wild-type (FY56) and rsp5-1 
ubp2Δ strains. 
 
 
Minimal sequence requirements for Rpn10 
monoubiquitination 
 
Having shown that Rpn10 restricts Rsp5 activity to produce Rpn10 
monoubiquitination (or multi-monoubiquitination) and that this has important 
implications for yeast growth, we next aimed to characterize the mechanism 
underlying Rpn10-driven monoubiquitination. The Rpn10 structure consists of a 
VWA domain that encompasses an N-terminal region of approximately 190 aa, and 
a UIM-containing C-terminal region (Lambertson et al, 1999; Fu et al, 1998). The 
UIM-containing sequence is found in the context of an α -helix that is flanked by 
highly flexible linkers (Wang et al, 2005; Zhang et al, 2009; Riedinger et al, 2010). 
Moreover, the C-terminal end contains lysine residues that are modified by 
Ubiquitin, as shown in S. cerevisiae and D. melanogaster (Isasa et al, 2010; 
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Lipinszki et al, 2013). With this information, we designed truncated versions of 
Rpn10 and tested their capacity to undergo monoubiquitination in our standard 
Rsp5-dependent Ubiquitin ligation reaction. Thus, we tested Rpn1040-268, a 
fragment that contains the VWA domain but lacks N-terminal residues involved in 
proteasome interaction (Fu et al, 1998), and Rpn10195-268, which only includes the 
C-terminal region of Rpn10 including the UIM. Rpn10 can be ubiquitinated at 
lysines 77, 84, 99 and 268, being K84 and K268 the most abundantly modified. 
Thus, Rpn1040-268 included the four lysines that can be modified whereas Rpn10195-
268 had only one lysine at the very C-terminus of the protein. We performed 
ubiquitination reactions with these fragments and we observed that both versions of 
Rpn10 were efficiently mono- or diubiquitinated by Rsp5 (Figure 28A and B), 
showing that both the N-terminal region and the VWA domain are dispensable for 
the reaction of ubiquitination. This is a relevant observation, since the VWA is a 
large domain, that represents approximately 75% of the whole protein, and plays 
roles in Rpn10- proteasome interaction and protein degradation (Verma et al, 2004; 
Fu et al, 1998). These two fragments were GST tagged and we wondered whether 
the tag was also a site of Ub attachment. Thus, we cleaved the GST tag in 
Rpn10195-268 and we observed that this fragment, that also lacked the VWA domain 
(Rpn10195-268) behaved as a very good substrate of Rsp5, generating prominent 
mono- and diubiquitinated forms (Figure 28C and D) in a reaction exquisitely 
dependent on the presence of the E3 (Figure 28D). The reaction with Ub K0, an 
Ubiquitin mutant that has no lysines and cannot synthetize Ub chains, produced 
monoubiquitinated Rpn10195-268, while Ub wild-type produced diubiquitinated 
Rpn10195-268 (Figure 28C). This could be explained either by Rsp5 ability to build 
short Ubiquitin chains in Rpn10 or by the conjugation of Ub to the amino-terminus 
of Rpn10195-268 (Ciechanover and Ben‐Saadon, 2004). To confirm the nature of the 
bands observed in 28C and D, we performed an ubiquitination reaction of Rpn10195-
268, immediately followed by the addition of Ubp2 (Figure 28E). An evident 
decrease in the diubiquitinated form of the mutant is observed after 3 hours of 
incubation with Ubp2 at 10 nM or after 1 hour at 50 nM Ubp2. An incubation of 3 
hours with 50 nM Ubp2 seems to almost completely deubiquitinate Rpn10195-268. 
Strikingly, an increase of the monoubiquitinated or the unmodified form of the 
mutant is not appreciated under these conditions. 
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Therefore, the reaction of Rpn10 monoubiquitination can be produced in an 
Rpn10 fragment of 73 amino acid residues. This fragment has a high disposition to 
disorder, only interrupted by a helicoidal structure that contains the UIM (Figure 
28F; (Hofmann & Falquet, 2001; Wang et al, 2005; Riedinger et al, 2010)). To carry 
out the prediction of unstructured regions we used the meta-predictor computer 
program PONDR-FIT. PONDR-FIT uses an amino acid sequence as the input and 
gives structure (order) or disorder as the output by combining the prediction of 
different software’s predictions. 
 
Figure 28. Monoubiquitination is efficiently catalyzed on the C-terminal region of 
Rpn10. 
A) Monoubiquitination reaction of the Rpn1040-268 fragment by Rsp5. Left lane, no 
reaction; right lane, after incubation. B) Ubiquitination reactions of Rpn10195-268 using 10 
nM and 50 nM Rsp5. C) Ubiquitination reaction of the Rpn10195-268 fragment after 
cleaving the GST tag using wild-type (left) and Ubiquitin K0 - without lysine residues 
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(right). D) Rpn10195-268 ubiquitination reaction in which Uba1, Ubc4, Rsp5 and Ubiquitin 
were added as indicated. E) A 3 hours ubiquitination reaction of Rpn10195-268 was 
performed, followed by an incubation with Ubp2 at different concentrations and during 
different times. F) Prediction of intrinsically disordered residues in Rpn10 of S. 
cerevisiae by PONDR-FIT software. Scores above 0.5 are predicted disordered 
residues and residues with a score below 0.5 are predicted to be ordered. The VWA 
domains and the α helix that contains the UIM are also indicated. 
 
 
 
In order to map in more detail the minimal sequence requirements for Rpn10 
monoubiquitination, we performed additional truncation analysis by generating 
progressively shorter versions of the fragment Rpn10195-268 (Figure 29A), and by 
testing them in Rsp5-dependent reactions. We observed that the Rpn10208-268 
fragment was modified by Rsp5, however, a truncation of a further three amino 
acids, Rpn10211-268, resulted in no modification by Rsp5 (Figure 29B), even when 
doubling the time of incubation (Figure 29C).  
 
 
Figure 29. Rpn10 truncation analysis identifies the regions indispensable for 
Rpn10 monoubiquitination. 
A) Schematical representation of the C-terminal fragments of Rpn10 used for 
ubiquitination reactions. B) Ubiquitination reactions of equimolar amounts of Rpn10 wt, 
Rpn10195-268, Rpn10208-268 and Rpn10211-268 using different concentrations of Rsp5. C) 
Ubiquitination reactions of Rpn10195-268,
 PPAYRpn10195-268, Rpn10211-268 and PPAYRpn10211-
268, run for 6 hours, instead of 3 hours (in B) at 30ºC with 10, 50 or 250 nM Rsp5. 
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Ligases belonging to the NEDD4 ligase family, such as Rsp5, have been 
shown to be able to ubiquitinate substrates containing an Ubiquitin-binding domains 
only if this domain is intact (Polo et al, 2002; Hoeller et al, 2006). For instance, the 
UIM has been shown to be necessary for the reaction of Rpn10 ubiquitination 
catalyzed by Rsp5 (Figure 21, 30, and (Isasa et al., 2010)). As it has been analyzed 
for Rpn10 full-length and PPAYRpn10 (Figure 21 and 30), we wished to determine 
the effect of mutating the UIM in the fragments. For this, we introduced a block 
substitution from residues 228 to 232 of the UIM to asparagines of Rpn10195-268 and 
Rpn10208-268, resulting in Rpn10195-268 UIM and Rpn10208-268 UIM. Additionally, we 
introduced a PPAY motif at the N-terminus of these four fragments, resulting in 
PPAYRpn10195-268, PPAYRpn10208-268, PPAYRpn10195-268 UIM and PPAYRpn10208-268 UIM. The 
Rpn10 fragments with an intact UIM were monoubiquitinated as expected (Figure 
30), while the ones with the UIM mutated were not modified. Although Rpn10208-268 
didn’t show a very efficient monoubiquitination, no band at all could be seen in the 
reaction with Rpn10208-268 UIM (Figure 30, right panel). Thus, once again, we 
observed that the UIM is required for Rpn10 ubiquitination and that, also in these 
short fragments, the PPAY motif is not enough to guarantee the reaction. 
 
Figure 30. The UIM is required for the ubiquitination of fragments Rpn10195-268, 
PPAYRpn10195-268, Rpn10208-268 and PPAYRpn10208-268. 
Ubiquitination reaction of Rpn10195-268, PPAYRpn10195-268, Rpn10195-268 UIM, PPAYRpn10195-
268 UIM, Rpn10208-268, PPAYRpn10208-268, Rpn10208-268 UIM and PPAYRpn10208-268 UIM. Lower 
panel shows a longer exposure (L) of the film. 
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In light of this, it was possible that the decreased monoubiquitination of 
Rpn10211-268 (Figure 29B and C) could have resulted from an impairment of the 
Ubiquitin-binding properties of the UIM. To investigate whether this was the case, 
we analyzed the ability of Rpn10211-268, Rpn10195-268 and Rpn10195-268 UIM (carrying a 
mutated UIM) to interact with polyubiquitin. We observed that Rpn10195-268, 
Rpn10211-268 and the UIM from Rnf114 as a positive control were equally capable of 
binding polyubiquitin, while the UIM mutant Rpn10195-268 UIM did not (Figure 31). 
 
 
Figure 31. The UIM of Rpn10A211-268 is functional. 
Binding assay of K63-linked polyubiquitin chains and K48-linked polyubiquitin chains to 
GST fusion proteins of Rpn10195-268, Rpn10195-268 UIM and Rpn10211-268 immobilized on 
glutathione sepharose beads. Binding to GST was used as a negative control and 
binding to the UIM of RNF114 (UIM) as a positive control. The input lane contains 
1/20th of the poly-Ubiquitin quantity used for the binding experiments. Bound material 
and input were analyzed by anti-Ubiquitin western blotting. Lower panel shows similar 
amounts of the proteins bound to the beads in a Coomassie blue staining. 
 
 
These results indicated that there is no loss of Ub binding of the  
Rpn10211-268 fragment, and suggested a role for the region between amino acids 
D208 and A211 in the monoubiquitination of Rpn10 that is independent of the 
Ubiquitin-binding capacity of the UIM. 
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To further characterize Rpn10 modification, the only lysine residue present in the 
shortest fragments of Rpn10, K268, was mutated. Fragments Rpn10195-268 K268R and 
Rpn10208-268 K268R, without lysines, were not ubiquitinated, indicating that K268 is 
essential for their ubiquitination. Interestingly, PPAYRpn10195-268 K268R without lysines 
but containing a PPAY motif at the N-terminus was modified (Figure 32). We must 
point out that all this protein carries a GST tag that contains several lysines and 
that it is therefore possible that PPAYRpn10195-268 K268R is ubiquitinated at the GST 
tag. The presence of a PPAY motif, together with the length and the nature of the 
residues of this fragment, could allow a better interaction with the ligase and, 
therefore, the ubiquitination of this mutant.  
Figure 32. Ubiquitin linkage in Rpn10 fragments. 
Ubiquitination reactions of Rpn10 fragments and lysine to arginine mutants. 
 
 
 Next, to determine the C-terminal region required for ubiquitination, we 
analyzed the behavior of Rpn10 C-terminal truncations at positions Q261, D254 
and E239, in which we introduced a lysine residue at the C-terminus (see Figure 
29A), as substrates in monoubiquitination reactions. We observed that Rpn10195-261 
and Rpn10195-254 were efficiently monoubiquitinated, whereas Rpn10195-239 was not 
(Figure 33A). We tested the three C-terminal truncations in a polyubiquitin binding 
assay, and we observed that the Rpn10195-239 truncation showed a notable 
decrease in polyubiquitin binding (Figure 33B). Therefore, the loss of 
monoubiquitination of the Rpn10195-239 fragment could be due to a dysfunctional 
UIM. Additionally, the proximity of the lysine residue to the Ub interacting surface in 
the Rpn10195-239 fragment (see Figure 29A) could be an additional cause of the 
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absence of monoubiquitination. Together, these results suggest that the region C-
terminal to residue D254 is not needed to get ubiquitinated Rpn10.  
 
 
Figure 33. A dysfunctional UIM explains loss of ubiquitination. 
A) Ubiquitination reactions of Rpn10195-268, Rpn10195-261, Rpn10195-254 and Rpn10195-239. 
B) Binding assay of GST fusion proteins Rpn10195-268, Rpn10195-254 and Rpn10195-239, 
immobilized on beads to K63-only polyubiquitin chains (input). 1/20th of the input used 
per binding was loaded. Bound material was eluted and analyzed by Ubiquitin western 
blotting. Right panel, coomassie staining of the amounts of fusion proteins used in each 
assay. 
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The unstructured linker between the VWA and the UIM 
prevents Rpn10 polyubiquitination 
 
Since the deletion of amino acids D208, S209 and D210 showed a dramatic 
effect in our analysis of N-terminally truncated Rpn10 forms, completely abrogating 
(mono)-ubiquitination, we studied this region in a full-length context (Figure 34).  
 
 
 
 
 
 
 
 
 
 
Figure 34. Rpn10195-268 sequence and diagram of full-length Rpn10 with positions 
D208, S209 and D210 deleted. 
Disordered regions are indicated by light grey arrows and the α-helix by a dark grey 
arrow. The UIM is underlined in the sequence and represented with white and black 
lines in the diagram. 
 
 
 
We deleted residues D208, S209 and D210 (Rpn10DSD208-210∆), and 
investigated the ubiquitination of this mutant protein. We observed that this deletion 
had an effect on the reaction, producing an oligo/polyubiquitin signal instead of 
mono-ubiquitination. This was not observed when using Ub K0 that cannot 
synthetize chains (Figure 35A and B), indicating that the several bands observed 
when using Ub wild-type are oligo/polyubiquitinated Rpn10DSD208-210∆. 
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Figure 35. Altering the unstructured linker flanking the UIM promotes 
polyubiquitination. 
A) Time course in vitro ubiquitination assay of Rpn10 and Rpn10DSD208-210Δ. Points at 
indicated times were taken and analyzed by Rpn10 western blotting. Asterisk, 
unspecific band. B) Time course in vitro ubiquitination reaction of Rpn10DSD208-210Δ using 
wild-type Ubiquitin and Ub K0. Points at indicated times were taken and analyzed by 
Rpn10 western blotting. 
 
 
 
Positions D208, S209 and D210 are part of an unstructured linker between the α-
helix 6 of the VWA domain and the UIM- containing α-helix 7 (Figure 36; (Wang et 
al, 2005; Boehringer et al, 2012)). Notably, this region contains a Glycine-rich 
region from positions G195 to G207 (Figure 36).  
 
 
B  
A 
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Figure 36. Multiple sequence alignment of Rpn10. 
Residues from 183 to 234 are shown in Saccharomyces cerevisiae. First and last 
boxes correspond to the residues within the α-helix 6 of the VWA domain and the UIM-
containing α-helix 7, respectively. Conserved glycine residues among species are 
shown inside light grey boxes. Vertical arrows point D208, S209 and D210 amino 
acids. The alignment of Rpn10 from 59 species was done with Ensembl software. The 
most representative species are shown. Asterisks show the conservation of a 
methionine (residue 199) and a glycine (residue 203) that were mutated in this study. 
 
 
To examine the importance of this, we generated mutants with a block substitution 
of the region S196-G204, in the context of full-length Rpn10 (Figure 37). 
Additionally, we generated point mutations at two different conserved positions, 
M199 and G203. To create opposing effects with regards to the polarity and the 
disorder of the segment, we mutated amino acid residues to alanines as well as to 
serines (Figure 37).  
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Figure 37. Diagram of the Rpn10195-268 fragment and full-length versions of Rpn10 
including the mutations analyzed. 
Disordered regions are indicated by light grey arrows and the α-helix by a dark grey 
arrow. The UIM is underlined in the sequence and represented with white and black 
lines in the diagram. 
 
 
Subsequently, Rpn10196-204A, Rpn10M196A,G204A, Rpn10196-204S and Rpn10M196S,G204S 
mutants were tested in Rsp5-dependent ubiquitination reactions. We observed that 
the Rpn10196-204A mutant underwent a dramatic increase in polyubiquitination, as 
compared to full-length wild-type Rpn10 (Figures 38 and 39). Rpn10M196A,G204A, 
Rpn10196-204S and Rpn10M196S,G204S mutants showed an intermediate effect, which 
appears to be similar to the one observed with Rpn10DSD208-210∆.  
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Figure 38. Change in the pattern of ubiquitination of Rpn10 mutants. 
Ubiquitination reactions of Rpn10 WT, Rpn10196-204A, Rpn10M199A-G203A, Rpn10196-204S 
and Rpn10M199S-G203S. 
 
 
 
We further evaluated the ubiquitination of Rpn10196-204A by performing a reaction 
with Ub K0 and methylated Ubiquitin that cannot form polyubiquitin chains. This 
showed that, like in the wild-type protein, two major lysines are ubiquitinated, 
indicating that the higher molecular weight ubiquitinated forms observed with 
Rpn10196-204A are not the result of more extensive monoubiquitination but of a true 
increase in polyubiquitination (Figure 39B and C). Importantly, this 
polyubiquitination is observed from the earliest time points onwards and increases 
with time, whereas polyubiquitination of wild-type Rpn10 is not observed at any 
time point (Figure 39A). 
Finally, we analyzed the competence of Rsp5HECT in ubiquitinating Rpn10196-204A. 
Although the reaction with Rsp5 full-length was more efficient in polyubiquitinating 
Rpn10196-204A, the HECT also exhibited polyubiquitination on this mutant. This 
capacity was valuable to study Rpn10196-204A polyubiquitination in vivo, again 
without affecting the numerous substrates that depend on the WW within the N-
terminus of Rsp5. 
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Figure 39. Rpn10196-204A is polyubiquitinated by Rsp5 full-length and Rsp5HECT. 
A) Time course in vitro ubiquitination assay of Rpn10 and Rpn10196-204A. Points at 
indicated times were taken and analyzed by Rpn10 western blotting. B) Ubiquitination 
reaction of Rpn10196-204A mutant using wild-type and methylated Ubiquitin. Asterisks, 
unspecific band. C) Time course in vitro ubiquitination reaction of Rpn10196-204A using 
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wild-type Ubiquitin and Ub K0. Points at indicated times were taken and analyzed by 
Rpn10 western blotting. D) Ubiquitination reaction of Rpn10 and Rpn10196-204A 
incubated with Rsp5 full-length (F) or Rps5HECT (H). Long (L) and short (S) exposures 
of the film are shown. 
 
Considering that Rpn10196-204A was the substrate to undergo the strongest 
polyubiquitination, we conclude that the disordered region between amino acids 
S196 to G204 (see Figures 36 and 37) normally prevents Rpn10 polyubiquitination, 
although residues D208-D210 also contribute. Interestingly, disorder and 
secondary structure prediction indicated that the Rpn10196-204A mutation causes a 
substantial increase in the order of this segment (Figure 40A) and induces a 
helicoidal structure (Figure 40B).  
 
 
 
Figure 40. The block-substitution to alanines induces a gain of order. 
A) Overlay of the profiles of the predicted intrinsically disordered residues in Rpn10 
(light grey) and in Rpn10196-204A (grey) by PONDR-FIT software. Scores above 0.5 are 
predicted disordered residues and residues with a score below 0.5 are predicted to be 
ordered. The VWA domains and the α-helix that contains the UIM are also indicated. 
B) C-terminal prediction of Rpn10 and Rpn10196-204A secondary structure obtained after 
running MeDoR, a predictor of secondary structures. The arrow represents a beta-
strand; the helices correspond to α-helices.  
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Finally, we asked what the effect would be, in vivo, of the dramatic change in the 
pattern of ubiquitination exhibited by the Rpn10196-204A mutant, as compared to 
Rpn10 and to a mutant with an intermediate effect. Thus, we analyzed the effect of 
the expression of Rpn10, Rpn10196-204A and Rpn10DSD208-210∆ mutants in strains 
lacking the RPN10 and RAD23 genes, in which the recruitment of substrates to the 
proteasome is deficient and shows synthetic slow growth phenotypes which can be 
rescued by expressing Rpn10 (Chen & Madura, 2002; Isasa et al, 2010). We 
observed a strong decrease of growth in cells expressing the Rpn10196-204A mutant 
at 37ºC, whereas the Rpn10DSD208-210∆ mutant showed an intermediate effect 
(Figure 41A).  
Moreover, total cell lysates from an rpn10Δ strain carrying Rpn10 or Rpn10196-204A 
were applied to a Superose 6 column in which separation is based on differences in 
the size of the analyte. A previous member from our lab determined by 
immunodetection of Rpn12 and α7 (two subunits of the proteasome) the fractions 
in which the proteasome elutes. We analyzed by western blotting against Rpn10 
fractions of these two cell lysates corresponding to the Rpn10 and the proteasome 
elution peaks. Rpn10196-204A and Rpn10 showed the same affinity towards the 
proteasome in vivo, suggesting that the Rpn10196-204A phenotypes are not caused 
by a decreased proteasomal association of this mutant (Figure 41B). 
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Figure 41. Rpn10196-204A mutant: effect on cell growth defect. 
A) Colony formation assay of rad23Δ rpn10Δ cells (strain 11d) expressing different 
Rpn10 forms. Cells were grown at the indicated temperatures. B) Total cell lysates 
from an rpn10Δ strain (S72) carrying Rpn10 or Rpn10196-204A, from its own promoter, 
were applied to a Superose 6 column. Fractions corresponding to the proteasomal and 
extraproteasomal peaks were analyzed by western blotting against Rpn10. Asterisk, 
unspecific band. 
 
 
 
In order to study whether the polyubiquitination of Rpn10196-204A and 
Rpn10DSD208-210∆ observed in vitro was recapitulated in vivo, we induced Rsp5HECT in 
rpn10Δ and rad23Δ rpn10Δ strains carrying plasmids expressing, from their own 
promoter, Rpn10, Rpn10196-204A or Rpn10DSD208-210∆ (Figure 42A-C). Rpn10 
monoubiquitination was very difficult to detect in vivo unless we induced Rsp5HECT. 
For this reason, we decided to enhance the ubiquitination of these mutants by 
inducing the HECT of Rsp5. Although we repeated the inductions 9 times, no 
HARsp5HECT could be detected by western blot. In addition, unexpectedly, the 
mutants grown in glucose were not polyubiquitinated but monoubiquitinated as 
Rpn10. A possible explanation for the observation of the monoubiquitination of 
Rpn10196-204A and Rpn10DSD208-210∆ was that endogenous Ubp2 was cleaving the 
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Ubiquitin chains from the mutants. Therefore, in another attempt to induce the 
HECT and to observe the polyubiquitination of Rpn10196-204A and Rpn10DSD208-210∆, 
we generated the double mutant rpn10Δ ubp2Δ. Again, the induction did not work 
and the mutants were monoubiquitinated (Figure 42D).  
 
 
 
Figure 42. Rpn10196-204A and Rpn10DSD208-210∆ are monoubiquitinated in vivo. 
A), B), C) and D) Different strains, rpn10Δrad23Δ, rpn10Δ and rpn10Δ ubp2Δ, were 
grown in glucose carrying plasmids Rpn10, Rpn10196-204A and Rpn10DSD208-210∆ from 
their own promoter. 
 
 
 
  Finally, we tried the induction of Rsp5HECT in an rpn10Δ (S72) strain with a 
different background, carrying plasmids expressing Rpn10 and Rpn10196-204A and 
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this proved to be successful. Nevertheless, polyubiquitination of Rpn10196-204A was 
not detected, either with galactose or glucose. Instead, the monoubiquitination of 
this mutant was observed and appeared to be of a similar intensity as the one 
observed with Rpn10 (Figure 43).  
 
Figure 43. Rpn10196-204A is monoubiquitinated in vivo when the HECT is induced. 
rpn10Δ (S72) strain carrying a HARsp5HECT galactose-inducible plasmid and plasmids 
Rpn10 or Rpn10196-204A was grown in galactose media for the indicated hours. Rpn10 
and Rpn10196-204A were analyzed by Rpn10 western blotting, shown in the upper 
panels. Lower panels show the induction levels analyzed by western blotting using an 
anti-HA antibody.  
 
 
 
In a preliminary study, we have also investigated the influence of expressing 
distinct forms of Rpn10 (Rpn10-WT, Rpn10196-204A) on the in vivo degradation of a 
mutant of CPY* a protein with a high turnover rate that is known to be caused by 
proteasomal degradation (Figure 44). We have previously observed that in a strain 
carrying the deletion of RPN10 (rpn10∆), the degradation of CPY* is delayed 
(Figure 44A and B). When expressing the mutant Rpn10196-204A, the turnover of 
CPY* is partially rescued (Figure 44B). However, additional assays should be done 
to obtain reliable statistic data and therefore, draw conclusions.  
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Figure 44. Lack of RPN10 or expression of Rpn10196-204A mutant delays CPY* 
degradation. 
A) Degradation of HA-tagged CPY* was compared in WT (S67) and rpn10Δ (S72) 
strains. Protein synthesis was blocked with 200 µg/ml cycloheximide. Samples were 
withdrawn at indicated time points. HA-CPY* was analyzed by immunoblotting. Blots 
were also developed with an anti-pgk1 antibody as a loading control. B) Degradation of 
HA-tagged CPY* was compared in rpn10Δ strain carrying Rpn10-WT, empty or 
Rpn10196-204A vectors. Protein synthesis was blocked with 200 µg/ml cycloheximide. 
Duration of the treatment with cycloheximide is indicated. HA-CPY* was analyzed by 
immunoblotting. Blots were also developed with an anti-pgk1 antibody as a loading 
control. The relative quantification of the CPY* levels in the rpn10Δ strain carrying 
Rpn10, empty vector or Rpn10196-204A was carried out with ImageJ software and 
intensities were normalized relative to the loading control pgk-1. 
 
 
 
 
Results 
 
84 
Effect of unstructured regions in S5a monoubiquitination 
 
  Based on the fact that Rpn10 monoubiquitination is observed in distant 
species such as S. cerevisiae and D. melanogaster (Isasa et al, 2010; Lipinszki et 
al, 2009), and that the Rpn10 orthologue in humans, S5a, has been shown to be 
mono- and diubiquitinated in the proteasome (Besche et al, 2014), we aimed to 
reconstitute the monoubiquitination of S5a using human Nedd4 Ubiquitin-protein 
ligase and the E2 UbcH5b. We observed that at different enzyme concentrations, 
S5a underwent monoubiquitination, showing abundant S5a-Ub1 and S5a-Ub2 forms 
(Figure 45; lanes 4 and 7). Moreover, we analyzed point mutations at positions 
M196 and G200, and a block substitution of the G193-G200 segment 
(S5aM196A,G200A and S5a193-200A mutants, respectively), corresponding to Rpn10 
mutants Rpn10 M196A,G204A and Rpn10196-204A, respectively.  
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Figure 45. Mutations of the unstructured region before the UIM1 of S5a cause a 
change in the process of ubiquitination. 
A) reactions of S5a, S5a193-201A and S5aM196A-G200A carried out for 3 hours at 37ºC. 
Amounts of UbcH5b are indicated. B) Schematical representation of Rpn10, S5a, 
S5a193-201A and S5aM196A-G200A. Alpha helix and disordered regions flanking the UIMs are 
shown. 
 
 
We observed that mutants and wild-type forms showed distinct behaviors. Whereas 
S5a showed a pattern of mono- and diubiquitination in all conditions used (Figure 
45, lanes 4 and 7), S5aM196A,G200A and S5a193-200A showed increased 
polyubiquitination at high concentrations of E2 (Figure 45A, compare lanes 5 and 6 
with lanes 8 and 9). Therefore, analogously to the results observed in Rpn10, the 
region preceding the UIM in S5a has an influence on the ubiquitination pattern. 
 
 
B 
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The complexity of the Ub code relies on a highly extended set of enzymatic 
activities, on the high diversity of Ubiquitin interacting domains, and on the 
specificity of Ubiquitin surface/Ubiquitin receptor interactions, altogether defining 
one of the most sophisticated signaling systems in biology (Dikic et al, 2009; 
Komander & Rape, 2012). In the present thesis we have uncovered a link between 
the capacity of the proteasomal receptor Rpn10 to undergo monoubiquitination and 
the presence of an unstructured region in Rpn10 protein. To do so, we have 
dissected the ubiquitination of Rpn10 from different point of views. 
 
 
The HECT of Rsp5 is sufficient to ubiquitinate Rpn10 
 
In our characterization of the process of Rpn10 monoubiquitination, we have 
observed that the HECT domain of Rsp5 is sufficient and very efficient in the 
catalysis of Rpn10 monoubiquitination. Therefore, the HECT domain contains all 
the required domains to ubiquitinate Rpn10, which are an E2 binding site found at 
the amino-terminal lobe (N-lobe) and the active-site cysteine that accepts the Ub 
transferred by the E2 at the carboxyl-terminal lobe (C-lobe) (see Figure 46). 
 
 
Figure 46. Schematical representation of Rsp5 full-length and Rsp5HECT. 
 
 
Interestingly, the HECT domain of Rsp5 alone seemed to be considerably 
more efficient in monoubiquitinating Rpn10 than full length Rsp5 (Figure 22B). 
Features in Rsp5 could help explain this observation. Firstly, Rsp5 contains a PY 
motif (LPQY) in the HECT domain that could be binding to the WWs that are found 
at the N-terminus of Rsp5, leaving the ligase partially in an inactive state (Lam 
2009, Lam 2013, Kee 2005, Kee 2006). Secondly, the N-lobe and C-lobe of the 
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HECT of Rsp5 are connected by a short unstructured linker that might give the 
flexibility required by the C-lobe to access the lysine on the target substrate (Kim & 
Huibregtse, 2009). It has been suggested that the linker also facilitates the 
orientation of the E3 towards the E2 (Huang et al, 1999). Taken together, the lack 
of the N-terminus of Rsp5 in Rsp5HECT could, on the one hand, avoid the inactive 
state due to the PY-WW interaction, and, on the other hand, provide more freedom 
to the HECT domain to orient itself towards the target lysine and the E2, facilitating 
the transfer of an Ub from the active cysteine of the HECT to the lysines within 
Rpn10 and the binding with the E2, respectively. 
On the contrary, Rsp5HECT showed a lower capacity to polyubiquitinate 
Rpn10196-204A than Rsp5 full-length (Figure 26D), suggesting that the ability of the 
HECT to link ubiquitins on a polyubiquitin chain could be lower than the one 
achieved by Rsp5 full length. This again could be explained by a change in the 
orientation adopted by the HECT domain with respect to the full-length ligase that 
would encounter difficulties to transfer a Ubiquitin from the active cysteine of the 
HECT to the last Ubiquitin of the chain. Another explanation could be related to 
differences in the self-ubiquitination of the full length and HECT ligases that would 
affect the ubiquitination of the substrate. There are too many questions to answer 
before being able to even hypothesize. One very first step to do is to determine the 
Km for the ubiquitination reaction of Rsp5 and Rsp5HECT towards Rpn10 and 
Rpn10196-204A. 
It would be interesting to assess whether the induction of Rsp5 full-length rather 
than Rsp5HECT could help observe the polyubiquitination of Rpn10196-204A in vivo.  
 
S. cerevisiae has four additional genes encoding HECT E3 proteins: Tom1, 
Hul4, Ufd4 and Hul5. It has been already reported that neither Ufd4 nor Hul5 are 
Ubiquitin E3 ligases for Rpn10 (Isasa et al, 2010). Our interest was then focused on 
the activity of the HECT of the two other ligases, Tom1HECT and Hul4HECT. 
Unfortunately, we observed that in vitro, Hul4HECT was catalytically inactive. There 
is little literature regarding this enzyme and we do not know the reason for its 
inactivity, although it could be that the protein looses its activity during the 
purification from E.coli. In vivo, none of these two ligases could be induced in a 
galactose-inducible plasmid, leaving us with no controls showing the effect of 
overexpression of other HECT domains on Rpn10 ubiquitination. More time should 
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be invested to achieve the induction of Tom1HECT and Hul4HECT in order to find out 
whether other HECT ligases are able to ubiquitinate Rpn10 or whether Rpn10 
ubiquitination is exclusively dependent on the Rsp5 ligase.  
 
 
Increased Rpn10 monoubiquitination decreases yeast 
growth  
 
The inability of the Rsp5HECT to interact with PPXY-containing substrates 
has provided us a tool to evaluate the functional relevance of increased Rpn10 
monoubiquitination in vivo. Notably, by expressing Rsp5HECT in cells we have been 
able to produce a slow-growth phenotype that is dependent on the 
monoubiquitination of Rpn10 (Figure 26B and E). This result is in agreement with 
that observed by expressing a Rpn10-Ubiquitin chimera, in a previous work (Isasa 
et al, 2010). To evaluate the specificity of this phenotype, we have analyzed the 
behavior of the Rpn10K84,268R mutant, which carries mutations on the two main 
targeted lysines in the reaction catalyzed by Rsp5 (Isasa et al, 2010), and we have 
observed that the Rpn10K84,268R mutant has a rescuing effect on yeast growth. 
Thus, these results unequivocally show that increased Rpn10 monoubiquitination 
decreases yeast growth. This observation is very relevant, considering the 
importance of the anti-proliferative effect of proteasome inhibition by chemical 
inhibitors (Goldberg, 2012). We envision inactivation of proteasome receptors as a 
potential biomedical approach for the inhibition of proteasome activity.  
 
 
Structural properties in Rpn10 promote Rpn10 
monoubiquitination  
 
Commonly, the mechanism of monoubiquitination is viewed as a process in 
which the enzymatic factors or cofactors involved contain information that impairs 
or counteracts polyubiquitin synthesis. For example, it has been shown that Rad18 
E3 ligase blocks the Ubiquitin-chain synthesis activity of the E2 Rad6 to promote 
PCNA monoubiquitination (Hibbert et al, 2011). Moreover, in the process of histone 
H2A monoubiquitination by the polycomb complex Bmi1-RING1, a model was 
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proposed in which the rigidity of the E2-E3 complex assembled to DNA and 
nucleosomes promotes K119 specific monoubiquitination (Bentley et al, 2011). 
Alternatively, it has been found that properties of the E2 dictate monoubiquitination, 
as observed in Ube2W in conjunction with FANCL, Brca1-Bard1 and CHIP E3 
ligases (Christensen et al, 2007; Alpi et al, 2008; Scaglione et al, 2011). Another 
interesting model suggests that the activity of deubiquitinating enzymes (DUBs) 
processes polyubiquitinated proteins to produce monoubiquitination (Kee et al, 
2005), as we observed in the assays we performed with Ubp2, where 
monoubiquitination was rescued from polyubiquitinated PPAYRpn10 (Figure 25A). 
Moreover, the process of monoubiquitination can be induced by an external protein 
cofactor that modulates enzyme processivity (Becuwe et al, 2012). Figure 47 
(sections A-D) contains different possible models of monoubiquitination, oriented 
on the factor that regulates the process. We have characterized here another type 
of monoubiquitination reaction in which the enzymes involved are proficient in 
polyubiquitin synthesis, and protein polyubiquitination is the default activity that they 
exhibit. Nonetheless, structural properties found in the substrate could be dictating 
a mechanism that produces monoubiquitination. We define this type of reaction as 
substrate-driven monoubiquitination (Figure 47, section E).  
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Figure 47. Models of monoubiquitination. 
A) E3-driven model: The Ubiquitin ligase determines the specificity. Different E2 
enzymes may be involved, with no influence on the product. B) E2-driven model: The 
Ubiquitin-conjugating enzyme determines the specificity. The E2 binds distinct cognate 
E3s to promote monoubiquitination to different substrates. C) DUB-driven model: a 
deubiquitinating activity trims the polyubiquitin chain of a polyubiquitinated protein 
producing a monoubiquitinated one. D) Cofactor-driven model: a cofactor promotes 
monoubiquitination of the substrate by preventing the polyubiquitination. E) Substrate-
driven model: structural properties of the substrate prevent it to be polyubiquitinated. 
 
 
Sometimes proteins or regions of proteins lack a well-structured three-
dimensional fold. This feature is very common in nature and is involved in several 
biological processes such as signaling, recognition and regulation (Dunker et al, 
2000). Disordered proteins can be predicted through bioinformatic tools that 
analyze the composition of the amino acid sequence. However, the quantitative 
and qualitative measures of this type of proteins are still not available (Xue et al, 
2012; Xie et al, 2007). To predict the disorder within Rpn10 and Rpn10196-204A, we 
have used several metapredictors that combine the outputs of several individual 
disorder predictors. Our data suggests that there is a conserved intrinsically 
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disordered region linking the last α-helix of the VWA domain (helix 6) and the α-
helix that contains the UIM (helix 7; Figures 28F and 36) and that this linker is 
required for the specificity of the monoubiquitination process. Mutations that 
change the properties of this region seemed to cause a change on the processivitiy 
of Rsp5, the Ubiquitin-protein ligase involved in the reaction of ubiquitination, 
promoting polyubiquitination (Figures 35, 37, 38 and 39). This is the case for 
Rpn10196-204A, whose polyubiquitination is probably due to the gain of structural 
order (a predicted helicoidal structure). Indeed, some amino acids are found more 
frequently in α-helices than others; this tendency is known as helix propensity. 
Excluding proline, glycine has the lowest helix propensity and alanine has the 
highest (Pace & Scholtz, 1998). The fact that the linker is glycine-rich and that 
glycines disrupt helices and adopt flexible conformations agrees with the prediction 
of disorder. The flexibility given by the glycines could be playing a role in the 
ubiquitination of Rpn10. 
Additionally, the Rpn10M196A,G204A, Rpn10196-204S, Rpn10M196S,G204S, and Rpn10DSD208-
210∆ mutations, which don’t show an increase in structural order, also show a slight 
increase of poly (Figure 38). These observations are compatible with a change of 
flexibility and with a change in E3 interaction in the mutants tested. Therefore, the 
behaviour of these Rpn10 mutations within the disordered sequence between α-
helices 6 and 7, suggests a functional adaptation to promote monoubiquitination. 
As a matter of fact, eukaryotic genomes are predicted to have a higher fraction of 
disordered proteins than bacteria and archaea, indicating that the unstructured 
regions may be participating in more complex processes (Dunker et al, 2005).  
The polyubiquitination of Rpn10DSD208-210∆ appears to be in contradiction with 
the effect of the deletion of the N-terminus of Rpn10 up to residue 211 (Rpn10211-
268), which abolishes monoubiquitination. We speculate that differences in the 
conformation of the full-length protein Rpn10DSD208-210∆ and the short fragment 
Rpn10211-268 and a different capacity of Rsp5 to interact with both proteins could 
explain the differences in their ubiquitination. The latter possibility could be easily 
tested by pull down studies. 
 
 
Interestingly, the combination of a post-translational modification and a disordered 
region within the same protein has been described as a mechanism to control 
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protein autoinhibition. Autoinhibition is the inhibition of the function of a protein 
domain via interactions with an inhibitory module in the same protein: the catalytic 
or binding site of the functional domain of the protein is blocked (Trudeau et al, 
2013). In our context, the functional domain is the UIM that is required to 
monoubiquitinate Rpn10 and to bind polyubiquitinated substrates. After 
monoubiquitination, the activity of the UIM could be inhibited due to allosteric 
mechanisms or direct blocking of the LAMAL motif in the UIM by the ubiquitins 
linked to Rpn10. The presence of an unstructured linker is, therefore, key to allow 
the “inactivation” of the UIM. 
 
Although Rpn10 is mostly monoubiquitinated at one position (Isasa et al, 
2010) three more lysines can be modified with a Ub molecule (multi-
monoubiquitination), suggesting that the interaction between the UIM and the 
substrate-bound Ub does not avoid the ubiquitination of the other three lysines. 
However, once Rpn10 is multi-monoubiquitinated, the interaction between the UIM 
and ubiquitins covalently linked to Rpn10 is favoured and, consequently, the UIM is 
no longer accessible and Rsp5 can build no chain extensions on Rpn10 (Figure 
48). 
 
Figure 48. Fold-back model applied to Rpn10. 
Left, full-length model of Rpn10 from Riedinger et al. (2011), showing the VWA domain 
and the C-terminus with the Ub binding domain motif highlighted in cyan. Right, model 
of monoubiquitinated Rpn10, showing the closed position of the C-terminal arm of 
Rpn10, derived from Riedinger et al, 2011. 
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On the contrary, when the flexible region in Rpn10 is changed into an α-helix, as in 
the Rpn10196-204A mutant, the C-terminal arm of Rpn10 containing the UIM is no 
longer free to move or rotate towards the linked ubiquitins in Rpn10 (Figure 49). 
The fold-back of the protein and therefore, the intramolecular interactions are 
avoided. As a consequence, the UIM is still accessible and Rpn10 can be 
repeatedly loaded with Ubiquitin molecules resulting in a polyubiquitinated protein.  
 
Figure 49. Model showing Rpn10 polyubiquitination of Rpn10. 
Left, full-length model of Rpn10196-204A, showing the VWA domain, the C-terminus with 
the Ub binding domain motif highlighted in cyan with an additional α-helix highlighted in 
yellow and red derived from Riedinger et al. (2011). Right, model of polyubiquitinated 
Rpn10196-204A, showing the open position of the C-terminal arm of Rpn10 and the 
polyUb chain. 
 
 
 
A complementary hypothesis that could explain the polyubiquitination of 
Rpn10196-204A is that when the unstructured region within Rpn10 looses flexibility, 
the spatial conformation of the protein is compromised and interactions with other 
proteins can be altered. Therefore, it could be that Rsp5 and Rpn10196-204A were 
able to interact in a way that Rsp5 and Rpn10 cannot and that this interaction 
facilitates the polyubiquitination of Rpn10196-204A. In fact, the study of the interaction 
between Rsp5 and both wild-type Rpn10 and mutant could shed light on this 
hypothesis. Additionally, the rigidity adopted by the mutant could also alter the 
orientation of its lysines towards the ligase allowing a better transfer of the Ub 
moieties.  
Ub#
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Unfortunately, protein secondary structure predictors have limitations: some 
metapredictors predicted that the N-terminus of Rpn10 is disordered, while it has 
been well shown in Schizosaccharomyces pombe that the first 190 amino acids are 
found in a globular domain, the VWA domain. Similarly, the UIM is predicted to be 
whitin a disordered region, whereas it is part of an α-helix A thorough study, 
including NMR or circular dichroism approaches, should be addressed to 
quantitatively determine the extent of order in the sequences of Rpn10 and 
Rpn10196-204A. 
 
Notably, the mutant exhibiting the strongest polyubiquitination effect, 
Rpn10196-204A, caused a slow growth phenotype at 37ºC (Figure 41A). Despite the 
fact that monoubiquitination of Rpn10 is reduced in the polyubiquitinated Rpn10196-
204A, we observe the same phenotypical effect as with monoubiquitinated Rpn10 
(Figure 26E). A possible interpretation is that the oligo/polyubiquitin chains bound 
to Rpn10196-204A mask the UIM, promoting inactivation of this Ubiquitin receptor. As 
a consequence, old or damaged proteins are less well degraded by the proteasome 
and are accumulated in the cell. This accumulation would lead to proteotoxic stress 
and a subsequent growth defect. To address this, we could analyze the steady 
state levels of polyubiquitinated proteins in the cell when Rpn10196-204A is 
polyubiquitinated. 
 
 
Ubiquitin binding domains as scaffolds for substrate-
driven ubiquitination 
 
The control of the activity of substrate receptors Rpn10 and Rpn13 has 
emerged as a pivotal checkpoint in the regulation of substrate recruitment to the 
proteasome and of the proteasome pathway. First, Rpn10 monoubiquitination has 
the capacity to regulate interaction with polyubiquitinated substrates (Isasa et al, 
2010) and with the ubiquilin type protein Dsk2 (Lipinszki et al, 2012). Moreover, 
Rpn10 can be regulated by its proteasome association status, existing both 
proteasome-bound and proteasome-unbound forms in vivo (Isasa et al, 2010; 
Matiuhin et al, 2008; Lipinszki et al, 2009; Puram et al, 2013). Interestingly, the 
distinct pools of Rpn10 might have different roles, as suggested by the capacity of 
Discussion 
 
98 
‘free’ Rpn10 to filter Dsk2 on its way to the proteasome, in yeast and drosophila 
(Matiuhin et al, 2008; Lipinszki et al, 2012). Furthermore, controlling the equilibrium 
of Rpn10 proteasome- bound/proteasome-unbound forms in vivo might have 
profound physiological consequences in mammalian cells. Recently, it has been 
shown that in mammalian brain, Rpn10 proteasome association/dissociation is 
tightly regulated by Id1 protein, having special relevance in dendrite development 
(Puram et al, 2013). Interestingly, the ubiquitination of the other main proteasome 
substrate receptor, Rpn13, has been recently shown to decrease substrate 
recruitment and 26S activity, and to correlate with situations of proteotoxic stress 
(Besche et al, 2014). Therefore, the inactivation of Rpn10 and Rpn13 by 
ubiquitination could be a very interesting physiological and biomedical scenario. 
Further research will be required to determine the link between Rpn10 and Rpn13 
ubiquitination and to uncover the functional implications of this putative link.  
 
A common aspect in the process of monoubiquitination of proteins 
containing UBDs is the involvement of Nedd4 enzymes, such as Rsp5 in yeast and 
Nedd4.2 in mammals. The Nedd4 Ubiquitin ligase family is highly conserved and 
involved in multiple and diverse tasks in cell physiology. These Ubiquitin ligases 
have been involved in the monoubiquitination of UIM containing proteins. It has 
been proposed that the UIM within these proteins promotes a molecular interaction 
with the Ub moiety linked to the substrate, generating a fold-back of the protein 
(Figure 49) (Polo et al, 2002; Shih et al, 2003; Hoeller et al, 2006; Isasa et al, 
2010). Analogously, the RING Ubiquitin ligase SCFMET30 monoubiquitinates the 
transcription factor Met4. The UIM of Met4 both restricts chain elongation on Met4 
and prevents the recognition and proteolysis of ubiquitinated Met4 by the 
proteasome (Flick et al, 2006). The fold-back model could explain the mechanism 
by which UIM-proteins inhibit their own polyubiquitination. This model implies 
certain capacity of substrates to undergo a conformational change. However, the 
requirement of specific structural properties facilitating a conformational change 
and, thus, preventing Ub chain extension has never been established. 
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Role of Ubp2 in regulating Rsp5-dependent Rpn10 
ubiquitination 
 
 The deubiquitinase enzyme, Ubp2, efficiently hydrolyses Ubiquitin-Ubiquitin 
links from conjugates that have been previously K63-polyubiquitinated by Rsp5 and 
reverses completely the in vitro ubiquitination of certain Rsp5 substrates (Kee et al, 
2005, 2006). A former member of our lab observed that the incubation of Ubp2, 
after an in vitro ubiquitination reaction, deubiquitinated Rpn10 but not reversed the 
ubiquitination completely (Isasa et al, 2010). We reproduced this experiment and 
we observed the same pattern (Figure 25A). Regarding PPAYRpn10, a mutant that 
becomes extensively polyubiquitinated, the catalysis of Ubp2 generated a mono- 
and diubiquitinated version of this mutant (Figure 25A), which is one of the 
mechanisms by which monoubiquitination can be generated. The incomplete 
hydrolysis of ubiquitinated PPAYRpn10 was similar to the inability of Ubp2 to trim 
back all the ubiquitins bound to Rpn10. 
Interestingly, it seems that the capacity of Ubp2 in deubiquitinating Rpn10 to a 
greater or lesser extent depends on the conditions under which the reactions are 
carried out. After we incubated Ubp2 and Rsp5 simultaneously in a reaction with 
Rpn10, we observed that the deubiquitinating activity of Ubp2 against Rpn10 was 
at least 5 times higher than the ubiquitinating activity of Rsp5 (Figure 25B). Indeed, 
although using 50 nM of Rsp5 and 10 nM of Ubp2, Rpn10 was still entirely 
unmodified. Remarkably, the extensively polyubiquitinated PPAYRpn10 needed five 
times more Ubp2 than Rpn10 to be totally deubiquitinated when Rsp5 was also 
present. The interaction between the PPAY and the WWs in Rsp5 might be 
strengthening PPAYRpn10 ubiquitination. 
However, when Rsp5HECT was used as the ligase and the reaction contained Ubp2 
from time 0, recovery of the unmodified Rpn10 was not observed, even when the 
Ubp2:Rsp5 stoichiometry was 1:1. In this context, PPAYRpn10 de was the same as 
for Rpn10 since the lack of WW in Rsp5HECT does not change the pattern of 
ubiquitination of PPAYRpn10 (Figure 25A and B). These results agree with our 
observation of the higher capacity of Rsp5HECT in catalyzing the monoubiquitination 
of Rpn10. 
In summary, we have observed that the ubiquitination/deubiquitination equilibrium 
of Rpn10 depends on the presence or absence of Ubp2 at the beginning of the 
reaction, which would affect the levels of self-ubiquitinated Rsp5. In a reaction 
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without Ubp2, Rsp5 can be largely self-ubiquitinated and ubiquitination of the 
substrate takes place. Once we add Ubp2, cleavage of the Ub molecules from the 
ligase and the substrate would occur (Rsp5 preferentially conjugates K63 chains to 
itself, and Ubp2 deubiquitinates Rsp5 (Kim & Huibregtse, 2009; Lam & Emili, 
2013)) (Figure 50A). The prior self-ubiquitination of Rsp5 could be an advantage to 
keep ubiquitinating Rpn10 over Ubp2 deubiquitinating it. Conversely, when Ubp2 is 
present in a reaction from the beginning, as Rsp5 is self-ubiquitinated and the 
substrate is ubiquitinated, Ubp2 would be deubiquitinating them. Rsp5 would no 
longer be able to build long polyUb chains on itself and, therefore, ubiquitinate 
Rpn10 as efficiently. Here, Ubp2 would hydrolyze all the Rpn10-Ubiquitin links 
(Figure 25B and 50B).  
 
Figure 50. Ubp2 deubiquitinates Rpn10 completely. 
A) The addition of Ubp2, after a Rpn10 ubiquitination reaction, catalyzes partial 
deubiquitination of Rsp5 and Rpn10. B) Ubp2 deubiquitinates completely Rpn10 when 
added simultaneously with the other factors of the ubiquitination reaction. 
 
 
 
Kee et al. showed that an UBA-containing protein called Rup1 stabilizes the 
interaction between Rsp5 and Ubp2 (Kee et al, 2005) and in a recent paper, it has 
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been shown that Rup1 and Rsp5 interact by means of a putative Rsp5-binding 
motif (PPPSY) and that their interaction increases Ubp2 deubiquitinating activity 
(Kee 2005, Lam 2009, Lam 2013). Additionally, Lam and collaborators suggested 
that Rup1 might change Rsp5 conformation from a non-active to an active state, 
which would stimulate Rsp5 self-ubiquitination and substrate ubiquitination (Lam & 
Emili, 2013). The presence of Rup1 in in vitro ubiquitination reactions was tested in 
our lab in the past. The catalytic rates of deubiquitination of Rpn10 were not 
increased by Rup1 presence and, thus, de-monoubiquitination of Rpn10 couldn’t be 
observed (Isasa, 2012). We wonder what would be the role of Rup1 on the Ubp2-
Rsp5-Rup1-PPAYRpn10 complex. Ubiquitination reactions with Ubp2 and Rup1, both 
included after the reaction, would determine whether Rup1 helps Ubp2 cleave the 
residual short Ubiquitin chains and the most proximal Ubiquitin moieties within 
PPAYRpn10 or cannot stimulate de-monoubiquitination, as with Rpn10. 
 
 
Strikingly, in the in vivo context, the levels of conjugated Rpn10 after 
overexpressing Rsp5HECT were not increased in a strain lacking Ubp2- ubp2Δ strain 
(Figure 27A and B). The same result was reproduced after inducing Rsp5HECT in the 
double mutant rsp5–1 ubp2Δ strain at a restrictive temperature (Figure 27C). Isasa 
and collaborators already reported that Ubp2 is highly active towards Rpn10-
monoubiquitin isopeptide bonds but that under some conditions the deubiquitination 
is not apparent (Isasa et al, 2010). Certainly, the equilibrium between mUb-
Rpn10/Rpn10 is controlled by other factors such as other DUBs that might act on 
Rpn10 or Rsp5. High levels of mUb-Rpn10 limit the interaction with substrates, 
which decreases proteasome activity and produces a severe slow-growth 
phenotype (Figure 26E). A more complex regulation of Rpn10 ubiquitination is likely 
to exist. 
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S5a ubiquitination, a model for Rpn10 ubiquitination?  
It is interesting to mention the universality of S5a (Rpn10 human ortholog) 
as a substrate described by Uchiki and coworkers (Uchiki et al, 2009). Uchiki 
proposed that the ubiquitination of S5a results from its binding to the polyubiquitin 
chain on the E3 ligase after auto-ubiquitination and suggested that, through this 
mechanism, S5a can be polyubiquitinated by all E3s when combined with UbcH5 
E2 enzyme (Figure 51). Strikingly, when we performed ubiquitination reactions with 
S5a, Nedd4 and UbcH5b, S5a showed a pattern of mono- and diubiquitination, 
never reaching the polyubiquitinated state (Figure 45A). This observation collides 
with the one observed by Uchiki and colleagues as they observed polyubiquitinated 
S5a when using different E3s such as the RING types, Siah2 and MuRF1, the U-
Box type, CHIP and the HECT types, E6AP, and Nedd4 (Uchiki et al, 2009). This 
same lab also showed that the polyubiquitination of the ligase was a requirement to 
obtain ubiquitinated S5a. S5a contains two UIMs that would interact with the 
polyubiquitin chain on the self-ubiquitinated ligase. This interaction would allow the 
proximity of S5a to the highly reactive Ub thioester that is formed between Ub and 
the active site of the ligase, which would trigger S5a ubiquitination.  
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Figure 51. S5a ubiquitination model. 
Uchiki’s model has been an inspiration to propose the following model for Rpn10 and 
Rpn10196-204A Rsp5-mediated ubiquitination 
 
 
To test whether the polyubiquitination of the ligase was necessary for the 
ubiquitination of S5a, Uchiki and coworkers performed ubiquitination reactions 
using methylated Ub, an Ubiquitin mutant that cannot form polyubiquitin chains 
(Hershko & Heller, 1985). They obtained a monoubiquitinated ligase, which led, 
under their conditions, to a non-modified S5a, indicating that S5a needs to bind to 
polyUb chains before being ubiquitinated. Interestingly, a similar reaction using 
Rpn10 as substrate and methylated Ub produced the same pattern of ubiquitination 
observed using wild-type Ubiquitin, which is mono- or multi-monoubiquitinated 
Rpn10 (Isasa et al, 2010). In summary, although Rpn10 also contains an UIM that 
is indispensable to allow its ubiquitination and to interact with Ubiquitin conjugates, 
it is still ubiquitinated when using ubiquitins that do not form chains (i.e. Ub K0, Ub 
methylated). Therefore, on the one hand, we would suppose that the mechanism 
by which Rpn10 is modified is at least partially different from the one followed by its 
orthologue, S5a. However, on the other hand, S5a and Rpn10 as well as S5a 
mutants (S5aM196A,G200A and S5a193-200A) and Rpn10 mutants (Rpn10196-204A and 
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Rpn10M199A-G203A) showed similar behaviours in our experiments, indicating that the 
mechanism could be similar. 
 
Taking Uchiki’s model into account, we propose that the UIM of Rpn10 is 
able to bind both poly- and monoubquitinated Rsp5. Once Rpn10 is multi-
monoubiquitinated, the interaction between the Ubiquitins attached to Rpn10 and 
the UIM becomes stronger than the one between the Ubiquitins attached to the 
ligase and the UIM, facilitated by the fold-back of Rpn10 (Figure 52A and B). On 
the contrary, the Rpn10196-204A mutant cannot fold-back, which enhances the 
binding between the UIM and the ligase and promotes polyubiquitination of the 
substrate. 
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Figure 52. The proposed mechanism of Rpn10 and Rpn10196-204A ubiquitination. 
A) 1- Ubc4 transfers a Ubiquitin to the active site of Rsp5. Rpn10 binds to Rsp5 and to 
the growing Ub chain on Rsp5 through the UIM domain, highlighted in cyan. 2- Rpn10 
is multi-monoubiquitinated because of the proximity between the active-site cysteine 
(cys) and the lysines on Rpn10. 3- Formation of an intramolecular binding between the 
UIM and a Ubiquitin bound to Rpn10, favored by a fold-back within Rpn10. The 
orientation of the lysines has changed and the highly reactive Ub thioester is too far to 
keep adding ubiquitins to Rpn10. B) In contrast with S5a, Rpn10 is multi-
monoubiquitinated when using methylated Ubiquitin. Same steps as in A)1, with the 
exception that now, the UIM domain binds only to one Ubiquitin in Rsp5. C) 1- As in 
A)1, the mutant Rpn10196-204A binds to the self-ubiquitinated Rsp5 through the UIM 
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domain. 2- Rpn10196-204A is multi-monoubiquitinated. 3- Rpn10196-204A cannot fold-back 
because of its gain in structural order and, therefore, it is polyubiquitinated. 
 
 
Disordered regions flank the UIM of proteins that 
undergo monoubiquitination 
 
Our work suggests a correlation in Rpn10 between the UIM, a flanking 
conserved disordered region and monoubiquitination. The prediction of conserved 
UIMs and unstructured regions in Rpn10 orthologues (Figure 53) suggests a 
conserved mechanism facilitating monoubiquitination. Additionally, disorder can be 
found anywhere within a protein although it is typically found at the termini, which is 
the case for Rpn10 orthologues (Uversky, 2013; Dunker et al, 2000). 
 
 
Figure 53. The regions flanking the UIMs show a disposition to disorder. 
Plots showing the disposition to disorder of Rpn10 from different species. The 
rectangle areas correspond to the positions of the UIM1 and UIM2 domains. 
 
 
We asked whether this correlation could be a trait of Ubiquitin-binding proteins 
regulated by monoubiquitination. We analyzed the disposition to disorder of Eps15, 
Vps27, Hrs, Vps9 and Cue1, which undergo monoubiquitination in vivo (Polo et al, 
2002; Shih et al, 2003; Hoeller et al, 2006). We observed that these proteins show 
high disposition to disorder in regions flanking the UIM (Figure 54).  
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Figure 54. Disposition to disorder of other proteins that are monoubiquitinated. 
Plots showing the disposition to disorder of Eps15, Vps27, Vps9, Cue1 and Hrs. The 
rectangle areas correspond to the positions of the UIM and CUE domains. 
 
We hypothesize that the presence of disordered regions could be a characteristic 
feature of monoubiquitination driven by the substrates. Further research will be 
required to validate this hypothesis. 
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The aim of my thesis research has been the study of the mechanism of Rpn10 
monoubiquitination, using Saccharomyces cerevisiae as a model organism. The 
remarking conclusions are as follow: 
 
• We have optimized the reaction of ubiquitination of Rpn10. 
• We have obtained polyubiquitinated Rpn10 by adding a PPAY motif at the 
N-terminus of Rpn10 indicating that the monoubiquitination of Rpn10 does 
not result from an impaired polyubiquitination activity of Rsp5, but is 
determined by specific features of Rpn10. 
• The UIM of Rpn10 is required to ubiquitinate Rpn10 and the PPAY motif 
does not guarantee the reaction.  
• The balance of the activity of the Ubiquitin ligase, Rsp5, and the 
deubiquitinase, Ubp2, determines the final outcome of Rpn10 ubiquitination: 
Ubp2 outcompetes Rsp5 and completely deubiquitinates Rpn10 in vitro. 
• The HECT domain of Rsp5 is sufficient to ubiquitinate Rpn10 in vivo and in 
vitro. Rsp5HECT proved to be more competent in ubiquitinating Rpn10 than 
TomHECT, another yeast HECT Ubiquitin ligase. 
• Rsp5HECT is more efficient in monoubiquitinating Rpn10 than Rsp5 full-
length. 
• Increased levels of monoubiquitinated Rpn10 by Rsp5 produce a severe 
yeast growth defect. 
• The VWA domain of Rpn10 is dispensable for Rpn10 ubiquitination and 
Rpn10208-268 is the shortest sequence that undergoes ubiquitination. 
Additionally, we have shown that the region C-terminal to residue D254 is 
not needed to get ubiquitinated Rpn10. 
• A disordered region in Rpn10, between the VWA and the UIM, plays a key 
role in promoting monoubiquitination by preventing Rpn10 
polyubiquitination. The Rpn10196-204A mutant, that carries a block-substitution 
to alanines in this region, between amino acids S196 to G204, generates 
Rpn10 polyubiquitination and introduces, predictably, a helicoidal structure. 
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• The region S196-G204 has an effect on cell viability by producing a 
decrease of growth in cells at 37ºC when mutated to alanines. 
• Polyubiquitination of Rpn10196-204A in vivo could not be detected. 
• Mutations in the region between the VWA and the UIM1 in S5a change the 
ubiquitination pattern. 
Our findings agree well with the fold-back model, although future 
experiments are needed to confirm the introduction of an α-helix in the 
region S196-G204. 
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Assays of ubiquitination in vitro 
Rpn10 in vitro ubiquitination reactions (50 µL) contained 50 nM of GST-Rpn10 or 
versions of Rpn10, 87 nM of human activating E1, 5,7 µM of GST-Ubc4, 50nM of 
GST-Rsp5 or 6HIS-Rsp5HECT and 35,3 µM of Ub or at the indicated concentrations. 
Reactions for Figure 3A contained 0.87 µg (150 nM) of GST-Rsp5. Different types 
of ubiquitins were used: recombinant wild-type, Ub K63-only, Ub K48-only, Ub 
K63R, Ub K48R, Ub K0 (BostonBiochem) and methylated Ub (Enzo Life Sciences). 
Rpn10 ubiquitination in vitro reactions were also performed using Tom1HECT and 
Hul4HECT at the indicated concentrations.  
in vitro S5a ubiquitination reactions (50 µL) contained 500 nM of GST-S5a or GST-
S5a mutants, 17,4 nM or 174 nM of human activating E1, 45 nM or 0.45 µM of his-
UbcH5b (BostonBiochem), 20 nM of GST-Nedd4, and 35,3 µM of Ubiquitin.  
Reactions were carried out in 100 mM Tris-HCl (pH 7.4), 200 mM NaCl, 10 mM 
ATP, 10mM MgCl2 and 1 mM DTT buffer at 30ºC (for Rpn10 reactions) and at 37 
ºC (for S5a reactions) and were incubated for 3 hours or for the indicated times. 
Reactions were stopped by the addition of reducing SDS-PAGE loading buffer and 
analysed by western blot against Rpn10. 
The auto-ubiquitination assays of Rsp5HECT, Tom1HECT and Hul4HECT were carried 
out in the same buffer as the ubiquitination reactions and contained 1 µg of human 
activating E1, 2 µg of GST-Ubc4, 2 µg of ligase, 0.5 µg of Ub and 10mM ATP in 
25,4 µl final volume. Reactions were incubated at 37ºC for 30 minutes. Reactions 
were stopped by the addition of reducing SDS-PAGE loading buffer and analysed 
by western blot against Ubiquitin. 
 
Assays of deubiquitination in vitro  
Deubiquitination assays were performed in the presence of 100 mM Tris-HCl (pH 
7.4), 200 mM NaCl, 10 mM ATP, 10mM MgCl2 and 1 mM DTT. Different amounts 
of GST-Ubp2 (10 nM, 25 nM and 50 nM) were added either once the ubiquitination 
reaction was finished or at the beginning of the ubiquitination reaction. Reactions 
were incubated at 30ºC for different times (15 min, 45 min and 120 min or 2h, 4h 
and 6h). Reactions were stopped by the addition of reducing SDS-PAGE loading 
buffer and analysed by western blot against Rpn10. 
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Ubiquitin binding experiments  
Rpn10195-268, Rpn10211-268, Rpn10195-268 UIM, Rpn10195-254 and Rpn10195-239 were 
purified as GST-fusion proteins on glutathione-sepharose beads and same 
amounts of proteins were used in binding assays. Equal amounts of input, 1.5 µg of 
either K48-linked or K63-linked poly-Ub chains were incubated with Rpn10 
fragments (in Figure 31 and 33) overnight at 4ºC in the presence of binding buffer 
containing 50 mM Tris-HCl pH 7.4, 1 mM EDTA, 100 mg.ml-1 BSA. Beads were 
washed with 10 volumes of this buffer supplemented with 150 mM NaCl. Bound 
proteins were eluted by boiling 5 min in 2x reducing SDS-PAGE loading buffer, 
separated by SDS-PAGE and immunoblotted with an anti-Ubiquitin antibody. The 
UIM from RNF114 (Figure 31) was used as a positive control and the GST protein 
and the beads alone as negative controls.  
 
Yeast methods and media 
Strain transformations were performed following standard techniques (Rose et al, 
1990). YPD medium consisted of 1% yeast extract, 2% Bacto-Peptone, and 2% 
dextrose. Synthetic media consisted of 0.7% Yeast Nitrogen Base supplemented 
with amino acids, adenine and uracil as described (Rose et al, 1990), 2% dextrose 
(SDC) or, if necessary, 1% galactose (SGRC). For plasmid selection, synthetic 
media lacking uracil, leucine or tryptophan or the lack of two of these amino acids 
were prepared. Cultures were grown at 30ºC or at the indicated temperature; rsp5–
1 ubp2Δ strain was induced at 35ºC for 7 hours (Figure 27C). Samples taken from 
growing cultures were normalized by optical density at 600 nm using Eppendorf 
Biophotometer plus (Eppendorf). Spot assays were prepared after 4 hours 
induction with galactose in liquid and agitation at 30ºC. Cells in Figure 26E were 
induced in liquid at 30ºC. After that the OD600 of each cell culture was adjusted to 
0.04, and then spotted in 5-fold serial dilutions onto plates with (SGRC) or without 
(SDC) galactose before incubation at 22ºC. Cells in Figure 41A were grown in 
liquid at 37ºC and spots were grown at 30ºC or 37ºC in SDC plates. Images of 
colony spot assays were taken using GeneGenius Bioimaging System (Syngene). 
Detailed description of genotypes of strains is provided below. 
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TABLE 1  
Yeast strains used in this study 
Strain Genotype Source 
SUB62 MATa lys2-801 leu2-3, 2-112 ura3-52, 
his3- Δ200 trp1-1 
Finley Lab 
11d Rpn10::natMX, 
Rad23::KanMX4 (Based on Sub62) 
 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 
 ura3Δ0 
Euroscarf 
S67 Wild-type (based on BY4741)  
S72 Rpn10::KanR (based on BY4741  
S33 Rpn4::KanR (based on BY4741)  
FY56 MATa ura3-52, his4-912-R5, 
lys2Δ 128 
Beaudenon Lab 
 
Analysis of Rpn10 in yeast 
Yeast wild-type, rpn10Δ, rpn10Δrad23Δ, rsp5–1 ubp2Δ and ubp2Δ strains were 
grown under normal conditions and an equivalent number of cells were taken after 
4 hours of induction or at the indicated time points (Figures 26, 27, 42 and 43). 
Cells were harvested, resuspended with buffer composed of 50 mM Tris-HCl (pH 
7.4), 1 mM EDTA, pelleted again and resuspended in Laemmli loading buffer. Cells 
were then lysed by vortexing 1 minute and boiling 2 minutes, twice, then vortexing 
1 minute and boiling 4 minutes. Supernatants were resolved by SDS-PAGE and 
analysed by immunoblotting against Rpn10, Pgk1 and Hemagglutinin.  
 
 ubp2Δ knockout 
To create the double mutant rpn10Δ ubp2Δ, linear DNA substrate was made by 
PCR amplification of a cassette encoding the kanamycin gene (pFAGKANmx) 
using bi-partite primers. These primers consisted of (from 5’→3’) 50 bases of 
homology to Ubp2, where the cassette is to be inserted, followed by 25 bases to 
prime the kanamycin cassette. DNA was next transformed into yeast cells and cells 
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were plated in YPD medium. Two days later, we replica plated the lawn on 
selective medium (YPD+G418). Once the new colonies were grown, some were 
used as DNA template to run a PCR to confirm the incorporation of the kanamycin 
gene. 
 
Immunoprecipitation 
 rpn10Δ (S72) strain carrying pRS425 Rpn10 or pRS425 Rpn10K84,268R and 
HARsp5HECT galactose-inducible plasmid was grown in glucose and galactose for 4 
hours. Cells were harvested and resuspended in Lysis buffer (50 mM Tris-HCl pH 
7.4, 1 mM EDTA, 100 mM NaCl and 1x concentration of protease complete 
inhibitor cocktail EDTA free (GE Healthcare)). The disruption of yeast cells was 
done by agitation with glass beads (0.4-0.5 mm, Sigma). 8 cycles of vortexing (60 
sec) were interspersed with cycles of cooling on ice to avoid overheating of the cell 
suspension. 
Protein concentration was measured by Bradford and same amounts of the four 
whole cell extracts (875 µg) as well as purified Rpn10 were incubated with 1,5 µl of 
Rpn10 antibody at 4ºC overnight. IgG beads (35 µl 50% slurry/binding) were next 
added for 2 hours at 4ºC. Beads were washed with 10 bed volumes with lysis 
buffer. Bound proteins were eluted by boiling 5 minutes in 2x reducing SDS-PAGE 
loading buffer, separated by SDS-PAGE and immunoblotted with an anti-Ubiquitin 
and anti-Rpn10 antibodies. 
 
Assays of deubiquitination in vivo 
For in vivo deubiquitinating activities, rpn10Δ (S72) strain carrying pRS425 Rpn10 
and HARsp5HECT galactose-inducible plasmid was grown in galactose for 4 hours. 
234 µg of whole cell extract were incubated with 600 nM of GST-Ubp2 in a buffer 
containing 50 mM Tris-HCl pH 7.4, 1mM EDTA and 200 mM NaCl at 30ºC. Same 
amounts of whole cell extract were incubated at 30ºC without Ubp2. Time points 
were taken at time 0, 15, 30 and 45 minutes after starting the incubation. Reactions 
were stopped by the addition of SDS-PAGE loading buffer and analysed by 
western blot against Rpn10 (Figure 26C).  
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Size-exclusion chromatography  
 rpn10Δ (S72) strain carrying Rpn10 or Rpn10196-204A was cultured (500 ml) and 
cells were harvested, resuspended in a 2-fold volume of 50 mM Tris-HCl pH 7.4, 1 
mM EDTA, 150 mM NaCl buffer and lysed using a cell disrupter (Constant Cell 
Disruptor Systems). Lysate was centrifuged twice at 10,000xg in cold for 40 min. 
The supernatant was recovered and centrifugation was repeated three times. Final 
lysate was filtered through a 0.45 µm filter before applying it to a Superose 6 gel 
filtration chromatography (GE Healthcare). The eluted fractions were analysed by 
western blot against Rpn10 antibody. 
 
Protein stabili ty by cycloheximide chase assay 
Comparison of CPY* stability has been achieved by the protein inhibitor, 
clycoheximide. Degradation of HA-tagged CPY* was compared in wild-type (S67) 
and rpn10∆ (S72) strains carrying empty vector pRS424, pRS424 Rpn10 or 
pRS424 Rpn10196-204A. Overnight cultures of the indicated strains were adjusted to 
an equal OD600 and allowed to grow in the exponential phase for 4 h at 30°C. 
Cultures were again normalized by OD600, and 200 µg/ml cycloheximide were 
added (Figure 44). Equal number of cells was taken at indicated time points after 
cycloheximide treatment. Samples were pelleted and resuspended in 1x Laemmli 
loading buffer and were analysed by western blot against HA and Pgk1 for 
quantification. 
 
Prediction of unstructured regions 
To carry out the prediction of unstructured regions we used a meta-predictor 
computer program called PONDR-FIT (Predictors of Natural Disordered Regions) 
(Xue et al, 2010). The meta-predictor uses an amino acid sequence as the input 
and gives structure (order) or disorder as the output by combining the prediction of 
different software’s predictions. Access to PONDR-FIT is available at 
www.disprot.org.  
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Prediction of secondary structures 
To predict the secondary structure of Rpn10 and Rpn10196-204A, we used MeDoR 
(Metaserver of Disorder) that includes a Secondary Structure prediction that makes 
use of the StrBioLib java library (LGPL), which is the basis for the Pred2ary 
program. The library can be found from its official web page http://www.strbio.org. 
MeDoR also helps to identify protein disorder by providing a graphical interface with 
a unified view of the output of multiple disorder predictors. 
 
Expression and purification of GST-fusion proteins in 
E.coli 
In E.coli, glutathione S-transferase fusion vectors (pGEX-4T-3) were used to 
express and purify the following proteins: Rpn10, PPAYRpn10, Rpn1040-268, Rpn10208-
268, PPAYRpn10208-268, Rpn10208-268 UIM, PPAYRpn10208-268 UIM, Rpn10195-268, 
PPAYRpn10195-268, Rpn10195-268 UIM, PPAYRpn10195-268 UIM, Rpn10211-268, PPAYRpn10211-
268, Rpn10195-268 K268R, PPAYRpn10195-268 K268R, Rpn10208-268 K268R, PPAYRpn10208-267 
K268R, Rpn10211-268 K268R, PPAYRpn10211-268 K268R, Rpn10DSD208-210Δ, Rpn10196-204A, 
Rpn10M199A-G203A, Rpn10196-204S, Rpn10 M199S-G203S, Rpn10195-239, Rpn10195-254, 
Rpn10195-261, Nedd4, S5a, S5a193-201A, S5a M196A-G200A, Rsp5, Tom1HECT, Hul4HECT 
and Ubc4. Bacterial cultures (500 mL) were grown to an OD600 of 0.7, induced with 
500 µM isopropylthiogalactoside (IPTG) for 15 h at 20ºC, resuspended with 2 
volumes of 50 mM Tris-HCl pH 7.4, 1 mM EDTA, 1x concentration of protease 
complete inhibitor cocktail EDTA free (GE Healthcare) buffer and lysed using either 
a cell disrupter (Constant Cell Disruptor Systems) or a sonicator (Vibra-Cell VCX 
750, Sonics). The supernatant was mixed with Glutathione (GSH) Sepharose 4B 
beads at a ratio of 1 ml of 50% beads slurry to 500 mL of initial culture size. The 
mixture was incubated at 4ºC rolling for 1 h. Beads were washed with 50 bed 
volumes of the previous lysis buffer supplemented with 150 mM NaCl. Proteins 
were eluted either with SDS loading buffer or with a reduced glutathione buffer of 
50 mM Tris-HCl pH 8.8, 1 mM EDTA and 35 mM reduced glutathione. When 
necessary (Figures 14 and 28C, D and E), GST-UbRpn10L85 and GST-Rpn10195-
268 were digested with biotinylated thrombin (Novagen) (1U enzyme for 10 µg 
target). Digestions were incubated overnight at 4ºC. The efficiency of cleavage was 
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determined by SDS-PAGE analysis. Thrombin was removed with benzamidine 
beads (Amersham Biosciences) according to the manufacturer's instructions. 
Additional purification steps were added to increase the purity of UbRpn10L85. 
UbRpn10L85 was concentrated and 500 µl were loaded to a size-exclusion 
chromatography column Superdex 200 (10/300). To obtain higher purity, a monoQ 
high resolution ion exchange chromatography was used with the next buffers: 
Buffer A (50mM Tris-HCl pH 7.6, 50mM NaCl, 1mM DTT, 1mM EDTA) and Buffer B 
(50mM Tris-HCl pH 7.6, 50mM NaCl, 1mM DTT, 1mM EDTA) with a linear ionic 
strength gradient of 0-40% elution buffer in 20 CV. 
 
Expression and purification of 6his-Rsp5HECT in E.coli 
pET28a was used to express and purify Rsp5HECT. The protocol for its induction 
and lysis was the same used for GST-proteins. The lysis buffer contained 50 mM 
Tris-HCl pH 7.4, 10mM imidazole, 1x concentration of protease complete inhibitor 
cocktail EDTA free (GE Healthcare), 150mM NaCl and 10% glycerol. The 
supernatant was mixed with Ni-NTA beads previously equilibrated with 10mM 
imidazole. For 50 mL of culture, 200 µl of Ni-NTA beads were used. The mixture 
was incubated at 4 ºC rolling for 1 h and then washed first with 10 bed volumes of 
50 mM Tris-HCl pH 7.4, 25 mM imidazole, 150 mM NaCl and 10% glycerol and 
finally with 10 bed volumes of the same buffer including 500 mM NaCl. Rsp5HECT 
bound to the resin was eluted by competition with imidazole following a gradient-
step imidazole elution ranging from 50 mM to 500 mM imidazole including 500 mM 
NaCl and 10% glycerol. 
 
Electrophoresis and immunoblot analysis  
In Figures 26A, B and C, 27, 41B, 42, 43 and 44, proteins were resolved by SDS-
PAGE 12% polyacrylamide gels with Tris-Glycine buffer. The rest of the proteins 
were resolved by 4-12% gradient SDS-PAGE with Tris-Glycine buffer (Invitrogen). 
For immunoblots, proteins were transferred to polyvinylidene difluoride membranes, 
which were then blocked, and incubated with antibodies using TBST buffer (50 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween 20) with 5% w/v nonfat powdered 
milk, and washed with TBST and with H2O. 
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Antibodies  
Polyclonal antibodies to Rpn10 were raised in rabbits against full length protein and 
second bleed antiserum was used (Isasa et al, 2010). Anti-S5a antibody was 
produced in rabbit and obtained from Enzo Life Sciences. Anti-hemagglutinin 
antibody produced in rabbit was obtained from Sigma-Aldrich. Anti-Ubiquitin (P4D1) 
is a mouse monoclonal antibody obtained from Santa Cruz Biotechnology. The 
pgk1 monoclonal antibody produced in mouse was obtained from Life 
Technologies. Anti-rabbit IgG Horseradish Peroxidase-linked whole antibody from 
Donkey was obtained from GE Healthcare. Goat anti-mouse IgG (H+L), peroxidase 
Conjugated antibody was obtained from Thermo Scientific.  
 
Plasmid constructions 
Plasmid and oligonucleotide primers detailed information is included below. 
 
All single and multiple nucleotide mutations were performed in one round and using 
Quick Change Site Directed Mutagenesis kit (Stratagene). 1% agarose gels in TAE 
(20mM Tris-Acetate, 0,5mM EDTA) were used to analyse DNA fragments for 
cloning. 
Constructions regarding the purification of Rpn10 mutant proteins were made in the 
Escherichia coli expression vector pGEX-4T-3 by PCR strategies. All of them were 
cloned into EcoRI and SalI cleavage sites except for UbRpn10L85. 
UbRpn10L85 (pPIL 106) construct was created in three steps. First, we obtained 
Rpn10L85 from Rpn10 wild-type (pMIC26) by PCR amplification (primers used 
were Rpn10L85 forward and reverse). Next, we cloned Rpn10L85 into Kpn1 and 
EcoR1 sites of pGEX Ub WT. Finally, we mutagenized the stop codon of Ub and 
the second triplet of kpn1 to obtain three glycines in a row using UbRpn10L85GGG 
primers. 
PPAYRpn10 construct (pPIL132) was derived from Rpn10 wild-type (pMIC26) by 
PCR amplification (primers used were R10M1PPAY Fw and R10K268 Rev) and 
cloned into Sal1 and EcoR1 sites of pGEX-4T-3. PPAYRpn10 included a sequence 
between the GST and the N-terminus of the protein encoding for the PPAY motif: 
CCTCCTGCATAC. 
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For N-terminal-deleted constructions, pPIL133, pPIL137, pPIL141 and pPIL143 5’-
amplification oligonucleotides were designed to create a new start codon and 
R10K40 Fw, R10D208 Fw, R10 G195 fw, R10 A211 fw primers were used, 
respectively. All of them were derived from pMIC26 and the reverse primer used for 
all of them was R10K268 Rev.  
PPAYRpn10195-268 and PPAYRpn10211-268 were derived from Rpn10 by PCR 
amplification (primers used were R10G195PPAY Fw and R10K268 Rev and 
R10A211PPAY Fw and R10K268 Rev, respectively) and cloned into Sal1 and 
EcoR1 sites of pGEX-4T-3. 
For the C-terminal-deleted constructions, pPIL195, pPIL206 and pPIL207 the 3’-
amplification oligonucleotides were designed to add a lysine just before the stop 
codon and were derived from pPIL141, using primers R10G195 E239+K fw, 
R10G195D254+K Fw and R10G195Q261+K Fw, respectively together with 
R10K268 Rev. 
 
Rpn10UIM (pPIL169), Rpn10195-268 UIM (pPIL171), PPAYRpn10195-268 UIM (pPIL172), 
Rpn10208-268 UIM (pPIL167) and PPAYRpn10208-268 UIM (pPIL168) were derived from 
pMIC26, pPIL141, pPIL141, pPIL137 and pPIL137, respectively. Residues from 
228 to 232 were mutated to asparagines by multiple nucleotide mutagenesis using 
primers R10 uim Fw and its reverse complement. 
 
Fragments of Rpn10 with the 268 lysine mutated to an arginine, pPIL161, pPIL162, 
pPIL163, pPIL164, pPIL165 and pPIL166 were derived from pPIL141, pPIL142, 
pPIL137, pPIL138, pPIL143 and pPIL144, respectively and mutated by single 
nucleotide mutagenesis using primers R10k268r fw and its reverse complement. 
 
Mutants within Rpn10 full length, pPIL194, pPIL205, pPIL210, pPIL211, and 
pPIL220 were obtained through mutagenesis using pMIC26 as a template. 
Residues from 196 to 204 were mutated either to alanines in pPIL194 or to serines 
in pPIL210 (primers R10 link Ala and R10 link Ser fw and their reverse 
complement, respectively). Residues M199 and G203 were mutated to alanines 
(primers R10 MG Ala fw and its reverse complement for pPIL205) or to serines 
(primers R10 mg Ser fw and its reverse complement for pPIL211). Residues from 
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208 to 210 were deleted in pPIL220 using primers R10G195Δ208-210 Fw and its 
reverse complement.  
S5a (pPIL193) was kindly provided by Dr. F. Hanaoka and was used as a template 
for constructing pPIL208 and pPIL209. We followed the same strategy described 
for plasmids pPIL194 and pPIL205 using primers S5a link Ala fw and S5a m-g to 
Ala fw and their reverse complement, respectively. 
pRS424 Rpn10 (pMIC93) was kindly provided by Dr. H. Fu and used as a template 
for constructing Rpn10DSD208-210Δ (pPIL222) and Rpn10196-204A (pPIL225) following 
the same strategy described for plasmids pPIL220 and pPIL194, respectively. 
pRS424 contains a TRP gene marker. 
Nedd4 (pPIL202) was kindly provided by B. Schulman. 
Tom1HECT (pPIL200) and Hul4HECT (pPIL201) were derived from genomic DNA by 
PCR using primers Tom1 Hect FW and Tom1 Rv and Hul4 Hect Fw and Hul4 Rv, 
respectively and cloned into BamH1 and Xho1 sites of pGEX-4T-3.  
Rsp5 was derived from pMIC81 and then cloned into Nde1 and EcoR1 sites of 
pET28a generating plasmid pPIL152 using primers Rsp5 Fw nde1 and Rsp5 Rv 
ecoR1.  
Rsp5HECT (pPIL157) was derived from pPIL152 by PCR amplification using primers 
Rsp5 L420 Nde1 Fw and Rsp5 Rv ecoR1. 
HARsp5HECT (pPIL214) was derived from pPIL157 and cloned into BamH1 and 
EcoR1 sites of pYES2 using primers HA-Rsp5 HECT Fw, that included the 
sequence encoding for hemagglutinin (TATCCATATGATGTTCCAGATTATGCT), 
and Rsp5 Rv ecoR1.  
HARsp5HECT C777A (pPIL218) was derived from pPIL214 by single nucleotide 
mutagenesis using Rsp5 c777a fw and its reverse complement, being the cysteine 
777 mutated to an alanine. pYES2 contains a URA3 marker gene. 
pRS425 empty (pBC238) was provided by Dr. J. Vilardell. 
Rpn10, together with the promoter of Rpn10 was derived from pRS424 and cloned 
into SacII site of pRS425 (which contains a LEU2 marker gene) resulting in 
pALI239.  
pRS425 Rpn10K84,268R (pPIL245) was derived from pRS425 Rpn10 (pALI239) by 
two rounds of single nucleotide mutagenesis using R10 K84R fw and R10 K268R 
fw and their respective reverse complements, being the lysines 84 and 268 
mutated to alanines. 
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UIM (pMJB1) corresponds to the UIM of Rnf114 from the amino acids 183 to 228 
and was provided by Dr. M. Biljmakers. 
 
Both DNA strands of cloned and mutated fragments in all plasmids described in this 
study were verified as correct by DNA sequence analysis using the 48-capillary 
ABI 3730 DNA Analyzer for capillary electrophoresis and fluorescent dye 
terminator detection. 
 
A list with the plasmids and primers used is included in the Appendix section.
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Rpn10 sequences 
 
Rpn10 WT 
         10         20         30         40         50 
MVLEATVLVI DNSEYSRNGD FPRTRFEAQI DSVEFIFQAK RNSNPENTVG  
        60         70         80         90        100 
LISGAGANPR VLSTFTAEFG KILAGLHDTQ IEGKLHMATA LQIAQLTLKH  
       110        120        130        140        150 
RQNKVQHQRI VAFVCSPISD SRDELIRLAK TLKKNNVAVD IINFGEIEQN  
       160        170        180        190        200 
TELLDEFIAA VNNPQEETSH LLTVTPGPRL LYENIASSPI ILEEGSSGMG  
       210        220        230        240        250 
AFGGSGGDSD ANGTFMDFGV DPSMDPELAM ALRLSMEEEQ QRQERLRQQQ  
       260      268 
 QQQDQPEQSE QPEQHQDK 
 
Rpn10195-268 sequence 
 195   
GSSGMGAFGGSGGDSDANGTFMDFGVDPSMDPELAMALRLSMEEEQ 
QRQERLRQQQQQDQPEQSEQPEQHQDK 
 
Rpn10208-268 sequence 
208   
DSDANGTFMDFGVDPSMDPELAMALRLSMEEEQQRQERLRQQQQQDQPEQSE 
QPEQHQDK 
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Rpn10211-268 sequence 
211   
ANGTFMDFGVDPSMDPELAMALRLSMEEEQQRQERLRQQQQQDQPEQSEQPEQHQ
DK 
 
Rpn10196-204A sequence 
 
        10         20         30         40         50 
MVLEATVLVI DNSEYSRNGD FPRTRFEAQI DSVEFIFQAK RNSNPENTVG  
        60         70         80         90        100 
LISGAGANPR VLSTFTAEFG KILAGLHDTQ IEGKLHMATA LQIAQLTLKH  
       110        120        130        140        150 
RQNKVQHQRI VAFVCSPISD SRDELIRLAK TLKKNNVAVD IINFGEIEQN  
       160        170        180        190        200 
TELLDEFIAA VNNPQEETSH LLTVTPGPRL LYENIASSPI ILEEGAAAAA  
       210        220        230        240        250 
AAAASGGDSD ANGTFMDFGV DPSMDPELAM ALRLSMEEEQ QRQERLRQQQ  
       260      268 
QQQDQPEQSE QPEQHQDK 
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Plasmids used in the present study 
 
Plasmid Details Reference 
pPIL106 GST-UbRpn10L85 (pGEX-4T-3) This study 
pPIL132 GST-PPAYRpn10 (pGEX-4T-3) This study 
pPIL133 GST-Rpn1040-268 (pGEX-4T-3) This study 
pPIL137 GST-Rpn10208-268 (pGEX-4T-3) This study 
pPIL141 GST-Rpn10195-268 (pGEX-4T-3) This study 
pPIL142 GST-PPAYRpn10195-268 (pGEX-4T-3) This study 
pPIL143 GST-Rpn10211-268 (pGEX-4T-3) This study 
pPIL144 GST-PPAYRpn10211-268 (pGEX-4T-3) This study 
pPIL152 6HIS- Rsp5 (pET28a) This study 
pPIL157 6HIS- Rsp5HECT (pET28a) This study 
pPIL161 GST-Rpn10195-268 K268R (pGEX-4T-3) This study 
pPIL162 GST-PPAYRpn10195-268 K268R (pGEX-4T-3) This study 
pPIL163 GST-Rpn10208-268 K268R (pGEX-4T-3) This study 
pPIL164 GST-PPAYRpn10208-267 K268R (pGEX-4T-3) This study 
pPIL165 GST-Rpn10211-268 K268R (pGEX-4T-3) This study 
pPIL166 GST-PPAYRpn10211-268 K268R (pGEX-4T-3) This study 
pPIL167 GST-Rpn10208-268 UIM (pGEX-4T-3) This study 
pPIL168 GST-PPAYRpn10208-268 UIM (pGEX-4T-3) This study 
pPIL169 GST-Rpn10UIM (pGEX-4T-3) This study 
pPIL171 GST-Rpn10195-268 UIM (pGEX-4T-3) This study 
pPIL172 GST-PPAYRpn10195-268 UIM (pGEX-4T-3) This study 
pPIL193 GST-S5a (pGEX2T(+)) Provided by F. Hanaoka 
pPIL194 GST- Rpn10196-204A (pGEX-4T-3) This study 
pPIL195 GST- Rpn10195-239 (pGEX-4T-3) This study 
pPIL200 GST- Tom1HECT (pGEX-4T-3) This study 
pPIL201 GST- Hul4HECT (pGEX-4T-3) This study 
pPIL202 GST- Nedd4 (pGEX) Provided by B. Schulman 
pPIL205 GST- Rpn10M199A-G203A (pGEX-4T-3) This study 
pPIL206 GST- Rpn10195-254 (pGEX-4T-3) This study 
pPIL207 GST- Rpn10195-261 (pGEX-4T-3) This study 
pPIL208 GST- S5a193-201A (pGEX-4T-3) This study 
pPIL209 GST- S5a M196A-G200A (pGEX-4T-3) This study 
pPIL210 GST- Rpn10196-204S (pGEX-4T-3) This study 
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pPIL211 GST- Rpn10 M199S-G203S (pGEX-4T-3) This study 
pPIL214 HARsp5HECT (pYES2) This study 
pPIL218 HARsp5HECT C777A (pYES2) This study 
pPIL220 GST- Rpn10DSD208-210Δ (pGEX-4T-3) This study 
pPIL222 Rpn10DSD208-210Δ (pRS424) This study 
pPIL225 Rpn10196-204A (pRS424) This study 
pBC238 pRS425 Provided by J. Vilardell 
pALI239 Rpn10 (pRS425) This study 
pPIL245 Rpn10K84,268R (pRS425) This study 
pMIC26 GST- Rpn10 (pGEX-4T-3) Crosas et al, 2006 
pMIC81 Rsp5 (pGEX) Provided by J. Huibregtse 
and S. Polo 
pMIC93 Rpn10 (pRS424) Provided by H. Fu 
pMBJ1 GST-UIM (pGEX-5X-2) Capon et al, 2008 
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Oligonucleotide primers used in the present study 
 
Only forward sequences of mutagenic primers are shown. 
 
Name Sequence 
R10L85 Fw CGTACGGTACCCTGCATATGGCCACT
GCGTTGCAGATCG R10L85 Rev CGGTAGAATTCCTATTTGTCTTGGTGT
TGT TCA GGC TGT TCAG UbR10L85 Fw TAAGACTAAGAGGTGGTGGAGGTGG
CC TGC ATA TGG CCA CTG C R10M1PPAY fw GACTGAATTCCCCTCCTGCATACATG
GTATTGGAAGCTACAGTGTTAGT
G 
 
 
R10K40 Fw GACTGAATTCCAAGAGAAACAGCAATCCTGAGAATACAG 
R10D208 Fw GACTGAATTCCTGGGATTCCGATGCCAATGGCACATTTATG 
R10K268 Rev CGGTAGTCGACCTATCTGTCTTGGTGTTGTTC 
R10 G195 fw GACTGAATTCCTGGGGATCCTCCGGTATGGGCGCCTTTGGT 
R10 A211 fw GACTGAATTCCTGGGCCAATGGCACATTTATGGACTTCGG 
R10G195ppay fw GACTGAATTCCTGGCCTCCTGCATACGGATCCTCCGGTATGG
GCG 
 
R10D208ppay Fw GACTGAATTCCTGGCCTCCTGCATACGATTCCGATGCCAATGG
CACATTTATG R10A211ppay fw GACTGAATTCCTGGCCTCCTGCATACGCCAATGGCACATTTAT
GGACT 
 
R10 uim Fw CATCAATGGACCCAGAAAACAACAACAACAACCGTCTGTCTAT
GGAAG R10k268r fw 
(pRS424) 
CAACACCAAGACAGATAGGTCGACTCGAGCGGC 
R10 link Ala fw CATAATTCTCGAAGAAGGAGCAGCAGCAGCAGCAGCAGCAGC
AGCATCTGGCGGTGATTCCGATG 
R10G195E239+K 
fw 
CTGTCTATGGAAGAAGAGAAATAAAGACAGGAAAGGTTAAG 
R10 MG Ala fw GAAGAAGGATCCTCCGGTGCGGGCGCCTTTGCTGGGTCTGG
CGGTGATTC  
R10G195D254+K -
Fw 
GCAGCAACAACAACAAGATAAATAAGAGCAGTCTGAACAGCCT
GAAC 
R10G195Q261+K 
Fw 
CAGCCTGAGCAGTCTGAACAGAAATAACAACACCAAGACAAAT
AG 
R10 link Ser fw GAAGAAGGATCCTCCTCTTCGTCCTCCTCTTCTTCGTCTGGCG
GTGATTC R10 mg Ser fw GAAGGATCCTCCGGTTCGGGCGCCTTTTCTGGGTCTGGCGGT
G R10G195Δ208-210 
Fw 
CTTTGGTGGGTCTGGCGGTGCCAATGGCACATTTATGGAC 
S5a link Ala fw CGATTTTGGCTGGTGAAGCTGCTGCCGCGGCGGCTGCTGCTG
CCAGTGACTTTGAATTTG 
S5a mg Ala fw GTGAAGGTGGTGCCGCGCTGGGTCTTGCTGCCAGTGACTTTG 
Ubp2-Kan Fw GTGGTAATTAAAAAGAAAGCTTTTGTTCAAGGTTAAGAAGGTAT
AAGGAAGACATGGAGGCCCAGAATACCCTCC 
Kan-Ubp2 Rv GGTACTTATGGCAATAGTGACATTTTACATAAACTCTTCATTGA
CTAAGACAGTATAGCGACCAGCATTCACATACG 
Rsp5 Rv-ecoR1 CGGTAGAATTCTCATTCTTGACCAAACCCTATGG 
Rsp5 Fw nde1 TACGTACGCATATGCCTTCATCCATATCCGTCAAG 
Rsp5 L420 -Nde1 
Fw 
TACGTACGCATATGCTTCCATCATCGCTAGACC 
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HA-Rsp5HECT Fw CGAGGGATCCATGTATCCATATGATGTTCCAGATTATGCTCTTC
CATCATCGCTAGACC 
Rsp5 c777a fw GCCAAAATCTCACACAGCTTTTAACAGAGTTGATTTG 
Tom1 Hect FW CGT ACGGATCCATGAGTGGTCCTTTCGCATTATTG 
Tom1 Rv CGG TAC TCG AGT CAG GCA AGA CCA AAC CCT TCA TGC 
Hul4 Hect Fw CGTACGGATCCATGGAACATGAAGCTGAACAGGC 
Hul4 Rv CGGTACTCGAGTTAGCGGAACCCGTAACCTTCAG 
HA-Tom1 HECT 
Fw (pYES) 
CGAGAAGCTTATGTATCCATATGATGTTCCAGATTATGCTAGTG
GTCCTTTCGCATTATTG 
Tom1 Rv (Xba) CGGTATCTAGATCAGGCAAGACCAAACCCTTCATGC 
HA-Hul HECT 
Fw hindiii 
(pYES) 
CGAGAAGCTTATGTATCCATATGATGTTCCAGATTATGCTGAAC
ATGAAGCTGAACAGGC 
Hul4HECT Rv CGGTATCTAGATCATTAGCGGAACCCGTAACCTTCAG 
R10 K268R fw 
(pRS425) 
AGCCTGAACAACACCAAGACAAATAGTAGTGTACAAAAATATCT
ATATGGGTCAT 
R10 K84R fw  
(pRS425) 
CGCAGATCGAGGGTAGGCTGCATATGGCCAC 
 
 
  
  
 
